Mar 31, 2023
Your Directors present this Fortieth Annual Report of your Company ("the Company" or "Aarti Industries Limited") together with the Audited Financial Statements of the Company for the Financial Year ended March 31, 2023.
1. Financial Highlights & Summary Financial Highlights
('' In Crs) |
||||
Particulars |
Standalone |
Consolidated |
||
2022-23 |
2021-22 |
2022-23 |
2021-22 |
|
Total Income from Operations (Gross) |
7,226 |
6,820 |
7,283 |
6,871 |
EBITDA |
1,088 |
1,711 |
1,089 |
1,720 |
Depreciation & Amortisation |
310 |
244 |
310 |
246 |
Profit from Operations before Other Income, Finance Costs and Exceptional Items |
778 |
1,467 |
779 |
1,474 |
Other Income |
0 |
1 |
1 |
1 |
Profit before Finance Costs |
778 |
1,468 |
780 |
1,475 |
Finance Costs |
166 |
102 |
168 |
102 |
Profit before Tax |
613 |
1,366 |
611 |
1,372 |
Total Tax Expenses |
67 |
184 |
66 |
186 |
Non-controlling Interest |
- - |
- - |
||
Net Profit for the period |
546 |
1,182 |
545 |
1186 |
Other Comprehensive Income (net of taxes) |
(35) |
18 |
(50) |
15 |
Total Comprehensive income for the year |
511 |
1,200 |
495 |
1,201 |
Earnings Per Share (?) (Basic & Diluted) |
15.06 |
32.61 |
15.04 |
32.71 |
Book Value Per Share (?) |
136 |
124 |
136 |
125 |
Your Company reported Gross Total Income at ? 7,226 Crores for FY 2022-23 as against ? 6,820 Crores for FY 2021-22. Similarly, the exports for the year were at ? 3,517 Crores for FY 2022-23 as against ? 2,950 Crores for FY 2021-22.
Likewise, the Consolidated Total income from operations for FY 2022-23 was at ? 7,283 Crores as compared to ? 6,871 Crores for FY 2021- 22 and exports for FY 2022-23 was ? 3,573 Crores v/s ''3,007 Crores for FY 2021-22.
Consolidated Financial Statements
In accordance with the provisions of Companies Act, 2013, Regulation 33 of the Listing Regulations,
and applicable Accounting Standards, the Audited Consolidated Financial Statements of the Company for the FY 2022-23, together with the Auditors'' Report, form part of this Annual Report.
Your Company has transferred ''55 Crores to the General Reserve (Previous Year: '' 129 Crores).
As on March 31, 2023, the Company has 6 (Six) direct subsidiaries, namely, Aarti Corporate Services Limited, Innovative Envirocare Jhagadia Limited, Aarti Polychem Private Limited, Aarti Bharuch Limited, Aarti Spechem Limited and Alchemie (Europe) Limited, and 2 (Two) indirect subsidiaries namely Shanti Intermediates Private
Limited and Nascent Chemical Industries Limited both hold through Aarti Corporate Services Limited.
During the year, the Hon''ble National Company Law Tribunal (NCLT), Ahmedabad Bench vide its order dated September21,2022approved the Scheme of Arrangement ("Scheme") between Aarti Industries Limited and Aarti Pharmalabs Limited and their respective shareholders under the provisions of Section 230-232 of Companies Act, 2013. Pursuant to the Scheme, Aarti Pharmachem Limited and Aarti USA Inc. ceased to be subsidiaries of your Company.
Further, the Ministry of Corporate Affairs has approved incorporation of Wholly Owned Subsidiary (WOS) of your Company, Augene Chemical Private Limited, bearing CIN:U20299GJ2023PTC141303 on May 18, 2023. The Registered Office of the Company is situated at Gujarat.
The Company does not have any material subsidiary whose net worth exceeds 10% of the consolidated
net worth of the Company in the immediately preceding accounting year or has generated 10% of the consolidated income of the Company during the previous Financial Year. A policy on material subsidiaries had been formulated and is available on the website of the Company and the web link thereto is:
https://www.aarti-industries.com/investors/ GetReport?strcont id=A8DuSuG1AT8OIQL33MM
During the year, the Board of Directors reviewed the affairs of the subsidiaries. In accordance with Section 129(3) of the Companies Act, 2013, we have prepared consolidated financial statements of the Company and all its subsidiaries, which form part of the Annual Report.
Further a statement containing salient features of the financial statement of our Subsidiaries/Jointly controlled entity in the prescribed format AOC-1 is included in the Report as Annexure-A and forms an integral part of this Report.
4. Share Capital
Your Company''s Equity Share Capital as on March 31, 2023 was as follows:
Particulars |
No. of Shares |
Face Value Per Share (in '') |
Total Amount (in '') |
Authorized Share Capital |
60,00,00,000 |
5 |
3,00,00,00,000 |
Issued, Subscribed & Paid-up Share Capital |
36,25,04,035 |
5 |
1,81,25,20,175 |
During the year 2022-23, there was no change in the authorized and paid up share capital of the Company.
The State of your Company''s affairs is given in the Management Discussion and Analysis, which forms part of this Annual Report.
6. Directors and Key Managerial Personnel (KMP)
I n accordance with the prevailing provisions of the Section 149 of the Companies Act, 2013 read with Regulation 17 of the Listing Regulations, as amended from time to time, as on March 31, 2023, the Board of Directors, comprises Sixteen Directors (with Six Executive Directors, Two Non-Executive NonIndependent and Eight Independent Directors).
At the 39th AGM held on September 26, 2022, Shri Rajendra V. Gogri (DIN: 00061003) was re-appointed
as the Managing Director of the Company for a period of five years w.e.f. July 1, 2023.
During the year, Smt. Hetal Gogri Gala (DIN: 00005499) had conveyed her intention to step down as an Executive Director since she had taken up executive role as ''Vice Chairperson and Managing Director of ''Aarti Pharmalabs Limited'' effective from October 17, 2022, however, she continues to be a ''Non-Executive Director'' of the Company.
Shri Narendra Jagannath Salvi (DIN: 00299202) had conveyed his intention to step down as an Executive Director since he had taken up executive role as the ''Managing Director'' of ''Aarti Pharmalabs Limited'' effective from October 17, 2022, however, he continues to be a ''Non-Executive Director'' of the Company.
In accordance with the regulatory requirements Shri Narendra J. Salvi retires by rotation in ensuing 40th Annual General Meeting. However, vide his letter dated June 21, 2023, he conveyed his intention to retire and requested the Board not to consider his re-appointment stating the reason ''Preoccupation''. The Board of Directors in its meeting held on June 28, 2023, took it on record and considered as ''not to fill up'' the vacancy thereby caused.
I n accordance with the regulatory requirements Shri Kirit R. Mehta (DIN: 00051703) also retires by rotation in the ensuing 40th Annual General Meeting. However vide letter dated June 21,2023 he conveyed his intention to retire due to health related reasons and requested the Board not to consider his re-appointment. The Board of Directors in its meeting held on June 28, 2023, took it on record and considered to ''fill up'' the vacancy thereby caused.
Pursuant to Regulation 36 of the Listing Regulations read with Secretarial Standard-2 on General Meetings, a brief profile of the Directors proposed to be appointed /re-appointed is made available, as an Annexure to the Notice of the Annual General Meeting.
Further, based on recommendation of Nomination and Remuneration Committee, the Board of Directors in its meeting held on June 28, 2023, appointed Prof. Aniruddha B. Pandit (DIN: 02471158) and Shri Shekhar S. Khanolkar (DIN: 02202839) as Additional Directors in the category of Independent Directors and Shri Ajay Kumar Gupta (DIN: 08619902) as Additional Director in the category of Executive Director, all with effect from June 29, 2023. Their appointments are subject to approval of the Members at the ensuing AGM of the Company. The brief resume regarding their appointment is given in the Notice.
Pursuant to the provisions of Regulation 34(3) read with Schedule V to the Listing Regulations, the Company has obtained a Certificate from CS Sunil M. Dedhia (COP No. 2031), of Sunil M. Dedhia & Co. Company Secretary in Practice and the Secretarial Auditor of the Company, certifying that none of the Directors of the Company have been debarred or disqualified from being appointed or continuing as Directors of companies by the Securities and Exchange Board of India or by the Ministry of Corporate Affairs or by any
such statutory authority. The said Certificate is annexed to the Corporate Governance Report of the Company for the Financial Year 2022-23.
During the year under review, there was no change in the Key Managerial Personnel of the Company.
Independent DirectorsStatement on declaration given by Independent Directors under sub-section (6) of section 149
In accordance with Section 149(7) of the Companies Act, 2013, all Independent Directors have given declarations that they meet the criteria of independence as laid down under Section 149(6) of the Companies Act, 2013 and Regulation 16 of the Listing Regulations.
In the opinion of the Board of Directors, the Independent Directors fulfil the conditions specified in the Companies Act, 2013 read with the rules made thereunder as well as Listing Regulations and are independent from Management, hold the highest degree of integrity and possess expertise in their respective fields with enormous experience.
All the Independent Directors have complied with the Code for Independent Directors prescribed in Schedule IV to the Companies Act, 2013.
All the Independent Directors of the Company have enrolled their names in the ''Independent Directors Data Bank'' maintained by Indian Institute of Corporate Affairs ("IICA").
Familiarisation Programme for Independent Directors
The Company has a Familiarisation programme for its Independent Director which is imparted at the time of appointment of an Independent Director on Board as well as annually. During the year, the Independent Directors of the Company were familiarised and the details of familiarisation programmes imparted to them are placed on the website of the Company and the web link thereto is: https://www.aarti-industries. com/Upload/PDF/Familiarisation-Programme-FY-2022-23.pdf
7. Directors'' Responsibility Statement
To the best of their knowledge and belief and according to the information and explanations obtained by them, your Directors make the following statements in terms of Section 134(3)(c) of the Companies Act, 2013:
a. That in the preparation of the annual financial statements for the year ended March 31, 2023, the applicable accounting standards have been followed along with proper explanation relating to material departures, if any;
b. That the Directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the company at the end of the Financial Year and of the profit and loss of the company for that period;
c. That the Directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the Assets of the Company and for preventing and detecting fraud and other irregularities;
d. That Directors have prepared the annual accounts on a going concern basis;
e. The Directors had laid down internal financial controls to be followed by the Company and that such internal financial controls are adequate and were operating effectively;
f. The Directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.
The Board of Directors met eight (8) times during the Financial Year under review. The details of the number of meetings of the Board and its Committees held during the Financial Year 2022-23 and the attendance of each Director/Member at these meetings are provided in the Corporate Governance Report forming part of the Annual Report. The intervening gap between the Board meetings was within the period prescribed under the Companies Act, 2013 and the Listing Regulations.
During the year, the Company has declared an Interim Dividend of ''1/- (@ 20%) each per share.
Your Board of Directors recommend a Final Dividend of ''1.50 (@ 30%) per share subject to approval of the Shareholders at the ensuing 40th AGM, aggregating to a total Dividend of '' 2.50 (@ 50%) per share (of '' 5 each) for the financial year 2022-23, resulting in a total payout '' 90.63 Crores (Previous Year: '' 126.88 Crores).
The Dividend payout is in accordance with the Dividend Distribution Policy which is available on the website of the Company.
As per Regulation 43A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), the top 1000 listed companies shall formulate a Dividend Distribution Policy. Accordingly, the policy was adopted to set out the parameters and circumstances that will be taken into account by the Board in determining the distribution of dividend to its shareholders and/or retaining profits earned by the company. A policy is available on the website of the Company and the web link thereto is: https://www.aarti-industries.com/investors/ GetReport?strcont id=b22bcY6v1CAOIQL33MM
10. Corporate Social Responsibility
Your Company through, Aarti Foundation and Dhanvallabh Charitable Trust - Our CSR arms undertake community interventions to enhance the lives of the communities. Besides our direct involvement, we partner with numerous implementing agencies to carry out need assessment and make impactful interventions. Our Focus areas during the year has been;
⢠Education & Skill Development
⢠Childcare & Healthcare Facilities
⢠Women Empowerment & Livelihood Opportunities
⢠Cluster & Rural Development
⢠Disaster Relief & Rehabilitation
⢠Eradication of Hunger & Poverty
⢠Water Conservation & Environment
⢠Research & Development work for upliftment of Society
The detailed policy on Corporate Social Responsibility is available on the website of the Company on the web link thereto is:
https://www.aarti-industries.com/investors/ GetReport?strcont id=rOxVNykXxlkOIOL33MM
A brief note on various CSR initiatives undertaken during the year including the composition of the CSR Committee is presented in this Annual report. The CSR annual report is annexed as Annexure-B and forms an integral part of the Report.
The details of the composition of the Audit Committee, terms of reference, meetings held, etc. are provided in the Corporate Governance Report, which forms part of this Report. During the year there were no cases where the Board had not accepted any recommendation of the Audit Committee.
12. Vigil Mechanism/Whistle Blower Policy
The Company has established a Vigil Mechanism and Whistle Blower Policy for its Directors and Employees to report concerns about unethical behaviour, actual or suspected fraud, actual or suspected leak of UPSI or violation of Company''s Code of Conduct. It also provides for adequate safeguards against the victimisation of employees and allows direct access to the chairperson of the audit committee in exceptional cases The said policy has been posted on the website of the Company and the web link thereto is:
https://www.aarti-industries.com/investors/ GetReport?strcont id=ZMPluse33MMnrACtosYOIOL33MM
The Company affirms that no person has been denied access to the Audit Committee Chairman.
13. Related Party Transactions
The Company has a Policy on Materiality of Related Party Transaction and dealing with Related Party Transaction which is uploaded on the Company''s website at the web- link given below:
https://www.aarti-industries.com/investors/ GetReport?strcont id=TNJu6Gnbr7sOIQL33MM
All related party transactions that were entered into during the FY 2022-23 were on arm''s length basis and were carried out in the ordinary course of the business.
There are no materially significant related party transactions made by the Company with Promoters, Key Managerial Personnel or other Designated Persons which may have potential conflict with interest of the Company at large.
The related party transactions are approved by the Audit Committee. Omnibus approval is obtained for the transactions which are foreseen and repetitive in nature. A statement of related party transactions is presented before the Audit Committee on a quarterly basis, specifying the nature, value and terms and conditions of transactions. A report of factual findings arising out of the accepted procedures carried out in regard to transactions with Related Parties is given by the Statutory Auditors on quarterly basis and the same is placed before the Audit Committee.
The details of related party transactions are provided in the accompanying financial statements.
Particulars of contracts or arrangements made with related parties
Since all related party transactions entered into by the Company were in ordinary course of business and were on an arm''s length''s basis, Form AOC-2 is not applicable to Company.
Your Company continues to manage its treasury operations efficiently and has been able to borrow funds for its operations at competitive rates. During the Financial Year, your Company had dual rating for its Commercial Papers (CPs) Programme of '' 400 Crores, which are revalidated from time to time:
Rating Agency |
CRISIL Rating |
India Ratings and |
Limited |
Research Private |
|
Limited |
||
Rating |
CRISIL A1 |
IND A1 |
During the Financial Year, the Company has issued CPs amounting to ''875 Crores in various tranches, out of which CPs amounting to ''475 Crores were listed on BSE Limited. Further, CPs amounting to ''800 Crores were redeemed during the Financial Year and the Company has not defaulted on payment of any dues to the Investors.
Your Company has not accepted any deposits covered under Chapter V of the Companies Act, 2013 [(i.e., deposits within the meaning of Rule 2(1)(c) of the Companies (Acceptance of Deposits) Rules, 2014)], during the Financial Year 2022-23.
16. Particulars of Loans, Guarantees, Investments and Securities
Particulars of loans given, investments made, guarantees given and securities provided during the year under review and as covered under the provisions of Section 186 of the Companies Act, 2013 have been disclosed in the notes to the standalone financial statements forming part of the Annual Report.
The statement containing particulars of employees as required under Section 197(12) of the Companies Act, 2013 read with Rule 5(2) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 is given in an Annexure and forms part of this report.
I n terms of Section 136(1) of the Companies Act, 2013, the Report and the Accounts are being sent to the Members excluding the aforesaid Annexure. Any Member interested in obtaining a copy of the Annexure may write to the Company Secretary at the Registered Office of the Company for a copy of it.
Material Developments in Human Resources/ Industrial Relations Front, including number of people Employed
Employees being our key stakeholders, the HR initiatives and policies revolve around garnering the opportunities to serve our employees better. In an attempt to devise a seamless succession planning process through VTS (Vertical Talent Strategy), we developed VTS for 23 Verticals, identifying high-potential employees and successors for critical roles. Our Talent Management team worked along with the verticals to create action plans for building a talent growth pipeline. Moving ahead in our journey of being a ''Preferred employer of Choice'', we received 100% participation in Voice 3.0-our employee engagement survey. Following the
excellent execution of Vertical Action Plans, Voice 3.0 also saw positive scores in many areas of employee engagement. The phenomenal scores in Voice 3.0 are also accredited to Metamorphosis sessions. These sessions have empowered employees by fostering a belief in long-term goals, belongingness, and leadership among executives and thus driving engagement.
In FY 23 we onboarded 1921 bright minds. Towards our strategy to groom internal talent and ensure career growth opportunities for them, we drove internal growth from 23% to 44% in FY 22-23 through Navodaya and Talent Spotting and we target 70% growth in FY 23-24. A state-of-the-art infrastructure has been developed in Mumbai and Vadodara to ensure employee comfort.
To further upskill and train employees in different areas of effectiveness, a robust training calendar and upskilling programs have been implemented (Eklavya, Kshitij, Utkarsh, Nipun, New FTM, GTD, NICMAR, ME, SKV, etc.). We have also developed a long-term incentive plan (PSOP) for employees
18. Aarti Industries Limited Performance Stock Option Plan 2022
Aarti Industries Limited Performance Stock Option Plan 2022 ("PSOP 2022") was approved by the shareholders through Postal Ballot on October 29, 2022, under which stock options would be granted to the eligible employees, in compliance with the provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Further, pursuant to the PSOP 2022, the Company has granted 80,142 options to eligible employees as per the recommendation of the Nomination and Remuneration Committee, at its meeting held on May 6, 2023.
Your Company has received a certificate from CS Sunil M. Dedhia (COP No. 2031), of Sunil M. Dedhia & Co. Company Secretary in Practice and the Secretarial Auditor of the Company that PSOP 2022 has been implemented in accordance with the provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 and the resolution passed by the shareholders. Any request for inspection of the said Certificate may please be sent to investorrelations@ aarti-industries.com
19. Material changes and commitment if any affecting the financial position of the company occurred between the end of the Financial Year to which this financial statements relate and the date of the report
There are no other material changes and commitments affecting the financial position of the Company occurred between the end of the Financial Year to which these financial statements relate and the date of the report.
20. Investor Education and Protection Fund (IEPF)
Pursuant to the applicable provisions of the Companies Act, 2013 read with IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 (''the Rules'') all unpaid or unclaimed dividends are required to be transferred by the Company to the IEPF established by the Government of India, after the completion of seven years. Further, according to the rules, the shares on which Dividend has not been paid and claimed by the Shareholders for seven consecutive years or more shall be transferred to the Demat account of the IEPF Authority. Accordingly, the Company has transferred the unclaimed and unpaid dividends of ''46,80,672/-. Further, 48,654 corresponding shares were transferred as per the requirement of the IEPF Rules.
21. Annual Return
Pursuant to Section 92(3) read with Section 134(3)(a) of the Companies Act, 2013, the Annual Return as on March 31,2023 is available in prescribed format on the Company''s website on www.aarti-industries.com
22. Corporate Governance
Corporate Governance essentially involves balancing the interests of a Company''s stakeholders. The Company continues to nurture a culture of good governance practices across functions, offices and manufacturing facilities.
Your Company has complied with the mandatory Corporate Governance requirements stipulated under the Listing Regulations. The separate Report on Corporate Governance is annexed hereto forming part of this report. The requisite certificate from Gokhale & Sathe, Chartered Accountants is attached to the Report on Corporate Governance.
23. Management''s Discussion and Analysis Report
Pursuant to Regulation 34 read with Schedule V to the Listing Regulations, Management''s Discussion and Analysis for the year under review is presented in a separate section forming part of the Annual Report.
24. Business Responsibility & Sustainability Reporting (BRSR)
The Listing Regulations mandate the inclusion of the Business Responsibility & Sustainability Reporting as part of the Annual Report for top 1000 listed entities based on market capitalisation. BRSR for the year under review, as stipulated under Regulation 34 (f) of Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/ CMD-2/P/CIR/2021/562 dated May 10, 2021 is in a separate section forming part of the Annual Report. The non-financial sustainability disclosures have been independently assured by TUV Nord.
25. Annual Board Evaluation
Pursuant to the provisions of Companies Act, 2013 and the Listing Regulations, a structured questionnaire was prepared after taking into consideration various aspects of the Board''s functioning, composition of the Board and its Committees, culture, execution and performance of specific duties, obligations and governance.
The performance of the Committees and Independent Directors were evaluated by the entire Board of Directors except for the Director being evaluated. The performance evaluation of the Chairman, NonIndependent Directors and Board as a whole was carried out by the Independent Directors. The Board of Directors expressed their satisfaction with the outcome of evaluation and the process followed thereof.
26. Nomination and Remuneration Policy
Pursuant to Section 178 of the Companies Act, 2013 and Regulation 19 of the Listing Regulations, your Company has in place a Nomination and Remuneration Policy which lays down a framework in relation to remuneration of Directors, Key Managerial Personnel and Senior Management of the Company. The policy also lays down criteria for selection and appointment of Board Members. The said policy has been posted on the website of the Company and the web link thereto is: https://www.aarti-industries.com/investors/ GetReport?strcont id=pTvbr0JryL0OIQL33MM
The details of this policy are given in the Corporate Governance Report.
Your Company recognises that risk is an integral and unavoidable component of business and is committed to managing the risk in a proactive and effective manner. The Company aims to use risk management to take better informed decisions and improve the probability of achieving its strategic and operational objectives.
In compliance with Regulation 21 of Listing Regulations, your Company has a Risk Management Committee consisting of Shri Rajendra Gogri (Chairman), Shri Rashesh Gogri, Shri Bhavesh R. Vora, Smt. Hetal Gogri Gala, Shri Renil Gogri, Shri Narendra J. Salvi, Shri Chetan Gandhi and Shri Ajaykumar Gupta. The Committee through its risk management framework continuously identifies, evaluates and takes appropriate measures to mitigate/ minimise various elements of risks. The Risk Management Committee meets periodically to ensure that appropriate methodologies, processes and systems are in place to monitor and evaluate risks associated with the business of the Company and also to monitor and oversee the implementation of the Risk Management Policy.
The said policy has been posted on the website of the Company and the web link thereto is: https://www.aarti-industries.com/investors/ GetReport?strcont id=dCIEPn8aX6wOIQL33MM
28. Compliance Management System
The Company with its sheer focus committed to achieve 100% compliance. We have adopted a third-party managed IT-based Compliance Management System. It has a repository of all applicable regulations and requisite compliances. It has an in-built alert system that sends alerts to the users and intimates concerned personnel about upcoming compliances. Last year, we added a module on ''License Management'' into our compliance management system. Newly added licence management system helps us in tracking the validity and renewal process of all applicable licences. We initiate the licence renewal process well in advance to avoid any delays.
Sustainability & Safety is very important for Chemical Industry in general and very critical for Aarti Industries in particular, that is the reason our strategic statement
is ''Sustainability for Sustainable Growth''. We at Aarti Industries Limited (AIL), are committed to maintain the world-class standards of health, safety, environment protection, security, human rights, product safety & quality and processes while conducting all our business operations, services, and expansion activities.
We believe that Safety is not one person''s job but it is for all the employees of the company from operators to Directors. In the Chemical Industry the most important thing for safety is the ''Operational Discipline''.
To enable the Best Safety culture, AIL has created an unique concept of Aarti Engaging Leaders, committed to live by Aarti Values of Care, Integrity and Excellence and enabling everyone to listen and speak powerfully.
Health and Safety at AIL has been enhanced through following interventions:
⢠Several Process Initiative Common (PICs) with specific objectives to enhance safety and sustainability across the organisation
⢠Robust Management governance through Apex sustainability council and sub councils for ensuring progress in various domains of sustainability
⢠Safety audit framework
⢠Dedicated Process safety teams from R&D (Molecule development) to pilot to operation and at corporate level.
⢠Aarti Logistics ControlCenter for ensuring Safe transport of chemicals.
⢠To ensure consistent high performance of the people, a competency enhancement framework is established.
⢠Proactive compliance to legal and statutory requirement through digitised platform and
⢠Trained and competent Fire and Emergency responders team.
We have unique initiatives like Daily BESAFE Huddles, Monthly LFI sessions for 360 degree action
implementation from external incident and internal experiences, Tacit knowledge sessions, Subject matter experts platform, Medical board of FMOs, knowledge capsules, Listening tours to interact with plant shop floor team.
We have established world class infrastructure in terms of High tech OHCs & Emergency Control Centers (ECCs) at each factory, State of art Fire Tenders and ambulances at each location, Digital platform for HSE indicators governance and management.
Our efforts in every dimension of Sustainability have yielded success in terms of improved scores in TfS (Together for Sustainability) assessment at various divisions. All our divisions have achieved IMS (Integrated Management Systems) certifications i.e. ISO9001, ISO 14001 & ISO45001.
During FY-2022-23, we initiated a Safety perception survey called "Aarti Suraksha Survey", the response to the Aarti Suraksha Survey was overwhelming. The Survey Participation was more than 9000 people including contractors and other business partners. The result from the Safety perception survey was very encouraging.
We have established a dedicated Process Safety team at our corporate and manufacturing locations, and have also set up a world-class infrastructure and research facility - Aarti Research and Technology Center. We have strengthened the Hazards & Operability study procedure by introducing different guidewords. The concept of TACIT Knowledge for learning and development is introduced which enables Process safety capability building.
To have high vigilance on plant operations and processes, process Engineers monitor daily process parameters. We maintain high safety standards for Chlorine Handling System across AIL through on the job training, mock drills. We have a robust Hazard Identification and Risk Assessment procedure (HIRA) in place, which is done for each individual activity/step involved in Standard Operating Procedures (SOPs). To ensure inherent safe design and operation, we conduct process safety studies for existing and new projects, including Thermal Safety Studies (DSC, TSu, RC1e)
and Powder Safety studies. To ensure continual Risk reduction, process parameters validation, Criticality Class Study, SIL, QRA, and HAC studies are conducted.
As a responsible organisation, we are committed to protect and prevent the environmental Damages. Efficient usage of water is of high priority to us, making it a high material topic for us and our delighted stakeholders. AIL has published and implemented comprehensive guidelines for the Waste management and Environmental Management system. A considerable number of Environmental Projects have been Successfully implemented, and we are beginning to see the benefits, such as effluent reduction, waste reduction, waste conversion into valuable products , Cost Reduction, CO2 Emission Reduction and space available for new effluent which will be generated from new expansion/products.
AIL has been recognized and acknowledged by various organisation by prestigious awards as ICC award for Excellence in Management of Environment, Golden Peacock Award for Environment Management, Platinum Award of 12th Exceed Environment Awards in the Category of Environment Preservation in Chemical & Fertilisers sector, Envirocare Green Award, CII National Award for Environmental Best Practices-"Waste and Resource Conservation" & Environment Friendly Company of the year by FICCI etc.
Environment - Water Management
Towards reducing our water footprint, we are focussing on 3R (Reduce, Reuse & Recycle) and strategizing to achieve zero-liquid discharge (ZLD) for our facilities. During FY 2022-23, AIL has taken various initiatives for Water conservation by introduction of water harvesting system, increased steam condensate recovery, increased MEE condensate recovery, STP treated water recycling and RO permeate recycling etc. Currently, 10 nos of our manufacturing sites have ZLD facilities. About 85% effluent quantity is being recycled back into process and 15% treated effluent quantity is being sent to CETP for further treatment and sent to deep sea. As part of water conservation , AIL has recycled steam condensate about 50% in the Boiler. Overall water withdrawal reduced about 40% due to ZLD units , steam condensate recycling in Boilers, Water Harvesting initiatives,STP treated water recycling etc. Further we have planned to achieve 100% ZLD ready status within the next 2 years. We have adopted a proactive approach for ZLD and incorporated it in the conceptualisation & designing phase of new projects.
AIL has provided adequate Air pollution control measures to control process and flue gas emissions like wet scrubbers, Dust collectors, Bag filters ESP etc. AIL has implemented a dry scrubber concept (lime dosing along with solid fuel) to control SO2 emissions significantly. All have implemented LDAR programs to detect and control fugitive emissions, vocs etc. AIL has provided online sensors for Hazardous gases. We have provided an effective emission monitoring and selection of continuous on-line stack monitors and Ambient Air Quality Monitoring system (AAQMS). AIL water and emission online monitoring parameters (OCEMS) has been connected to CPCB and GPCB portal.
Environment - Waste Management
Our waste management approach is systematically divided into three priorities depending upon the various operating conditions and type of waste generated. First priority is to produce less waste, second priority is 4Rs (Reuse, Recover, Recycle, Reprocess), third priority is treatment and disposal. AIL being a responsible organisation ensures utilisation of the hazardous waste in a safe and environmentally sound manner and with comprehensive legal compliance by conducting audits of the vendors responsible for reusing processing and disposal of waste. During FY 2022-23, We have Improved Hazardous waste management by taking many initiatives like Waste management guideline were implemented, introduction of compressive checklist for all HW vehicles, all the HW vehicles are connected to ALC and monitoring for 24 hrs *7 days, introduction of end users audits and approvals system, completed Rule 9 trials runs and obtained CPCB SOP for HCL conversion into CaCl2. AIL has started value added initiatives i.e Landfilling and Incinerable waste sending to cement industries for co-processing .
Aarti industries has integrated sustainability into its business strategy through its 4 strategic dimensions: Sustainability, People Well being, Partner delight
and Prosperity. Every dimension has its goals and objectives. These are accomplished through a well devised implementation strategy of Aarti Management System. The Goals and objectives are reviewed in well established councils which are chaired by the CEO.
The following accomplishments endorse our progress in the sustainability journey.
Our robust performance on EH&S has led to our success in getting a Responsible Care (RC) logo. RC is a global chemical manufacturing industry''s environmental, health, safety and security performance initiative. RC logo is not only an endorsement of our exemplary EH&S practices but also it shall help us in improving our environmental, health, safety and security (EHS&S) performance for facilities, processes and products throughout the entire operating system through its guiding principles.
While we care for our employees, ''Care'' towards the surrounding community is also a prime focus at AIL. Various initiatives such as Tanker Drivers'' health and eye checkups, community education program for Fire fighting and emergency preparedness, Infrastructure development for schools, scholarship and grants to needy students for their higher education, mobile dental vans, rural infrastructure development etc. have yielded significant benefits to the community.
Our significant efforts in improving our ESG performance has led to achieving a gold medal in EcoVadis CSR assessment, placing AIL among the top 5 percentile of companies assessed by EcoVadis.
AIL has received Management band "B" for the second consecutive year in CDP Climate Change, indicating coordinated actions on climate issues by AIL. The B rating is higher than the world average for the chemical sector.
AIL has also received "A-" on CDP Supplier Engagement, in the leadership band. Our rating has improved from
B- in 2021 to A-, this indicates implementation of best practice by AIL during supplier engagement.
Sustainalytic has improved ESG risk rating of Aarti industries for Year 2022. Aarti industries has been rated medium risk for 2022 with the ESG risk score of 24.5 (Lower rating demonstrates lower risk). Our risk rating has been improved compared to 2021 where AIL was rated High risk with the ESG risk score of 35.3.
We have initiated an Operational Excellence journey with focus to improve reliability. Initiatives like OEE (Overall Equipment Effectiveness) improvement, Quality Circles, Autonomous maintenance and through investigation of T-IHC (Throughput Incident of High Consequence) deviation have resulted in improvement in reliability through involvement of the associate family and in turn benefited in achieving our safety and sustainability objectives. Implementing Model Plant Initiative to improve plant infrastructure and so to improve safety and reliability. While doing this engagement of all employees at all levels is under focus to focus on ownership and sustenance.
33. Statutory Auditors & Auditors'' Report
In accordance with the provisions of Section 139 of the Companies Act, 2013, Gokhale & Sathe, Chartered Accountants (Firm Registration No.: 103264W) were appointed as Statutory Auditor of your Company at the 39th Annual General Meeting for a term of 5 years, to hold office from that meeting till the conclusion of 44th Annual General Meeting to be held in 2027.
There are no qualifications, reservations or adverse remarks or disclaimer made by the Auditor in their report. The Auditors of the Company have not reported any instances of fraud committed against the Company by its officers or employees as specified under Section 143(12) of the Companies Act, 2013.
I n terms of the Section 148 of the Companies Act, 2013 read with the Companies (Cost Record and Audit) Rules, 2014, the Company is required to maintain cost accounting records and have them audited every year.
The Board accordingly, has appointed Ketaki D. Visariya, Cost Accountants, (Membership No.16028) as the "Cost Auditors" of the Company for FY 2023-24. The remuneration payable to the Cost Auditor is required to be placed before the Members in a General Meeting for their approval. Accordingly, a resolution for seeking Member''s approval for the remuneration payable to Ketaki D. Visariya, Cost Accountants, is included at Item No. 15 of the Notice convening the Annual General Meeting in terms of Rule 14 of the Companies (Audit & Auditors) Rules, 2014.
The Company has maintained cost records as specified under section 148(1) of the Act.
35. Secretarial Auditor & Report
Pursuant to the provisions of Section 204 of the Companies Act, 2013 and rules made thereunder, the Company had appointed CS Sunil M. Dedhia (COP No. 2031), Proprietor of Sunil M. Dedhia & Co., Company Secretary in Practice to undertake the Secretarial Audit of the Company.
Pursuant to provisions of Section 204(1) of the Companies Act, 2013 and Regulation 24A of the Listing Regulations, the Secretarial Audit Report for the Financial Year ended March 31, 2023 issued by CS Sunil M. Dedhia (COP No. 2031), of Sunil M. Dedhia & Co. Company Secretary in Practice and the Secretarial Auditor of the Company is annexed as Annexure-C and forms an integral part of this Report. During the year under review, the Secretarial Auditor had not reported any fraud under Section 143(12) of the Act.
There is no qualification, reservation or adverse remark or disclaimer made by the Auditor in their report. As regards the observations of the Secretarial Auditor in their Report, the same is self explanatory and need no further clarifications.
36. Internal Control Systems and their adequacy
Your Company has clearly laid down policies, guidelines and procedures that form part of internal control systems, which provide for automatic checks and balances. Your Company has maintained a proper and adequate system of internal controls. The Company has appointed Shri Rakesh Pandey as an Internal
Auditor who periodically audits the adequacy and effectiveness of the internal controls laid down by the Management and suggests improvements. This ensures that all Assets are safeguarded and protected against loss from unauthorised use or disposition and that the transactions are authorised, recorded and reported diligently. Your Company''s internal control systems commensurate with the nature and size of its business operations. Internal Financial Controls are evaluated and Internal Auditors'' Reports are regularly reviewed by the Audit Committee of the Board.
Statutory Auditors Report on Internal Financial Controls as required under Clause (i) of sub-section 3 of Section 143 of the Companies Act, 2013 is annexed with the Independent Auditors'' Report.
37. Secretarial Standards Compliance
During the year under review, the Company has complied with all the applicable Secretarial Standards issued by the Institute of Company Secretaries of India and approved by the Central Government pursuant to Section 118 of the Companies Act, 2013.
38. Number of cases filed, if any, and their disposal under section 22 of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013
Your Company is fully committed to uphold and maintain the dignity of every woman working with the Company. The Company has Zero tolerance towards any action on the part of any one which may fall under the ambit of ''Sexual Harassment at workplace''. The Policy framed by the Company in this regard provides for protection against sexual harassment of women at workplace and for prevention and redressal of such complaints.
The Company has complied with the provisions relating to the constitution of Internal Complaints Committee ("ICC") under the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013. ICC have been set up to redress complaints received regarding sexual harassment.
The status of the Complaints during the FY 2022-23 is as follows:
Particulars |
No. of Complaints |
Number of Complaints pending as on beginning of the Financial Year |
0 |
Number of Complaints filed and resolved during the Financial Year |
0 |
Number of Complaints pending as on the end of the Financial Year |
0 |
39 Conservation of energy, technology absorption, foreign exchange earnings and outgo
Particulars relating to conservation of energy, technology absorption, foreign exchange earnings and outgo required under Section 134(3)(m) of the Companies Act, 2013, read with Rule 8(3) of the Companies (Accounts) Rules, 2014, as amended from time to time, are provided in Annexure-D to this report.
40. Significant and material orders passed by the regulators or courts
During the year, the Hon''ble National Company Law Tribunal (NCLT), Ahmedabad Bench vide its order dated September 21, 2022 approved the Scheme of Arrangement (Scheme) between Aarti Industries Limited (Demerged Company) and Aarti Pharmalabs Limited (Resulting Company) and their respective shareholders under the provisions of Section 230-232 of Companies Act, 2013.
41. Details of application made or any proceeding pending under the Insolvency and Bankruptcy Code, 2016 during the Financial Year alongwith their status as at the end of the Financial Year
During the Financial Year 2022-23, there was no application made and proceeding initiated / pending by any Financial and/or Operational Creditors against your Company under the Insolvency and Bankruptcy Code, 2016 ("the Code").
Further, there is no application or proceeding pending against your Company under the Code.
42. Details of difference between the amount of valuation at the time of one time settlement and the valuation done at the time of taking a loan from the Banks or Financial Institutions along with the reasons thereof
During the Financial Year 2022-23, the Company has not made any settlement with its bankers for any loan/ facility availed or/and still in existence.
Acknowledgement
The Board of Directors places on record its sincere appreciation for the dedicated services rendered by the
employees of the Company at all levels and the constructive cooperation extended by them. Your Directors would like to express their grateful appreciation for the assistance and support by all Shareholders, Government Authorities, Auditors, Financial Institutions, Customers, Employees, Suppliers, other business associates and various other stakeholders.
For and on behalf of the Board
Rajendra V. Gogri
Chairman and Managing Director DIN: 00061003
Mumbai / June 28, 2023
Mar 31, 2022
Your Board of Directors ("Board") are pleased to present this Thirty Ninth Annual Report of your Company ("the Company" or "Aarti Industries Limited") together with the Audited Statement of the Company for the Financial Year ended March 31, 2022.
'' in Crores |
||||
Particulars |
Standalone |
Consolidated |
||
2021-22 |
2020-21 |
2021-22 |
2020-21 |
|
Total Income from Operations (Gross) |
7,765 |
4,808 |
7,919 |
5,023 |
EBIDTA |
1,891 |
935 |
1,929 |
982 |
Depreciation & Amortisation |
281 |
218 |
289 |
231 |
Profit from Operations before Other Income, Finance Costs and Exceptional Items |
1,609 |
716 |
1,640 |
750 |
Other Income |
3 |
2 |
1 |
1 |
Profit before Finance Costs |
1,612 |
718 |
1,641 |
751 |
Finance Costs |
113 |
86 |
114 |
86 |
Profit before Tax |
1,500 |
632 |
1,527 |
665 |
Total Tax Expenses |
211 |
119 |
219 |
129 |
Non-controlling Interest |
- |
- |
- |
(12) |
Net Profit for the period |
1,289 |
514 |
1,307 |
523 |
Other Comprehensive Income (net of taxes) |
25 |
40 |
22 |
48 |
Total Comprehensive income for the year |
1,314 |
554 |
1,329 |
571 |
Earnings Per Share (?) (Basic & Diluted) |
35.55 |
29.47 |
36.06 |
30.04 |
Book Value Per Share (?) |
160 |
196 |
163 |
202 |
Your Company reported Gross Total Income from operations at '' 7,765 Crores for FY 2021-22 as against '' 4,808 Crores for FY 2020-21. Similarly the exports for the year were at '' 3,358 Crores for FY 2021-22 as against '' 2,004 Crores for FY 2020-21.
Your Company''s Earnings Before Interest Depreciation and Taxes stood at '' 1,891 Crores in FY 2021-22 as compared to '' 935 Crores in FY 2020-21, registering a growth of 102%. Likewise Profit Before Tax stood at '' 1,500 Crores in FY 202122 as compared to '' 632 Crores in FY 2020-21.
Likewise, Net Profit after Tax & Deferred Tax stood at '' 1,289 Crores in FY 2021-22 as compared to '' 514 Crores in FY 2020-21.
Likewise the Consolidated Total income from operations for FY 2021-22 stood at '' 7,919 Crores as compared to '' 5,203 Crores for FY 2020-21 and exports for FY 2021-22 was '' 3,478 Crores v/s '' 2,188 Crores for FY 2020-21.
On a Consolidated basis, your Company''s Earnings Before Interest Depreciation and Taxes stood at '' 1,929 Crores in FY 2021-22 as compared to '' 982 Crores in FY 202021, registering a growth of 96%. Similarly, Net Profit after
consolidation stood at '' 1,307 Crores in FY 2021-22 as compared to '' 523 Crores in FY 2020-21.
During the year, the Board has declared two Interim Dividend @ '' 1/- (@20%) each per share.
Your Directors recommend a Final Dividend of '' 1.50 (@ 30%) per share, aggregating to a total Dividend of '' 3.50 (@ 70%) per share (of '' 5 each) for the financial year 2021-22, resulting in a total payout '' 126.88 Crores (Previous Year: '' 80.51 Crores).
The dividend payout is in accordance with the Dividend Distribution Policy which is available on the website of the Company.
As per Regulation 43A of the Listing Regulations, the top 1000 listed companies shall formulate a dividend distribution policy. Accordingly, the policy was adopted to set out the parameters and circumstances that will be taken into account by the Board in determining the distribution of dividend to its shareholders and/or retaining profits earned by the company.
Corporate Social Responsibility
Your Company through, Aarti Foundation and Dhanvallabh Charitable Trust - Our CSR arms undertake community interventions to enhance the lives of the communities. Besides our direct involvement, we partner with numerous implementing agencies to carry out need assessment and make impactful interventions. Our Focus areas during the year has been;
⢠Cluster and Rural Development
⢠Education and Skill Development
⢠Childcare and Health Facilities
⢠Women Empowerment & Livelihood Opportunities
⢠Disaster Relief & Rehabilitation
⢠Eradication of Hunger & Poverty
⢠Water Conservation & Environment
⢠Research & Development work for upliftment of Society
The detailed policy on Corporate Social Responsibility is available on the website of the Company on the web link thereto is: https://www.aarti-industries.com/investors/ GetReport?strcont id=rOxVNykXxIkOIOL33MM
A brief note on various CSR initiatives undertaken during the year is presented in this Annual report. CSR annual report is annexed as Annexure-A and forms an integral part of the Report.
Related Party Transactions
The Company has a Policy on Materiality of Related Party Transaction and dealing with Related Party Transaction which is uploaded on the Company''s website at the web- link given below: https://www.aarti-industries.com/investors/ GetReport?strcont id=TNJu6Gnbr7sOIOL33MM
All related party transactions that were entered into during the FY 2021-22 were on arm''s length basis and were carried out in the ordinary course of the business. There are no materially significant related party transactions made by the Company with Promoters, Key Managerial Personnel or other Designated Persons which may have potential conflict with interest of the Company at large.
The related party transactions are approved by the Audit Committee. Omnibus approval is obtained for the transactions which are foreseen and repetitive in nature. A statement of related party transactions is presented before the Audit Committee on a quarterly basis, specifying the nature, value and terms and conditions of transactions. A report of factual findings arising out of the accepted procedures carried out in regard to transactions with Related Parties is given by the Statutory Auditors on quarterly basis and the same is placed before the Audit Committee.
A policy is available on the website of the Company and the web link thereto is :-https://www.aarti-industries.com/ investors/GetReport?strcont id=b22bcY6v1CAOIOL33MM
Your Company has transferred '' 129 Crores to General Reserve (Previous Year: '' 51.50 Crores).
During the year 2021-22, there was change in the authorised and paid up share capital of the Company.
Pursuant to an approval of the members given during the Extra Ordinary General Meeting held on June 14, 2021, the authorised share capital was increased from '' 1,15,07,51,600 (Rupees One Hundred Fifteen Crores Seven Lakhs Fifty One Thousand and Six Hundred) to '' 3,00,00,00,000/- (Rupees Three Hundred Crores Only) by creation of additional 36,98,49,680 (Thirty Six Crore Ninety Eight Lakhs Forty Nine Thousand Six Hundred Eighty) equity shares of '' 5/- each.
As on the date of this report the Authorised Share Capital of the Company stands at '' 300,00,00,000 (Rupees Three Hundred Crores Only) divided into 60,00,00,000 (Sixty Crores) equity shares of ''5/-each.
Bonus Shares @ 1:1
The Company on June 24, 2021, has allotted 17,42,34,474 nos. of fully paid up Equity Shares of '' 5/- each in the proportion of 1:1 [i.e. One Bonus Equity Share(s) of nominal value '' 5/- each for every 1(One) Equity Share(s) of nominal value of '' 5/- each held by the Shareholders as on record date (i.e. June 23, 2021)]. Pursuant to the said allotment of Equity Shares, the paid-up share capital of the Company increased from '' 87,11,72,370 consisting of 17,42,34,474 Equity Shares to '' 1,74,23,44,740 consisting of 34,84,68,948 Equity Shares.
Qualified Institution Placement @ '' 855 per share
The Company on June 30, 2021, has allotted 1,40,35,087 nos. of fully paid up Equity Shares of '' 5/- each at a premium of '' 850 per Share, through Qualified Institution Placement (QIP). Pursuant to the allotment of said Equity Shares, the paid-up equity share capital of the Company increased from '' 1,74,23,44,740 consisting of 34,84,68,948 Equity Shares to '' 1,81,25,20,175 consisting of 36,25,04,035 Equity Shares.
Apart from the above, there was no change in the Share Capital.
The Company has neither issued shares with differential rights as to the dividend, voting or otherwise nor issued sweat equity shares. There is no scheme for employee stock option or provision of money for shares to the Employees or Directors of the Company.
The details of related party transactions are provided in the accompanying financial statements.
Since all related party transactions entered into by the Company were in ordinary course of business and were on an arm''s length''s basis, Form AOC-2 is not applicable to Company.
The Company has not accepted any deposits from the public and as such, no amount on account of principal or interest on deposits from the public was outstanding as on the date of Balance Sheet.
The Company does not have any deposits which are not in compliance with the requirements of Chapter V of the Companies Act, 2013.
Particulars of Loans, Guarantees, Investments and Securities
Particulars of loans given, investments made, guarantees given and securities provided during the year under review and as covered under the provisions of Section 186 of the Companies Act, 2013 have been disclosed in the notes to the standalone financial statements forming part of the Annual Report.
Material Developments in Human Resources/Industrial Relations Front, including number of people Employed
At AIL, employee well-being and growth form the core of everything we do and we consistently strive to co-create practices that help us in building a world-class experience for our people.
To meet our growth aspirations, we onboarded around 1500 bright talents last year. We created various growth avenues for our internal talent, thus accomplishing 18% internal growth transitions in FY 22. In our endeavor to become a Best Place to Work, we accomplished the second set of Voice survey receiving participation from over 99% employees while formulating a vertical wise action plan on the basis of feedback from the survey.
We nurture the culture of One Team, One Voice on the journey of Building Future Together, with an unwavering focus on Excellence and High Performance. As part of this effort, our Talent Management and Capability Building teams collectively work towards the Organization''s Vision and Mission by assessing, developing & leveraging the capabilities of employees to build a motivated, engaged, high-performing environment, and bringing holistic capability building opportunities and solutions at individual, team and organizational levels. We have launched below initiatives this year, as a part of our employee development and well-being:
Cross-Functional Learning Through Kshitij Cross-functional skills provide better value to talent, as chances of innovation and creativity are higher among groups having cross-functional collaborations. Mindful of this aspect, we launched Kshitij, a cross-functional domain learning in April 2022. Under Kshitij we have had 5 batches across various locations & have completed 3 sessions.
Developing Employee Career Path Through Eklavya
Focusing on the developmental journey of Field Operator and DCS Supervisor, we launched Eklavya, a career development initiative in May 2022. 31 Field Operators & 13 DCS Supervisors have been already nominated to start their journey in respective areas under Eklavya.
Meraki- an Initiative for the Development of OTS/MTS
With an objective to sensitize OT/MTs batch on setting smart goals and preparing one''s Swot analysis, Meraki was launched in May 2022. The session created awareness around mentoring, benefits of the program and self-development.
Started with the objective to converse the values and culture of AIL to Associate employees, Samvad is an awareness session on AIL''s various HR Policies & Employee Benefits.
With an objective to provide employees an opportunity to get certified as a LEAN Practitioner, Utkarsh was launched in May 2022. Conducted across 3 and half months, 3 batches of Utkarsh have been held impacting 90 employees.
With the objective to train the internal trainers and create a pool for the need of future capabilities, the Nipun Initiative was launched across AIL in May 2022. Spread across three batches, the programme will cover 90 employees.
Honing Leadership Competencies with Agility Workshop
To establish the foundation for Aarti''s 2022-26 goals and to have an agile and responsive leadership team, we conducted an Agility workshop for leaders and above job families in association with a third party vendor. The workshop focused on case study models, team activity and "Shark Tank" to emphasize on the significance of agile decision making. 200 hours of workshop sessions have been conducted for the Executive & Senior Leader job family and 388 hours of sessions have been held for the Leader job family.
Particulars of Employees
The statement containing particulars of employees as required under Section 197(12) of the Companies Act, 2013 read with Rule 5(2) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 is given in an Annexure and forms part of this report.
In terms of Section 136(1) of the Companies Act, 2013, the Report and the Accounts are being sent to the Members excluding the aforesaid Annexure. Any Member interested in obtaining a copy of the Annexure may write to the Company Secretary at the Registered Office of the Company for a copy of it.
Material changes and commitment if any affecting the financial position of the company occurred between the end of the financial year to which this financial statements relate and the date of the report
There are no other material changes and commitments affecting the financial position of the Company occurred between the end of the Financial Year to which these financial statements relate and the date of the report.
Consolidated Financial Statements
In accordance with the provisions of Companies Act, 2013 (hereinafter referred to as "the Act"), Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (hereinafter referred to as "Listing Regulations") and applicable Accounting Standards, the Audited Consolidated Financial Statements of the Company for the FY 2021 -22, together with the Auditors'' Report, forms part of this Annual Report.
Investor Education and Protection Fund (IEPF)
Pursuant to the applicable provisions of the Companies Act, 2013 read with IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 ("the Rules") all unpaid or unclaimed dividends are required to be transferred by the Company to the IEPF established by the government of India, after the completion of seven years. Further, according to the rules, the shares on which Dividend has not been paid or claimed by the Shareholders for seven consecutive years or more shall be transferred to the Demat account of the IEPF Authority. Accordingly, the Company has transferred the unclaimed and unpaid dividends of '' 48,43,265/-. Further 22,215 corresponding shares were transferred as per the requirement of the IEPF Rules.
Annual Return
Pursuant to Section 92(3) read with Section 134(3) (a) of the Act, the Annual Return as on March 31, 2022 is available in prescribed format on the Company''s website on www.aarti-industries.com
As on March 31, 2022, the Company has 9 (Nine) direct subsidiaries namely, Aarti Corporate Services Limited, Innovative Envirocare Jhagadia Limited, Aarti Polychem Private Limited, Aarti Pharmalabs Limited, Aarti Bharuch Limited, Aarti Spechem Limited, Aarti Pharmachem Limited, Aarti USA Inc. and Alchemie (Europe) Limited, and 2 (Two) indirect subsidiaries namely, Shanti Intermediates Private Limited, Nascent Chemical Industries Limited both hold through Aarti Corporate Services Limited.
The Company does not have any material subsidiary whose net worth exceeds 10% of the consolidated net worth of the Company in the immediately preceding accounting year or has generated 10% of the consolidated income of the Company during the previous Financial Year. A policy on material subsidiaries had been formulated and is available on the website of the Company and the web link thereto is: https:// www.aarti-industries.com/investors/GetReport7strcont id=A8DuSuG1AT8OIQL33MM.
During the year, the Board of Directors reviewed the affairs of the subsidiaries. In accordance with Section 129(3) of the Companies Act, 2013, we have prepared consolidated financial statements of the Company and all its subsidiaries, which forms part of the Annual Report.
Further a statement containing salient features of the financial statement of our Subsidiaries/Jointly controlled entity in the prescribed format AOC-1 is included in the Report as Annexure-C and forms an integral part of this Report.
Directors and Key Managerial Personnel (KMP)
In accordance with the prevailing provisions of the Section 149 of the Companies Act, 2013 read with Regulation 17 of the Listing Regulations, as amended from time to time, as on March 31, 2022, the Board of Directors comprises of Sixteen Directors (with Eight Executive Directors and Eight Independent Directors).
Shri Ramdas M. Gandhi, Independent Director of the Company left for heavenly abode on July 16, 2021. He was on the Board of the Company since January 29, 1990. The Company places on record appreciation for his guidance, mentoring and contribution to the growth of the Company throughout his tenure.
At the Postal Ballot held on November 24, 2021, Smt. Natasha Kersi Treasurywala (DIN: 07049212) has been appointed as the Independent Director for a period of three years w.e.f. October 14, 2021. In accordance with the provisions of Section 152 of Companies Act, 2013, Shri Renil Rajendra Gogri (DIN: 01582147) and Shri Manoj Mulji Chheda (DIN: 00022699), Executive Directors of the Company are liable to retire by rotation at the ensuing Annual General Meeting and, being eligible, offer themselves for reappointment. The Board recommends their re-appointment for the consideration of the
Members. The existing term of the Chairman and Managing Director Shri Rajendra Vallabhaji Gogri (DIN: 00061003) will come to an end on June 30, 2023. Based upon the performance evaluation rating, merits and recommendation of the Nomination and Remuneration Committee of the Board, your Directors recommend his re-appointment for a further period of Five years effective from July 1, 2023.
Pursuant to Regulation 36 of the Listing Regulations read with Secretarial Standard-2 on General Meetings, a brief profile of the Directors proposed to be re-appointed is made available as an Annexure to the Notice of the Annual General Meeting.
None of the Directors of the Company are disqualified or debarred as per SEBI order from being appointed/ re-appointed/ holding position as Directors of the Company.
Statement on declaration given by Independent Directors under sub-section (6) of section 149.
In accordance with Section 149(7) of the Companies Act, 2013, all Independent Directors have given declarations that they meet the criteria of independence as laid down under Section 149(6) of the Companies Act, 2013 and Regulation 16 of the Listing Regulations.
In the opinion of the Board, Independent Directors fulfill the conditions specified in Companies Act, 2013 read with the Schedules and Rules issued thereunder as well as Listing Regulations and are independent from Management and hold the highest degree of integrity and are individuals who are experts in their respective fields with enormous experience.
All the Independent Directors of the Company have enrolled their names in the online database of Independent Directors by Indian Institute of Corporate Affairs in terms of the recently introduced regulatory requirements.
Familiarisation Programme for Independent Directors
The Company has a Familiarisation programme for its Independent Director which is imparted at the time of appointment of an Independent Director on Board as well as annually. During the year, the Independent Directors of the Company were familiarised and the details of familiarisation programmes imparted to them are placed on the website of the Company and the web link thereto is: https://www.aarti-industries.com/Upload/PDF/Familiarisation-Programme-FY-2021-22.pdf.
During the year under review, there was no change in the Key Managerial Personnel of the Company.
Directors'' Responsibility Statement
To the best of their knowledge and belief and according to the information and explanations obtained by them, your
Directors make the following statements in terms of Section 134(3)(c) of the Companies Act, 2013:
a. That in the preparation of the annual financial statements for the year ended March 31, 2022, the applicable accounting standards have been followed along with proper explanation relating to material departures, if any;
b. That the Directors had selected such accounting policies and applied them consistently and made judgements and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the company at the end of the Financial Year and of the profit and loss of the company for that period;
c. That the Directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the Assets of the Company and for preventing and detecting fraud and other irregularities;
d. That Directors have prepared the annual accounts on a going concern basis;
e. The Directors had laid down internal financial controls to be followed by the Company and that such internal financial controls are adequate and were operating effectively;
f. The Directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.
Corporate Governance essentially involves balancing the interests of a Company''s stakeholders. The Company continues to nurture a culture of good governance practices across functions, offices and manufacturing facilities.
Your Company has complied with the mandatory Corporate Governance requirements stipulated under the Listing Regulations. The separate Report on Corporate Governance is annexed hereto forming part of this report. The requisite certificate from Kirtane & Pandit LLP, Chartered Accountants is attached to the Report on Corporate Governance.
Management''s Discussion and Analysis Report
Pursuant to Regulation 34 read with Schedule V to the Listing Regulations, Management''s Discussion and Analysis for the year under review is presented in a separate section forming part of the Annual Report.
Business Responsibility Reporting (BRR)
The Listing Regulations mandate the inclusion of the BRR as part of the Annual Report for top 1000 listed entities based on market capitalisation. Business Responsibility and Sustainability Reporting for the year under review, as
stipulated under Regulation 34 (f) of Listing Regulations read with SEBI Circular No. CIR/CFD/ CMD/10/2015 and SEBI/HO/ CFD/CMD-2/P/CIR/2021/562 dated November 4, 2015 and May 10, 2021 respectively, are in a separate section forming part of the Annual Report.
Meetings
The Board of Directors met Seven(7) times during the financial year under review. The details of the number of meetings of the Board held during the Financial Year 2021-22 and the details of attendance of each Director at these meetings are provided in the Corporate Governance Report forming part of the Annual Report. The Maximum Gap between two meetings did not exceed 120 days, as prescribed in the Companies Act, 2013.
Annual Board Evaluation
Pursuant to the provisions of Companies Act, 2013 and the Listing Regulations, a structured questionnaire was prepared after taking into consideration various aspects of the Board''s functioning, composition of the Board and its Committees, culture, execution and performance of specific duties, obligations and governance.
The performance of the Committees and Independent Directors were evaluated by the entire Board of Directors except for the Director being evaluated. The performance evaluation of the Chairman, Non-Independent Directors and Board as a whole was carried out by the Independent Directors. The Board of Directors expressed their satisfaction with the outcome of evaluation and the process followed thereof.
Nomination and Remuneration Policy
Your Company has in place a Nomination and Remuneration Policy which lays down a framework in relation to remuneration of Directors, Key Managerial Personnel and Senior Management of the Company. The policy also lays down criteria for selection and appointment of Board Members.
The details of this policy are given in the Corporate Governance Report.
Risk Management
In compliance with Regulation 21 of Listing Regulations, Your Company has a Risk Management Committee consisting of Shri Rajendra V. Gogri (Chairman), Shri Rashesh Gogri, Shri Bhavesh R. Vora, Smt. Hetal Gogri Gala, Shri Renil Gogri, Shri Narendra J. Salvi, Shri Chetan B. Gandhi and Shri Ajaykumar Gupta. The Committee through its dynamic risk management framework continuously identifies, evaluates and takes appropriate measures to mitigate/minimize various elements of risks.
Safety, Health and Environment
Being a responsible organization, we at Aarti Industries Limited (AIL), are committed to maintain the world-class standards of health, safety, security, human rights, environment protection, product quality and processes while conducting all our business operations, services, and expansion activities. To enable this, AIL has created a culture of Aarti Engaging Leaders, committed to live by Aarti Values of Care, Integrity and Excellence and empowering everyone in the hierarchy to speak powerfully. Further to have better implementation of our strategy, we have realigned the structure of organization into Pillar / Vertical / Group structure.
During FY 2021-22, We have implemented various elements under our flagship initiative "By Employees Sustainability Assurance for Employees (BE SAFE)", a mega initiative with objectives of ''Assurance on Complete Health Check of the Plants'' and ''Zero-Harm''. With help of these, we have succeeded in bringing behavioural change amongst our people.
Furthermore, we have developed and implemented several Process Initiative Common (PICs) with specific objectives. Some of the focus areas are elimination of exposure to hazardous chemicals, reduction of electrical incidents to zero, achievement of zero leakage status, etc. In addition to PICs we have also designed and adopted guidelines and Standard Operating Procedures (SOPs) to minimize discretionary actions which may lead to accidents and hazards. Such standardizations have strengthened our efforts towards environment, health & safety.
Our robust performance on EH&S has led to our success in getting a Responsible Care (RC) logo. RC is a global chemical manufacturing industry''s environmental, health, safety and security performance initiative. RC logo is not only an endorsement of our exemplary EH&S practices but also it shall help us in improving our environmental, health, safety and security (EHS&S) performance for facilities, processes and products throughout the entire operating system through its guiding principles.
Our significant efforts in improving our ESG performance has led to achieving a gold medal in EcoVadis CSR assessment, placing AIL among the top 5 percent of companies assessed by EcoVadis.
At AIL we are committed to achieve 100% compliance. We have adopted a third-party managed IT-based Compliance Management System. It has a repository of all applicable
regulations and requisite compliances. It has an in-built alert system that intimates concerned personnel about upcoming compliances. Last year, we added a module on ''License Management'' into our compliance management system. Newly added license management system helps us in tracking the validity and renewal process of all applicable licenses. We initiate the license renewal process 90 days in advance to avoid any delays.
As a responsible organization, we are committed to protect and prevent the environment. Efficient usage of water is of high priority to us, making it a high material topic for us and our delighted stakeholders. Towards reducing our water footprint, we are focussing on 3R (Reduce, Reuse & Recycle) and strategizing to achieve zero-liquid discharge (ZLD) for our facilities. Currently, 16 of our manufacturing sites have ZLD facilities. Further we have planned to achieve 100% ZLD status within the next 3 years. We have adopted a proactive approach for ZLD and incorporated it in the conceptualisation & designing phase of new projects.
Continuation of plant activities during COVID-19 pandemic was a challenging task. We adopted new norms of social distancing, workplace hygiene, and shift management to eliminate exposure and spread of COVID-19. We undertook several initiatives to manage the pandemic situation; some of these are mentioned below:
⢠Commitment for abiding with COVID-19 precautions by incorporating it in Safety Pledge
⢠Arrangement of shelter and food for workers and their families
⢠Dedicated panel of doctors along with one specialist doctor for providing medical aid to all employees
⢠Assuring Emotional & Mental well-being of employees through "ANAHATA" initiative
⢠Intensive COVID-19 testing for our employees
⢠Periodical sanitization of workplace
⢠Provision of immunity boosters to our workers and employees
⢠Providing all possible supports to employees with COVID-19 disease
⢠Providing transport facilities to employees and workers
In addition to these, we have developed COVID-19 management plans for various scenarios segregated into L-1,
L-2, and L-3 levels. Based on our robust preparedness and responsiveness we successfully ensured business continuity during COVID-19 pandemic.
Reliability
We have initiated an Operational Excellence journey with focus to improve reliability. Initiatives like OEE (Overall Equipment Effectiveness) improvement, Quality Circles, Autonomous maintenance and through investigation of T-IHC (ThroughputIncident of High Consequence) deviation have resulted in improvement in reliability through involvement of the associate family and in turn benefited in achieving our safety and sustainability objectives.
Some of the initiatives in this regard as briefed below:
Vigil Mechanism/Whistle Blower Policy
The Company has established a Vigil Mechanism and Whistle Blower Policy for its Directors and employees to report concerns about unethical behaviour, actual or suspected fraud, actual or suspected leak of UPSI or violation of Company''s Code of Conduct. It also provides for adequate safeguards against the victimisation of employees and allows direct access to the chairperson of the Audit Committee in exceptional cases The said policy has been posted on the website of the Company and the web link thereto is: https:// www.aarti-industries.com/investors/GetReport7strcont id=ZMPluse33MMnrACtosYOIQL33MM
The Company affirms that no person has been denied access to the Audit Committee Chairman.
Statutory Auditors
In accordance with the provisions of Section 139 of the Companies Act, 2013, Kirtane & Pandit LLP. Chartered Accountants (Firm Registration No: 105215W/W100057) were appointed as the Statutory Auditor of your Company at the 35th Annual General Meeting for a term of 4 years, to hold office from that meeting till the conclusion of 39th Annual General Meeting to be held in 2022.
In view of the above, the Board on the recommendation of the Audit Committee appointed Gokhale & Sathe, Chartered Accountants (Firm Registration. No. 103264W) as the Statutory Auditors of the Company to hold office from the conclusion of this Annual General Meeting till the conclusion of 44th Annual General Meeting to be held in 2027. At the request of the Company, Gokhale & Sathe have communicated their eligibility and willingness to accept the office, if appointed. Members are requested to appoint Auditors and to fix their remuneration as mentioned at Item No. 5 of the notice.
Auditors'' Report
There are no qualifications, reservations or adverse remarks or disclaimer made by the Auditor in their report. The Auditors of the Company have not reported any instances of fraud committed against the Company by its officers or employees as specified under Section 143(12) of the Companies Act, 2013.
Cost Auditors
In terms of the Section 148 of the Companies Act, 2013 read with the Companies (Cost Record and Audit) Rules, 2014 the Company is required to maintain cost accounting records and have them audited every year.
The Board has appointed Ketki D. Visariya, Cost Accountants, (Membership No.16028) as the Cost Auditors of the Company for FY 2022-23 under Section 148 and all other applicable provisions of the Act.
The remuneration payable to the Cost Auditor is required to be placed before the Members in a General Meeting for their approval. Accordingly, a resolution for seeking Member''s approval for the remuneration payable to Ketki D. Visariya, Cost Accountants, is included at Item No. 9 of the notice convening the Annual General Meeting.
The Company has maintained cost records as specified under section 148(1) of the Act.
Secretarial Auditor & their Report
Pursuant to the provisions of Section 204 of the Companies Act, 2013 and rules made thereunder, the Company had appointed CS Sunil M. Dedhia (COP No. 2031), Proprietor of Sunil M. Dedhia & Co., Company Secretary in Practice to undertake the Secretarial Audit of the Company.
Pursuant to provisions of Section 204(1) of the Companies Act, 2013 and Regulation 24A of the Listing Regulations, the Secretarial Audit Report for the financial year ended March 31, 2022 issued by CS Sunil M. Dedhia (COP No. 2031), Proprietor of Sunil M. Dedhia & Co. Company Secretary in Practice and the Secretarial Auditor of the Company is annexed as Annexure - B and forms an integral part of this Report. During the year under review, the Secretarial Auditor had not reported any fraud under Section 143(12) of the Act. There is no qualification, reservation or adverse remark or disclaimer made by the Auditor in their report. As regards, the observations of the Secretarial Auditor in their Report, the same is self explanatory and need no further clarifications.
Internal Control Systems and their adequacy
Your Company has clearly laid down policies, guidelines and procedures that forms part of internal control systems, which provide for automatic checks and balances. Your Company has maintained a proper and adequate system of internal
controls. The Company has appointed Shri Rakesh Pandey as an Internal Auditor who periodically audits the adequacy and effectiveness of the internal controls laid down by the Management and suggests improvements. This ensures that all Assets are safeguarded and protected against loss from unauthorised use or disposition and that the transactions are authorised, recorded and reported diligently. Your Company''s internal control systems commensurate with the nature and size of its business operations. Internal Financial Controls are evaluated and Internal Auditors'' Reports are regularly reviewed by the Audit Committee of the Board.
Statutory Auditors Report on Internal Financial Controls as required under Clause (i) of Sub-section 3 of Section 143 of the Companies Act, 2013 ("the Act") is annexed with the Independent Auditors'' Report.
Secretarial Standards Compliance
During the year under review, the Company has complied with all the applicable Secretarial Standards issued by the Institute of Company Secretaries of India and approved by the Central Government pursuant to Section 118 of the Companies Act, 2013.
Number of cases filed, if any, and their disposal under section 22 of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013
Your Company is fully committed to uphold and maintain the dignity of every woman working with the Company. The Company has Zero tolerance towards any action on the part of any one which may fall under the ambit of ''Sexual Harassment at workplace''. The Policy framed by the Company in this regard provides for protection against sexual harassment of women at workplace and for prevention and redressal of such complaints.
Internal Complaints Committees (ICC) have been set up to redress complaints received regarding sexual harassment.
Status of the Complaints during the FY 2021-22 is as follows:
Particulars |
No. of |
Complaints |
|
Number of Complaints pending as on beginning of the Financial Year |
0 |
Number of Complaints filed and resolved during the Financial Year |
2 |
Number of Complaints pending as on the end of the Financial Year |
0 |
The Company has complied with the provisions relating to the constitution of Internal Complaints Committee under the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013.
Conservation of energy, technology absorption, foreign exchange earnings and outgo
The particulars relating to conservation of energy, technology absorption, foreign exchange earnings and outgo required under Section 134(3)(m) of the Companies Act, 2013, read with Rule 8(3) of the Companies (Accounts) Rules, 2014, as amended from time to time, are provided in Annexure-D to this report.
Significant and material orders passed by the regulators or courts
There are no significant material orders passed by the Regulators/Courts which would impact the going concern status of the Company and its future operations.
The Board of Directors places on record its sincere appreciation for the dedicated services rendered by the employees of the Company at all levels and the constructive cooperation extended by them. Your Directors would like to express their grateful appreciation for the assistance and support by all Shareholders, Government Authorities, Auditors, Financial Institutions, Customers, Employees, Suppliers, other business associates and various other stakeholders.
For and on behalf of the Board
Rajendra V. Gogri
Chairman and Managing Director Mumbai/August 10, 2022 DIN: 00061003
Mar 31, 2021
Your Board of Directors ("Board") are pleased to present this Thirty Eighth Annual Report of your Company ("the Company" or "Aarti Industries Limited") together with the Audited Statement of the Company for the Financial year ended March 31, 2021.
in Crores |
||||
STANDALONE |
CONSOLIDATED |
|||
2020-21 |
2019-20 |
2020-21 |
2019-20 |
|
Total Income from Operations (Gross) |
4,808 |
4,408 |
5,023 |
4,621 |
EBIDTA |
935 |
930 |
982 |
977 |
Depreciation & Amortisation |
218 |
173 |
231 |
185 |
Profit from Operations before Other Income, Finance Costs and Exceptional Items |
716 |
757 |
750 |
792 |
Other Income |
2 |
11 |
1 |
9 |
Profit before Finance Costs |
718 |
768 |
751 |
801 |
Finance Costs |
86 |
122 |
86 |
125 |
Profit before Tax |
632 |
646 |
665 |
676 |
Total Tax Expenses |
119 |
123 |
129 |
129 |
Non-controlling Interest |
- |
- |
(12) |
(11) |
Net Profit for the period |
514 |
523 |
523 |
536 |
Other Comprehensive Income (net of taxes) |
40 |
(56) |
48 |
(57) |
Total Comprehensive income for the year |
554 |
467 |
571 |
479 |
29.47 |
30.04 |
30.04 |
30.77 |
|
Book Value Per Share (?) |
196 |
167 |
202 |
176 |
Your Company reported Gross Total Income at '' 4,808 Crores for FY 2020-21 as against '' 4,408 Crores for FY 2019-20. Similarly the exports for the year were at '' 2,004 Crores for FY 2020-21 as against '' 1,841 Crores for FY 2019-20.
Your Companyâs Earnings Before Interest Depreciation and Taxes stood at '' 935 Crores in FY 2020-21 as compared to '' 930 Crores in FY 2019-20, registering a growth of 0.54%. Likewise Profit Before Tax stood at '' 632 Crores in FY 2020-21 as compared to '' 646 Crores in FY 2019-20.
Likewise, Net Profit after Tax & Deferred Tax stood at '' 514 Crores in FY 2020-21 as compared to '' 523 Crores in Financial Year 2019-20.
Likewise the Consolidated Total income for FY 2020-21 was at '' 5,023 Crores as compared to '' 4,621 Crores for FY 201920 and exports for FY 2020-21 was '' 2,188 Crores v/s '' 1,966 Crores for FY 2019-20.
On a Consolidated basis, your Companyâs Earnings Before Interest Depreciation and Taxes stood at '' 982 Crores in FY 2020-21 as compared to '' 977 Crores in FY 2019-20, registering a growth of 0.51%. Similarly, Net Profit after consolidation stood at '' 523 Crores in FY 2020-21 as compared to '' 536 Crores in FY 2019-20.
During the year, the Company has paid an Interim Dividend of '' 1.50 (@ 30%) per share.
Your Directors recommend a final Dividend of '' 1.50 (@ 30%) per share, aggregating to a total Dividend of '' 3.00 (@ 60%) per share (of '' 5 each) for the financial year 2020-21, resulting a total payout '' 80.51 Crores (Previous Year: '' 60.98 Crores).
The dividend payout is in accordance with the Dividend Distribution Policy which is available on the website of the Company.
As per Regulation 43A of the Listing Regulations, the top 1000 listed companies shall formulate a dividend distribution policy. Accordingly, the policy was adopted to set out the parameters and circumstances that will be taken into account by the Board in determining the distribution of dividend to its shareholders and/or retaining profits earned by the company. A policy is available on the website of the Company and the web link thereto is: https://www.aarti-industries.com/investors/ GetReport?strcont id=b22bcY6v1CAOIQI 33MM
Your Company has transferred '' 51.50 Crores to General Reserve (Previous Year: '' 52.50 Crores).
During the year 2020-21, there was no change in the authorised and paid up share capital of the Company.
Authorized Share Capital
Pursuant to an approval of the members given during the ExtraOrdinary General Meeting held on June 14, 2021, the authorised share capital was increased from ''1,15,07,51,600 (Rupees One Hundred Fifteen Crores Seven Lakhs Fifty One Thousand and Six Hundred) to '' 3,00,00,00,000/- (Rupees Three Hundred Crores Only) by creation of additional 36,98,49,680 (Thirty Six Crore Ninety Eight Lakhs Forty Nine Thousand Six Hundred Eighty) equity shares of '' 5/- each.
As on the date of this report the Authorised Share Capital of the Company stands at '' 300,00,00,000 (Rupees Three Hundred Crores Only) divided into 60,00,00,000 (Sixty Crores) equity shares of '' 5/-each.
Paid Up Share Capital Bonus Shares @ 1:1
The Company on June 24, 2021, has allotted 17,42,34,474 nos. of fully paid up Equity Shares of '' 5/- each in the proportion of 1:1 [i.e. One Bonus Equity Share(s) of nominal value '' 5/- each for every 1 (One) Equity Share(s) of nominal value of '' 5/- each held by the Shareholders as on record date (i.e. June 23, 2021)]. Pursuant to the said allotment of Equity Shares, the paid-up share capital of the Company increased from '' 87,11,72,370 consisting of 17,42,34,474 Equity Shares to '' 1,74,23,44,740 consisting of 34,84,68,948 Equity Shares.
Qualified Institution Placement @ '' 855 per share
The Company on June 30, 2021, has allotted 1,40,35,087 nos. of fully paid up Equity Shares of '' 5/- each at a premium of '' 850 per Share, through Qualified Institution Placement (QIP). Pursuant to the allotment of said Equity Shares, the paid-up equity share capital of the Company increased from '' 1,74,23,44,740 consisting of 34,84,68,948 Equity Shares to '' 1,81,25,20,175 consisting of 36,25,04,035 Equity Shares.
Apart from the above, there was no change in the Share Capital.
The Company has neither issued shares with differential rights as to the dividend, voting or otherwise nor issued sweat equity shares. There is no scheme for employee stock option or provision of money for shares to the Employees or Directors of the Company.
Corporate Social Responsibility
Your Company through, Aarti Foundation and Dhanvallabh Charitable Trust - Our CSR arms undertake community interventions to enhance the lives of the communities. Besides our direct involvement, we partner with numerous implementing agencies to carryout need assessment and make impactful interventions. Our Focus areas during the year has been;
⢠Cluster & Rural Development
⢠Education & Skill Development
⢠Childcare & Healthcare Facilities
⢠Women Empowerment & Livelihood Opportunities
⢠Disaster Relief & Rehabilitation
⢠Eradication of Hunger & Poverty
⢠Water Conservation & Environment
⢠Research & Development work for upliftment of Society
The detailed policy on Corporate Social Responsibility is available on the website of the Company on the web link thereto is: https://www.aarti-industries.com/investors/ GetReport?strcont id=rQxVNykXxIkOIQL33MM
A brief note on various CSR initiatives undertaken during the year is presented in this Annual report. CSR annual report is annexed as Annexure-A and forms an integral part of the Report.
The Company has a Policy on Materiality of Related Party Transaction and dealing with Related Party Transaction which is uploaded on the Companyâs website at the web- link given below:
https://www.aarti-industries.com/investors/ GetReport?strcont id=TNJu6Gnbr7sOIQI 33MM
All related party transactions that were entered into during the FY 2020-21 were on armâs length basis and were carried out in the ordinary course of the business. There are no materially significant related party transactions made by the Company with Promoters, Key Managerial Personnel or other Designated Persons which may have potential conflict with interest of the Company at large.
The related party transactions are approved by the Audit Committee. Omnibus approval is obtained for the transactions which are foreseen and repetitive in nature. A statement of related party transactions is presented before the Audit Committee on quarterly basis, specifying the nature, value and terms and conditions of transactions. A report of factual findings arising out of the accepted procedures carried out in regard to transactions with Related Parties is given by the Statutory Auditors on quarterly basis and the same is placed before the Audit Committee.
The details of related party transactions are provided in the accompanying financial statements.
Since all related party transactions entered into by the Company were in ordinary course of business and were on an armâs lengthâs basis, Form AOC-2 is not applicable to Company.
The Company has not accepted any deposits from the public and as such, no amount on account of principal or interest on deposits from the public was outstanding as on the date of Balance Sheet.
The Company does not have any deposits which are not in compliance with the requirements of Chapter V of the Companies Act, 2013.
Particulars of Loans, Guarantees, Investments and Securities
Particulars of loans given, investments made, guarantees given and securities provided during the year under review and as covered under the provisions of Section 186 of the Companies Act, 2013 have been disclosed in the notes to the standalone financial statements forming part of the Annual Report.
Material Developments in Human Resources/Industrial Relations Front, including number of people Employed
It was a year of letting go of the age-old traditional methods of doing businesses and managing people in exchange of embracing a new and technologically advanced approach. Year 2020-21 thus presented a completely new opportunity to overhaul the existing system within organisations and implement modern value-based systems.
At Aarti, nurturing talent is one of our cultural attributes. We are committed to help our employees identify their strengths and development areas and guide them in reaching their maximum potential. Aartiâs Talent Management Framework focuses on identifying, nurturing and developing the talent in the organisation and helping them fulfil their potential. The framework equips them with the knowledge, skills, and abilities to contribute in the companyâs business objectives and grow
in the bargain. During the year various developments were undertaken, a few of them includes;
Aayam: Expanding Horizons
An unique organisational transformation and leadership development initiative, has helped to create unimaginable breakthroughs, elevate leadership and strengthen organisational values. We have also created new robust processes, resolved issues, and built an environment for high performance.
Gurukul - leaders create leadersâ is an initiative which was started with the objective of creating the future leaders for the organisation; leaders who will lead the organisation towards unimaginable breakthroughs.
VOICE Co-create, Drive Change
One of the dimensions of Aarti Engaging Leader Framework is ''Listening & Speaking Powerfullyâ. ''Voice - Co-create, Drive Changeâ is yet another endeavour to enable this by providing a mechanism through which the voice of all employees can be heard.
Gyan Sandhi and Aarti TALKS
Aarti Industries Limited believes in knowledge sharing and shared learning as it helps in developing collaboration among the peers, helps in synthesising multiple viewpoints and also learning from peerâs experiences.
Pehal (Town hall Meeting)
A town hall meeting is an organisation-wide meeting in which the management keeps their team updated about important information. It helps in promoting teamwork and collaborations.
Industrial Relations have been Cordial during the year through benchmarked people policies and practices to ensure high employeesâ morale. As on March 31, 2021, the Company had 7,111 permanent employees at the manufacturing facilities and administrative offices.
Particulars of Employees
The statement containing particulars of employees as required under Section 197(12) of the Companies Act, 2013 read with Rule 5(2) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 is given in an Annexure and forms part of this report.
In terms of Section 136(1) of the Companies Act, 2013, the Report and the Accounts are being sent to the Members excluding the aforesaid Annexure. Any Member interested in obtaining a copy of the Annexure may write to the Company Secretary at the Registered Office of the Company for a copy of it.
The Company does not have any material subsidiary whose net worth exceeds 10% of the consolidated net worth of the Company in the immediately preceding accounting year or has generated 10% of the consolidated income of the Company during the previous Financial Year. A policy on material subsidiaries had been formulated and is available on the website of the Company and the web link thereto is: https:// www.aarti-industries.com/investors/GetReport?strcont id=A8DuSuG1AT8OIQL33MM
During the year, the Board of Directors reviewed the affairs of the subsidiaries. In accordance with Section 129(3) of the Companies Act, 2013, we have prepared consolidated financial statements of the Company and all its subsidiaries, which form part of the Annual Report.
Further a statement containing salient features of the financial statement of our Subsidiaries/Jointly controlled entity in the prescribed format AOC-1 is included in the Report as Annexure-C and forms an integral part of this Report.
Directors and Key Managerial Personnel (KMP)
In accordance with the prevailing provisions of the Section 149 of the Companies Act, 2013 read with Regulation 17 of the Listing Regulations, as amended from time to time, as on March 31, 2021, the Board of Directors, comprises of Sixteen Directors (with Eight Executive Directors and Eight Independent Directors).
Shri Ramdas M. Gandhi, Independent Director of the Company left for heavenly abode on July 16, 2021. He was on the Board of the Company since January 29, 1990. The Company places on record appreciation for his guidance, mentoring and contribution to the growth of the Company throughout his tenure.
At 37th AGM held on September 21,2020, Shri Narendra J. Salvi (DIN: 00299202) has been appointed as the Executive Director for a period of five years w.e.f. April 1, 2020.
In accordance with the provisions of Section 152 of Companies Act, 2013, Shri Parimal H. Desai (DIN: 00009272) and Smt. Hetal Gogri Gala (DIN: 00005499) Executive Directors of the Company are liable to retire by rotation at the ensuing Annual General Meeting and, being eligible, offer themselves for reappointment. The Board recommends their re-appointment for the consideration of the Members.
The existing term of the Managing Director Shri Rashesh C. Gogri (DIN: 00066291) will come to an end on June 8, 2022. Based upon the performance evaluation rating, merits and recommendation of Nomination and Remuneration Committee of the Board, your Directors recommend his re-appointment for a further period of Five years effective from June 9, 2022.
Material changes and commitment if any affecting the financial position of the company occurred between the end of the financial year to which this financial statements relate and the date of the report
Except the change in Share Capital as stated above in this report, there are no other material changes and commitments affecting the financial position of the Company occurred between the end of the Financial Year to which these financial statements relate and the date of the report.
Consolidated Financial Statements
In accordance with the provisions of Companies Act, 2013 (hereinafter referred to as "the Act"), Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (hereinafter referred to as "Listing Regulations") and applicable Accounting Standards, the Audited Consolidated Financial Statements of the Company for the FY 2020-21, together with the Auditorsâ Report, form part of this Annual Report.
Investor Education and Protection Fund (IEPF)
Pursuant to the applicable provisions of the Companies act, 2013 read with IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 (''the Rulesâ) all unpaid or unclaimed dividends are required to be transferred by the Company to the IEPF established by the government of India, after the Completion of seven years. Further, according to the rules, the shares on which Dividend has not been paid or claimed by the Shareholders for seven consecutive years or more shall be transferred to the Demat account of the IEPF Authority. Accordingly the Company has transferred the unclaimed and unpaid dividends of '' 36,86,098/-. Further 27445 corresponding shares were transferred as per the requirement of the I EPF Rules.
Pursuant to Section 92(3) read with Section 134(3)(a) of the Act, the Annual Return as on March 31, 2021 is available in prescribed format on the Companyâs website on www.aarti-industries.com
As on March 31, 2021, the Company has 9 (Nine) direct subsidiaries, namely, Aarti Corporate Services Limited, Innovative Envirocare Jhagadia Limited, Aarti Polychem Private Limited, Aarti Organics Limited, Aarti Bharuch Limited, Aarti Spechem Limited, Aarti Pharmachem Limited, Aarti USA Inc. and Alchemie (Europe) Limited, and 2 (Two) indirect subsidiaries namely Shanti Intermediates Private Limited, Nascent Chemical Industries Limited both hold through Aarti Corporate Services Limited.
During the year under review, Ganesh Polychem Limited ceased to be Subsidiary of the Company w.e.f March 17, 2021 and became a jointly controlled entity with 50% Shareholding.
b. That the Directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the company at the end of the Financial Year and of the profit and loss of the company for that period;
c. That the Directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the Assets of the Company and for preventing and detecting fraud and other irregularities;
d. That Directors have prepared the annual accounts on a going concern basis;
e. The Directors had laid down internal financial controls to be followed by the Company and that such internal financial controls are adequate and were operating effectively;
f. The Directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.
Corporate Governance
Corporate Governance essentially involves balancing the interests of a Companyâs stakeholders. The Company continues to nurture a culture of good governance practices across functions, offices and manufacturing facilities.
Your Company has complied with the mandatory Corporate Governance requirements stipulated under the Listing Regulations. The separate Report on Corporate Governance is annexed hereto forming part of this report. The requisite certificate from Kirtane & Pandit LLP, Chartered Accountants is attached to the Report on Corporate Governance.
Management''s Discussion and Analysis Report
Pursuant to Regulation 34 read with Schedule V to the Securities and Exchange Board of India (LODR) Regulations, 2015 ("Listing Regulations"), Managementâs Discussion and Analysis for the year under review is presented in a separate section forming part of the Annual Report.
Business Responsibility Reporting (BRR)
The Listing Regulations mandate the inclusion of the BRR as part of the Annual Report for top 1000 listed entities based on market capitalisation. Business Responsibility Reporting for the year under review, as stipulated under Regulation 34 (f) of Listing Regulations read with SEBI Circular No. CIR/CfD/ CMD/10/2015 dated November 4, 2015 is in a separate section forming part of the Annual Report.
Pursuant to Regulation 36 of the Listing Regulations read with Secretarial Standard-2 on General Meetings, a brief profile of the Directors proposed to be Re-appointed is made available, as an Annexure to the Notice of the Annual General Meeting.
None of the Directors of the Company are disqualified or as per SEBI order debarred from being appointed / re-appointed / holding position as Directors of the Company.
Statement on declaration given by independent directors under sub-section (6) of section 149
In accordance with Section 149 (7) of the Companies Act, 2013, all Independent Directors have given declarations that they meet the criteria of independence as laid down under Section 149(6) of the Companies Act, 2013 and Regulation 16 of the Listing Regulations.
In the opinion of the Board, Independent Directors fulfill the conditions specified in Companies Act, 2013 read with the Schedules and Rules issued thereunder as well as Listing Regulations and are independent from Management and hold the highest degree of integrity and are individuals who are experts in their respective fields with enormous experience.
All the Independent Directors of the Company have enrolled their names in the online database of Independent Directors by Indian Institute of Corporate Affairs in terms of the recently introduced regulatory requirements.
Familiarisation Programme for Independent Directors
The Company has a Familiarisation programme for its Independent Director which is imparted at the time of appointment of an Independent Director on Board as well as annually. During the year, the Independent Directors of the Company were familiarised and the details of familiarisation programmes imparted to them are placed on the website of the Company and the web link thereto is: https://www.aarti-industries.com/Upload/PDF/Fmiliarisation-Programme-FY-7070-71.pdf
During the year under review, there was no change in the Key Managerial Personnel of the Company.
Directors'' Responsibility Statement
To the best of their knowledge and belief and according to the information and explanations obtained by them, your Directors make the following statements in terms of Section 134(3)(c) of the Companies Act, 2013:
a. That in the preparation of the annual financial statements for the year ended March 31, 2021, the applicable accounting standards have been followed along with proper explanation relating to material departures, if any;
The Board of Directors met Five(5) times during the financial year under review. The details of the number of meetings of the Board held during the Financial Year 2020-21 and the details of attendance of each Director at these meetings are provided in the Corporate Governance Report forming part of the Annual Report. The Maximum Gap between two meetings did not exceed 120 days, as prescribed in the Companies Act, 2013.
Pursuant to the provisions of Companies Act, 2013 and the Listing Regulations, a structured questionnaire was prepared after taking into consideration, various aspects of the Boardâs functioning, composition of the Board and its Committees, culture, execution and performance of specific duties, obligations and governance.
The performance of the Committees and Independent Directors were evaluated by the entire Board of Directors except for the Director being evaluated. The performance evaluation of the Chairman, Non-Independent Directors and Board as a whole was carried out by the Independent Directors. The Board of Directors expressed their satisfaction with the outcome of evaluation and the process followed thereof.
Nomination and Remuneration Policy
Your Company has in place a nomination and remuneration policy which lays down a framework in relation to remuneration of Directors, Key Managerial Personnel and Senior Management of the Company. The policy also lays down criteria for selection and appointment of Board Members.
The details of this policy are given in the Corporate Governance Report.
In compliance with Regulation 21 of Listing Regulations, Your Company has a Risk Management Committee consisting of Shri Rajendra Gogri (Chairman), Shri Rashesh Gogri, Shri Bhavesh R. Vora, Smt. Hetal Gogri Gala, Shri Renil Gogri, Shri Narendra J. Salvi, Shri Chetan Gandhi and Shri Ajaykumar Gupta. The Committee through its dynamic risk management framework continuously identifies, evaluates and takes appropriate measures to mitigate/minimize various elements of risks.
Safety, Health and Environment
Being a responsible organization, we at Aarti Industries Limited (AIL), are committed to maintain the world-class standards of health, safety, security, human rights, environment protection, product quality and processes while conducting all our business operations, services, and expansion activities. To enable this, AIL has created a culture of Aarti Engaging Leaders, committed to live by Aarti Values of Care, Integrity and Excellence and empowering everyone in the hierarchy to speak powerfully. Further to have better implementation of our strategy, we have
realigned the structure of organization into Pillar / Vertical / Group structure.
During FY 2020-21, We have implemented various elements under our flagship initiative "By Employees Sustainability Assurance for Employees (BE SAFE)", a mega initiative with objectives of ''Assurance on Complete Health Check of the Plantsâ and ''Zero-Harmâ. With help of these, we have succeeded in bringing behavioural change amongst our people.
Furthermore, we have developed and implemented several Process Initiative Common (PICs) with specific objectives. Some of the focus areas are elimination of exposure to hazardous chemicals, reduction of electrical incidents to zero, achievement of zero leakage status, etc. In addition to PICs we have also designed and adopted guidelines and Standard Operating Procedures (SOPs) to minimize discretionary actions which may lead to accidents and hazards. Such standardizations have strengthened our efforts towards environment, health & safety.
Responsible Care
Our robust performance on EH&S has led to our success in getting Responsible Care (RC) logo. RC is a global chemical manufacturing industryâs environmental, health, safety and security performance initiative. RC logo is not only an endorsement of our exemplary EH&S practices but also it shall help us in improving our environmental, health, safety and security (EHS&S) performance for facilities, processes and products throughout the entire operating system through its guiding principles.
EcoVadis
Our significant efforts in improving our ESG performance has led to achieving gold medal in EcoVadis CSR assessment, placing AIL among the top 5 percent of companies assessed by EcoVadis.
Compliance Management System
At AIL we are committed to achieve 100% compliance. We have adopted a third-party managed IT-based Compliance Management System. It has a repository of all applicable regulations and requisite compliances. It has an in-built alert system that intimates concerned personnel about upcoming compliances. Last year, we added a module on ''License Managementâ into our compliance management system. Newly added license management system helps us in tracking the validity and renewal process of all applicable licenses. We initiate the license renewal process 90 days in advance to avoid any delays.
Zero Liquid Discharge
As a responsible organization, we are committed to protect and prevent the environment. Efficient usage of water is of high priority to us, making it a high material topic for us and our delighted stakeholders. Towards reducing our water
footprint, we are focussing on 3R (Reduce, Reuse & Recycle) and strategizing to achieve zero-liquid discharge (ZLD) for our facilities. Currently, 14 of our manufacturing sites have ZLD facilities. Further we have planned to achieve 100% ZLD status within the next 3 years. We have adopted a proactive approach for ZLD and incorporated it in the conceptualisation & designing phase of new projects.
COVID Management
Continuation of plant activities during COVID-19 pandemic was a challenging task. We adopted new norms of social distancing, workplace hygiene, and shift management to eliminate exposure and spread of COVID-19. We undertook several initiatives to manage the pandemic situation; some of these are mentioned below:
⢠Commitment for abiding with COVID-19 precautions by incorporating it in Safety Pledge
⢠Arrangement of shelter and food for workers and their families
⢠Dedicated panel of doctors along with one specialist doctor for providing medical aid to all employees
⢠Assuring Emotional & Mental well-being of employees through "ANAHATA" initiative
⢠Intensive COVID-19 testing for our employees
⢠Periodical sanitization of workplace
⢠Provision of immunity boosters to our workers and employees
⢠Providing all possible supports to employees with COVID-19 disease
⢠Providing transport facilities to employees and workers
In addition to these, we have developed COVID-19 management plans for various scenarios segregated into L-1, L-2, and L-3 levels. Based on our robust preparedness and responsiveness we successfully ensured business continuity during COVID-19 pandemic.
Reliability
We have initiated an Operational Excellence journey with focus to improve reliability. Initiatives like OEE (Overall Equipment Effectiveness) improvement, Quality Circles, Autonomous maintenance and through investigation of T-IHC (Throughput-Incident of High Consequence) deviation have resulted in improvement in reliability through involvement of the associate family and in turn benefited in achieving our safety and sustainability objectives.
Some of the initiatives in this regard as briefed below:
Vigil Mechanism/Whistle Blower Policy
The Company has established a Vigil Mechanism and Whistle Blower Policy for its Directors and employees to report concerns about unethical behaviour, actual or suspected fraud, actual or suspected leak of UPSI or violation of Companyâs Code of Conduct. It also provides for adequate safeguards against the victimisation of employees and allows direct access to the chairperson of the audit committee in exceptional cases The said policy has been posted on the website of the Company and the web link thereto is: https:// www.aarti-industries.com/investors/GetReport?strcont id=ZMPluse33MMnrACtosYOIQL33MM
The Company affirms that no person has been denied access to the Audit Committee Chairman.
In accordance with the provisions of Section 139 of the Companies Act, 2013, Kirtane & Pandit LLP. Chartered Accountants (Firm Registration No: 105215W/W100057) were appointed as Statutory Auditor of your Company at the 35th Annual General Meeting for a term of 4 years, to hold office from that meeting till the conclusion of 39th Annual General Meeting to be held in 2022. As per the provisions of Section 139 of the Act, they have confirmed that they are not disqualified from continuing as Auditors of the Company.
There are no qualifications, reservations or adverse remarks or disclaimer made by the Auditor in their report. The Auditors of the Company have not reported any instances of fraud committed against the Company by its officers or employees as specified under Section 143(12) of the Companies Act, 2013.
In terms of the Section 148 of the Companies Act, 2013 read with the Companies (Cost Record and Audit) Rules, 2014 the Company is required to maintain cost accounting records and have them audited every year.
The Board has appointed Ketaki D. Visariya, Cost Accountants, (Membership No.16028) as the Cost Auditors of the Company for FY 2021-22 under Section 148 and all other applicable provisions of the Act.
The remuneration payable to the Cost Auditor is required to be placed before the Members in a General Meeting for their ratification. Accordingly, a resolution for seeking Memberâs ratification for the remuneration payable to Ketaki D. Visariya, Cost Accountants, is included at Item No. 7 of the notice convening the Annual General Meeting.
The Company has maintained cost records as specified under section 148(1) of the Act.
any one which may fall under the ambit of ''Sexual Harassment at workplace. The Policy framed by the Company in this regard provides for protection against sexual harassment of women at workplace and for prevention and redressal of such complaints.
Internal Complaints Committees (ICC) have been set up to redress complaints received regarding sexual harassment. Details of Internal Complaints Committee.
Status of the Complaints during the FY 2020-21 is as follows:
Secretarial Auditor & their Report
Pursuant to the provisions of Section 204 of the Companies Act, 2013 and rules made thereunder, the Company had appointed CS Sunil M. Dedhia (COP No. 2031), Proprietor of Sunil M. Dedhia & Co., Company Secretary in Practice to undertake the Secretarial Audit of the Company.
Pursuant to provisions of Section 204(1) of the Companies Act, 2013 and Regulation 24A of the Listing Regulations, the Secretarial Audit Report for the financial year ended March 31, 2021 issued by CS Sunil M. Dedhia (COP No. 2031), Proprietor of Sunil M. Dedhia & Co. Company Secretary in Practice and the Secretarial Auditor of the Company is annexed as Annexure - B and forms an integral part of this Report. During the year under review, the Secretarial Auditor had not reported any fraud under Section 143(12) of the Act.
There is no qualification, reservation or adverse remark or disclaimer made by the Auditor in their report. As regards the observations of the Secretarial Auditor in their Report, the same is self explanatory and need no further clarifications.
Internal Control Systems and their adequacy
Your Company has clearly laid down policies, guidelines and procedures that form part of internal control systems, which provide for automatic checks and balances. Your Company has maintained a proper and adequate system of internal controls. The Company has appointed Shri Rakesh Pandey as an Internal Auditor who periodically audits the adequacy and effectiveness of the internal controls laid down by the management and suggests improvements. This ensures that all Assets are safeguarded and protected against loss from unauthorised use or disposition and that the transactions are authorised, recorded and reported diligently. Your Companyâs internal control systems commensurate with the nature and size of its business operations. Internal Financial Controls are evaluated and Internal Auditorsâ Reports are regularly reviewed by the Audit Committee of the Board.
Statutory Auditors Report on Internal Financial Controls as required under Clause (i) of Sub-section 3 of Section 143 of the Companies Act, 2013 ("the Act") is annexed with the Independent Auditorsâ Report.
Secretarial Standards Compliance
During the year under review, the Company has complied with all the applicable Secretarial Standards issued by the Institute of Company Secretaries of India and approved by the Central Government pursuant to Section 118 of the Companies Act, 2013.
Number of cases filed, if any, and their disposal under section 22 of the sexual harassment of women at work place (prevention, prohibition and redressal) act, 2013
Your Company is fully committed to uphold and maintain the dignity of every woman working with the Company. The Company has Zero tolerance towards any action on the part of
Particulars |
No. of Complaints |
Number of Complaints pending as on beginning of the Financial Year |
NIL |
Number of Complaints filed and resolved during the Financial Year |
NIL |
Number of Complaints pending as on the end of the Financial Year |
NIL |
The Company has complied with the provisions relating to the constitution of Internal Complaints Committee under the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013.
Conservation of energy, technology absorption, foreign exchange earnings and outgo
The particulars relating to conservation of energy, technology absorption, foreign exchange earnings and outgo required under Section 134(3)(m) of the Companies Act, 2013, read with Rule 8(3) of the Companies (Accounts) Rules, 2014, as amended from time to time, are provided in Annexure-D to this report.
Significant and material orders passed by the regulators or courts
There are no significant material orders passed by the Regulators/Courts which would impact the going concern status of the Company and its future operations.
Acknowledgement
The Board of Directors places on record its sincere appreciation for the dedicated services rendered by the employees of the Company at all levels and the constructive cooperation extended by them. Your Directors would like to express their grateful appreciation for the assistance and support by all Shareholders, Government Authorities, Auditors, financial institutions, Customers, employees, suppliers, other business associates and various other stakeholders.
For and on behalf of the Board Sd/-
Rajendra V. Gogri
Chairman and Managing Director
Place: Mumbai Date: August 6, 2021
Mar 31, 2018
To,
The Members of
AARTI INDUSTRIES LIMITED
The Directors are pleased to present this Thirty Fifth Annual Report and the Audited Statement of Accounts for the year ended March 31, 2018.
Financial Highlights
(Figures in Rs. Crores)
STANDALONE |
CONSOLIDATED |
|||
Particulars |
2017-18 |
2016-17 |
2017-18 |
2016-17 |
Total Income from Operations (Net) |
3699 |
3050 |
3806 |
3163 |
EBIDTA (without other income) |
657 |
608 |
699 |
654 |
Depreciation & Amortization |
136 |
115 |
146 |
123 |
Profit/(Loss) from Operations before Other Income, Finance Costs and Exceptional Items |
521 |
493 |
553 |
531 |
Other Income/Exceptional Items |
2 |
3 |
8 |
2 |
Profit/(Loss) before Finance Costs |
523 |
496 |
561 |
533 |
Finance Costs |
131 |
117 |
132 |
117 |
Profit/(Loss) before Tax |
392 |
379 |
429 |
416 |
Total Tax Expenses |
76 |
72 |
83 |
88 |
Non-controlling Interest |
- |
- |
(13) |
(12) |
Net Profit/(Loss) after consolidation |
316 |
307 |
333 |
316 |
Earnings Per Share (Rs.) |
38.92 |
37.35 |
40.95 |
38.45 |
Book Value Per Share (Rs.) |
186.37 |
159.53 |
203.62 |
173.69 |
Financial Performance
Your Company reported Gross Total Income of Rs. 3,699 Crores for FY 2017-18 as compared to Rs. 3,050 Crores for FY 201617. Similarly the exports for the year were of Rs. 1,593 Crores for FY 2017-18 as compared to Rs. 1,415 Crores for FY 2016-17.
Your Companyâs Earnings Before Interest Depreciation and Taxes stood at Rs. 659 Crores for FY 2017-18 as compared to Rs. 611 Crores for FY 2016-17, registering a growth of 8%. Net Profit Before Tax rose by 4% to Rs. 392 Crores for FY 2017-18 as compared to Rs. 379 Crores for FY 2016-17.
Net Profit after Tax & Deferred Tax also grew by 3% to Rs. 316 Crores for FY 2017-18 as compared to Rs. 307 Crores for FY 2016-17.
The Consolidated Total Income for FY 2017-18 was of Rs. 3,806 Crores as compared to Rs. 3,163 Crores for FY 2016-17 and exports for FY 2017-18 were Rs. 1,691 Crores as compare to Rs. 1,523 Crores for FY 2016-17.
On a Consolidated basis, your Companyâs Earnings Before Interest Depreciation and Taxes stood at Rs. 707 Crores for FY 2017-18 as compared to Rs. 655 Crores for FY 2016-17, registering a growth of 8%. Net Profit after consolidation grew by 5% to Rs. 333 Crores for FY 2017-18 as compared to Rs. 316 Crores for FY 2016-17. Consolidated EPS surged by about 7% at Rs. 40.95 for FY 2017-18, as compared to Rs. 38.45 for FY 2016-17.
Dividend
Your directors are pleased to recommend a Dividend of Rs. 1 (@20%) per Share (of Rs. 5/-each) amounting to dividend pay out of Rs. 8.13 Crores for the financial year 2017-18 (Previous Year Rs. 8.21 Crores). Your Company will pay the Tax on dividend as per the provisions of the income Tax Act, 1961.
Transfer to Reserves
Your Company has transferred Rs. 32 Crores to General Reserve (Previous Year: Rs. 31 Crores) and Rs. 30 Crores to Debenture Redemption Reserve (Previous Year: Rs. 30 Crores).
Company has transferred to Capital Redemption Reserve Rs. 0.41 Crores equal to the nominal value of the shares bought back as on appropriation from the General Reserve.
Share Capital
The Company had on March 15, 2018 completed Buyback of 8,20,383 (Eight Lakh Twenty Thousand Three Hundred Eighty Three) fully paid up Equity Shares (representing up to about 1% of the total number of Equity shares of the Company) from the Equity Shareholders/ Beneficial owners of the Company who held Equity Shares as on the record date i.e. January 5, 2018 (âRecord Dateâ) on a proportionate basis through the tender offer using stock exchange mechanism (âTender offerâ) at a price of Rs. 1200/- (Rupees One Thousand Two Hundred Only) per Equity Share (âBuyback Priceâ). The number of Equity Shares thus reduced from 8,21,20,383 to 8,13,00,000 post Buyback and accordingly Issued, Subscribed and Paid-up Capital reduced to Rs. 40,65,00,000/Apart from the above, there were no changes in the Share Capital during the Financial Year under review.
Investor Education and Protection Fund (IEPF)
Pursuant to the applicable provisions of the Companies Act, 2013 read with IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 (âthe Rulesâ) all unpaid or unclaimed dividends are required to be transferred by the Company to the IEPF established by the Government of India, after the completion of seven years. Further, according to the rules, the shares on which Dividend has not been paid or claimed by the Shareholders for seven consecutive years or more shall be transferred to the Demat account of the IEPF Authority. Accordingly the Company has transferred the unclaimed and unpaid dividends of Rs. 14,99,573/- to IEPF and 2,56,266 such shares were transferred as per the requirement of the IEPF Rules.
Managementâs Discussion and Analysis Report
Managementâs Discussion and Analysis Report for the year under review, as stipulated under Regulation 34 read with Schedule V to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (âListing Regulationsâ), is presented in a separate section forming part of the Annual Report.
Corporate Governance
Corporate Governance essentially involves balancing the interests of a Companyâs stakeholders. Corporate Governance practices of our Company are a reflection of our values, polices and relationship with our stakeholders. Your Company has complied with the mandatory Corporate Governance requirements stipulated under Regulation 34(3) of the Listing Regulations. Report on Corporate Governance is annexed hereto forming part of this report.
Conservation of Energy, Technology Absorption, Foreign Exchange Earnings and Outgo
Information required under Section 134(3)(m) of the Companies Act, 2013, read with Rule 8(3) of the Companies (Accounts) Rules, 2014, as amended from time to time, forms a part of this in Annexure-E.
Directors / Key Managerial Personnel (KMPs)
Vice Chairman, Shri Shantilal T. Shah (DIN: 00004850) and Whole time Director, Shri Parimal H. Desai (DIN: 00009272), of the Company shall retire by rotation at the ensuing Annual General Meeting (AGM) and being eligible, offers themselves for re appointment.
Shri Radheshyam S. Rohra (DIN: 00163318), who was appointed as an additional Director in the category of Independent Director by the Board of Directors effective from December 21, 2017, has been proposed by the Board based on recommendation of Nomination and Remuneration Committee (NRC), to be appointed as an Independent Director as such at ensuing AGM.
Present Term of Prof. Ganapati D. Yadav (DIN: 02235661) and Smt. Priti P. Savla (DIN: 00662996) Independent Directors of the Company would be expiring on September 23, 2018. Your Directors based on recommendation of Nomination and Remuneration Committee (NRC) propose their re-appointment as an Independent Directors for a second term by passing a special resolution.
Shri Raj Sarraf has been appointed as the Company Secretary and Compliance Officer of the Company with effect from November 16, 2017 in place of Smt. Mona Patel who resigned with effect from November 14, 2017.
Familiarisation Programme
The Independent Directors of the Company were familiarised and the details of familiarisation programmes imparted to them are placed on the website of the Company and the web link thereto is http://aarti-industries.com/investors/corporategovernance/
Remuneration and Nomination Policy
The Board of Directors has framed a policy which lays down a framework in relation to remuneration of Directors, Key Managerial Personnel and Senior Management of the Company. The policy also lays down criteria for selection and appointment of Board Members.
The details of this policy are given in the Corporate Governance Report.
Board Evaluation
Pursuant to the provisions of Companies Act, 2013 and the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, a structured questionnaire was prepared after taking into consideration, various aspects of the Boardâs functioning, composition of the Board and its Committees, culture, execution and performance of specific duties, obligations and governance.
The performance evaluation of the Independent Directors was completed. The performance evaluation of the Chairman and Non-Independent Directors was carried out by the Independent Directors. The Board of Directors expressed their satisfaction with the evaluation process.
Independent Directorsâ Declaration
All Independent Directors have given declarations in the prescribed format that they meet the criteria of independence as laid down under Section 149(6) of the Companies Act, 2013 and Regulation 16 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015.
Directorsâ Meetings
The details of the number of meetings of the Board held during the Financial Year 2017-18 forms part of the Corporate Governance Report. Maximum gap between two meetings did not exceed 120 days, as prescribed in the Companies Act, 2013.
Human Resources Development and Industrial Relations
The Company enjoyed excellent relationship with workers and staff during the year under review. The Company care for its Stakeholders, Customers, Suppliers and Community at large which reflects in companyâs policy, programs and development efforts. Your Company is committed to build and strengthen our human capital by defining policies that support their growth, goals, and help them achieve excellence. As on March 31, 2018 the Company had 4,642 permanent employees at its manufacturing plants and administrative offices.
Disclosure Under the Sexual Harassment of Women at Work Place (Prevention, Prohibition and Redressal) Act, 2013
Your Company has Zero tolerance towards any action on the part of any one which may fall under the ambit of âSexual Harassmentâ at workplace, and is fully committed to uphold and maintain the dignity of every women working with the Company. The Policy framed by the Company in this regard provides for protection against sexual harassment of women at workplace and for prevention and redressal of such complaints.
Particulars |
No. of Complaints |
Number of Complaints pending as on beginning of the Financial Year |
NIL |
Number of Complaints filed during the Financial Year |
NIL |
Number of Complaints pending as on the end of the Financial Year |
NIL |
Personnel
The statement containing particulars of employees as required under Section 197(12) of the Companies Act, 2013 read with rule 5(2) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 is given in an Annexure and forms part of this report.
In terms of Section 136(1) of the Companies Act, 2013, the Report and the Accounts are being sent to the Members excluding the aforesaid Annexure. Any Member interested in obtaining a copy of the Annexure may write to the Company Secretary at the Registered Office of the Company for a copy of it.
Corporate Social Responsibility
Our company through, Aarti Foundation & Dhanvallabh Charitable Trust and various other NGOs has been doing work in following Segments:
Cluster & Rural Development
Education & Skill Development
Childcare & Healthcare Facilities
Women Empowerment & Livelihood Opportunities
Disaster Relief & Rehabilitation
Eradication of Hunger & Poverty
Water Conservation & Environment
Research & Development work for upliftment of Society
Rural Education, Water Conservation, Tribal Welfare, Agriculture, Animal Husbandry, Health and Hygiene, Disaster Relief and Rehabilitation, are the main areas of focus in the social welfare plans of our CSR Activities. Many of our Pilot projects had been appreciated by various NGOâs and Other Corporate Houses who have also started adopting those models thereby multiplying the magnitude of the reach of these social activities for the benefit of the Society at large.
The detailed policy on Corporate Social Responsibility is available on the website of the Company on the weblink http://aarti-industries.com/investors/corporategovernance/
A brief note on various CSR initiatives undertaken during the year is presented earlier in this Annual report.
CSR annual report is annexed as Annexure-A and forms an integral part of the Report.
Material Changes and Commitments
The Board of Directors in their meeting held on June 28, 2018 has approved the Scheme of Arrangement pertaining to demerger of Home & Personal Care Segment of the Company into Arti Surfactants Limited and demerger of manufacturing under taking of Nascent Chemical Industries Limited into Company.
Company has incorporated a wholly owned subsidiary, Arti Surfactants Limited on June 18, 2018 for proposed demerger and absorption of Home & Personal Care under taking.
Auditors
Statutory Auditors
In the 35th Annual General Meeting (AGM) of the Company Reappointment of M/s. Kirtane & Pandit LLP (Firm Registration No: 105215W/ W100057), Chartered Accountants would be considered by the members of the Company to hold office from the conclusion of 35th AGM until the conclusion of 39th AGM of the Company.
Cost Auditors
The Cost Auditor Ms. Ketki D. Visariya (Fellowship No.16028), Cost Accountant was re-appointed by the Company under provisions of Section 148(5) read with Section 141 of the Companies Act, 2013 and she attended the Audit Committee Meeting, where cost audit reports are discussed.
The due date for filing the Cost Audit Reports in XBRL mode for the Financial Year ended March 31, 2017 was September 30, 2017 and the Cost Audit Reports were filed on September 27, 2017. The due date for filing the Cost Audit Reports for the Financial Year ended March 31, 2018 is September 30, 2018.
The Company is seeking the ratification from the Shareholders for the Remuneration of Ms. Ketki D. Visariya, Cost Auditor of the Company for the Financial Year ending March 31, 2019 vide resolution no. 13 of the Notice of AGM.
Secretarial Auditor & Their Report
Pursuant to the provisions of Section 204 of the Companies Act, 2013 and rules made thereunder, the Company has appointed CS Sunil M. Dedhia (COP No. 2031), Proprietor of Sunil M. Dedhia & Co., Company Secretaries to undertake the Secretarial Audit of the Company. The Secretarial Audit Report is included as Annexure D and forms an integral part of this Report.
Explanation or Comments on disqualifications, reservations, adverse remarks or disclaimers in the auditorâs reports:
There have been no disqualifications, reservations, adverse remarks or disclaimers in the auditorâs reports, requiring explanation or comments by the Board.
Risk Management
Risk Management Committee through its dynamic risk management framework continuously identifies, evaluates and takes appropriate measures to mitigate various elements of risks.
Internal Control Systems and Their Adequacy
Your Company has clearly laid down policies, guidelines and procedures that form part of internal control systems, which provide for automatic checks and balances. Your Company has maintained a proper and adequate system of internal controls. This ensures that all Assets are safeguarded and protected against loss from unauthorized use or disposition and that the transactions are authorised, recorded and reported diligently. Your Companyâs internal control systems commensurate with the nature and size of its business operations. Internal Financial Controls are evaluated and Internal Auditorsâ Reports are regularly reviewed by the Audit Committee of the Board.
Statutory Auditors Report on Internal Financial Controls as required under Clause (i) of Sub-section 3 of Section 143 of the Companies Act, 2013 (âthe Actâ) is annexed with the Independent Auditorsâ Report.
Business Responsibility Reporting
Business Responsibility Reporting for the year under review, as stipulated under Regulation 34 read with SEBI Circular No CIR/ CFD/CMD/10/2015 dated November 4, 2015 is in a separate section forming part of Annual Report.
Safety, Health and Environment
Your Company is committed to ensure a sound Safety, Health and Environment (SHE) performance related to its activities, products and services. Your Company had been continuously taking various steps to develop and adopt Safer Process technologies and unit operations. Your Company has been investing heavily in areas such as Process Automation for increased safety and reduction of human error element, Enhanced level of training on Process and Behaviour based safety, adoption of safe & environmental friendly production process, Installation of Bioreactors, Chemical ROs, Multiple effect evaporator and Incinerator, etc to reduce the discharge of effluents, commissioning of Waste Heat recovery systems, and so on to ensure the Reduction, Recovery and Reuse of effluents & other utilities. Monitoring and periodic review of the designed SHE Management System are done on a continuous basis.
Some of the ongoing initiatives in this regard are briefed below:
Introducing Aarti Management System: An in-house developed framework of 32 elements detailing procedures and processes catering to all Plant Related Activities - 3 elements namely MOC (to manage change), BBS (major root causes of incidents are due to behaviour) and Permit Systems catering to reduce SHE related risks had been launched and being implemented at various levels of operations. Other elements are being developed and reviewed and would be adopted in due course
Review Existing Process Safety Parameters: Structured & regular HAZOP meetings are being carried out as per scheduled HAZOP calendar to further strengthen process safety of existing processes. Also HIRA (Hazard Identification and Risk Assessment) for procedures and practices are being initiated for some of the units and would be gradually implemented across various units.
Maintenance element with a purpose to achieve rated performance of assets throughout rated life is being launched. Standardisation of maintenance practices are under progress. Also the Plant Maintenance module (an IT enabled solution) are also being implemented with an objective to map and monitor all maintenance activities through the IT enabled system. This would help to have online reporting and tracking of various scheduled and unscheduled maintenance breakdown activities.
Systematic and well documented scale up procedure including risk assessment and process safety study at each stage of development from R&D to Pilot to Commercial Scale, to ensure inherently safe processes, has been developed.
With these and various other initiatives, your Company firmly places the SHE at the top of its goals and aims to provide a workplace which is safer and healthier for the society at large.
Related Party Transactions
All related party transactions that were entered into during the Financial Year were on armâs length basis and carried out in the ordinary course of the business. There are no materially significant related party transactions made by the Company with Promoters, Key Managerial Personnel or other designated persons which may have potential conflict with interest of the Company at large.
All related party Transactions are presented to the Audit Committee for approval. Omnibus approval is obtained for the transactions which are foreseen and repetitive in nature. A statement of all related party transactions is presented before the Audit Committee on quarterly basis, specifying the nature, value and terms and conditions of transactions.
The related party transactions policy is uploaded on the Companyâs website at the web-link given below : http://aarti-industries.com/investors/corporategovernance/
The details of Related party transactions are provided in the accompanying financial statements.
Since all related party transactions entered into by the Company were in ordinary course of business and were on an arms lengthâs basis, Form AOC-2 is not applicable to Company.
Whistle Blower Policy
The Company has a whistle blower policy to report genuine concerns or grievances. The Whistle Blower policy has been posted on the website of the Company and the web link thereto is http://aarti-industries.com/investors/corporategovernance/
Particulars of Loans, Guarantees or Investments
Details of Loans, Guarantees and Investments covered under the provisions of Section 186 of the Companies Act, 2013 are given in the Notes to the financial statements.
Deposits
The Company did not have any deposits at the beginning of the year under review. The Company has neither accepted nor renewed any deposits during the year under review.
The Company does not have any deposits which are not in compliance with the requirements of Chapter V of the Companies Act, 2013.
Annual Return
The details forming part of the extract of Annual Return in the Form MGT-9, as required under Section 92 of the Companies Act, 2013 is included in the Report as Annexure-B and forms an integral part of the Report.
Subsidiary Companies
The Company has 7 (Seven) direct subsidiaries, namely, Aarti Corporate Services Limited, Alchemie (Europe) Limited, Innovative Envirocare Jhagadia Limited, Ganesh Polychem Limited, Aarti USA Inc., Aarti Polychem Private Limited, Arti Surfactants Limited (incorporated on June 18, 2018) and 2 (two) indirect subsidiaries namely Shanti Intermediates Private Limited and Nascent Chemical Industries Limited both hold through Aarti Corporate Services Limited.
During the year, the Board of Directors reviewed the affairs of the subsidiaries. In accordance with Section 129(3) of the Companies Act, 2013, we have prepared consolidated financial statements of the Company and all its subsidiaries, which form part of the Annual Report.
Further a statement containing salient features of the financial statement of our Subsidiaries in the prescribed format AOC-1 is included in the Report as Annexure-C and forms an integral part of this Report. The statement also provides the details of performance, financial position of each of the Subsidiaries.
Material Subsidiary
The Company does not have any material subsidiary whose net worth exceeds 20% of the consolidated net worth of the Company in the immediately preceding Financial Year or has generated 20% of the consolidated income of the Company during the previous Financial Year. A policy on material subsidiaries had been formulated and is available on the website of the Company and the web link thereto is http://aarti-industries.com/investors/corporategovernance/
Dividend Distribution Policy
As per Regulation 43A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the top 500 listed companies shall formulate a dividend distribution policy. Accordingly, the policy has been adopted to set out the parameter and circumstances that will be taken in to account by the Board in determining the distribution of dividend to its shareholders and/ or retaining profits earned by the company. A policy is available on the website of the Company and the web link thereto is http://aarti-industries.com/investors/ corporategovernance/
Significant and Material Orders Passed by the Regulators or Courts
There are no significant material orders passed by the Regulators/Courts which would impact the going concern status of the Company and its future operations.
Directorsâ Responsibility Statement
To the best of their knowledge and belief and according to the information and explanations obtained by them, your Directors make the following statements in terms of Section 134(3)(c) of the Companies Act, 2013 :
a. That in the preparation of the annual financial statements for the year ended March 31, 2018, the applicable accounting standards have been followed along with proper explanation relating to material departures, if any;
b. That the directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the company at the end of the Financial Year and of the profit and loss of the company for that period;
c. That the Directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the Assets of the Company and for preventing and detecting fraud and other irregularities;
d. That Directorsâ have prepared the annual accounts on a going concern basis;
e. The directors, had laid down internal financial controls to be followed by the Company and that such internal financial controls are adequate and were operating effectively;
f. The directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.
Acknowledgement
The Board of Directors places on record its sincere appreciation for the dedicated services rendered by the employees of the Company at all levels and the constructive co-operation extended by them. Your Directors would also like to express their grateful appreciation for the assistance and support by all Shareholders, Government Authorities, Auditors, Financial Institutions, Customers, employees, suppliers, other business associates and various other stakeholders.
For and on behalf of the Board
Place : Mumbai Rajendra V. Gogri
Date: June 28, 2018 Chairman and Managing Director
Mar 31, 2017
Directors'' Report
To the Members of AARTI INDUSTRIES LIMITED
The Directors are pleased to present this Thirty Fourth Annual Report and the Audited Financial Statement for the year ended 31st March, 2017.
FINANCIAL RESULTS
(Figures in RS, Crores)
PARTICULARS |
STANDALONE |
CONSOLIDATED |
||
2016-17 |
2015-16 |
2016-17 |
2015-16 |
|
Total Income from Operations (Gross) |
3050 |
2934 |
3163 |
3007 |
EBIDTA |
608 |
530 |
653 |
572 |
Depreciation & Amortization |
115 |
93 |
123 |
98 |
Profit/(Loss) from Operations before Other Income, Finance Costs and Exceptional Items |
493 |
437 |
531 |
474 |
Other Income/Exceptional Items |
3 |
10 |
2 |
6 |
Profit/(Loss) before Finance Costs |
496 |
447 |
533 |
480 |
Finance Costs |
117 |
116 |
117 |
117 |
Profit/(Loss) before Tax |
379 |
331 |
416 |
363 |
Tax Expenses |
||||
a) Provision for Taxation-Current (net of MAT entitlement) |
49 |
43 |
59 |
55 |
b) Provision for Deferred Tax |
22 |
17 |
28 |
19 |
c) Short/(excess) Tax Provisions of earlier years |
1 |
19 |
1 |
21 |
Total Tax Expenses |
72 |
79 |
88 |
95 |
Share of Profit/(Loss) of Associates |
- |
- |
- |
- |
Non controlling Interest |
- |
- |
(12) |
(11) |
Net Profit/(Loss) after consolidation |
307 |
252 |
316 |
257 |
Earnings Per Share ( H) |
37.35 |
30.30 |
38.45 |
30.83 |
Book Value Per Share (H) |
159.53 |
131.26 |
173.69 |
142.75 |
Note :- Result for year ended 31st March, 2017 are in compliance with the Indian Accounting Standards (Ind-AS) notified by Ministry of Corporate Affairs. Consequently result for year ended 31st March, 2016 have been restated to comply with Ind-AS to make them comparable.
DIVIDEND
Your directors are pleased to recommend a Dividend of H1 (@20%) per Share (Face value of H5/-each) for the financial year 2016-17
Your Company has transferred RS,31 Crores to General Reserve (Previous Year: RS,25.25 Crores) and RS,30 Crores to Debenture Redemption Reserve (Previous Year: RS,30 Crores) also RS,0.60 Crores has been transferred to Capital Redemption Reserve pursuant to the scheme of Buy Back.
FINANCIALS
Your Company reported Gross Total Income at RS,3,050 Crores for FY 2016-17 as against RS,2,934 Crores for FY 2015
16. Similarly the exports for the year were at RS,1,415 Crores for FY 2016-17 v/s RS,1,352 Crores for FY 2015-16.
Your Company''s Earnings Before Interest Depreciation and Taxes stood at RS,611 Crores in FY 2016-17 as compared to RS,540 Crores in FY 2015-16, registering a growth of 13%. Likewise Net Profit Before Tax rose by 14% to RS,379 Crores in FY 2016-17 as compared to RS,331 Crores in FY 2015-16.
Likewise, Net Profit after Tax & Deferred Tax also grew by 21% to RS,307 Crores in FY 2016-17 as compared to RS,252 Crores in Financial Year 2015-16.
Likewise the Consolidated Total income for FY 2016-17 was at RS,3,163 Crores as compared to RS,3,007 Crores for FY 201516 and exports for FY 2016-17 was RS,1,523 Crores vs RS,1,431 Crores for FY 2015-16.
On a Consolidated basis, your Company''s Earnings Before Interest Depreciation and Taxes stood at RS,655 Crores in FY 2016-17 as compared to RS,578 Crores in FY 2015-16, registering a growth of 13%. Similarly, Net Profit after consolidation grew by 23% to RS,316 Crores in FY 2016-17 as compared to RS,257 Crores in FY 2015-16. Likewise, Consolidated EPS surged by about 25% at RS,38.45 for FY 2016-17, as compared to RS,30.83 for FY 2015-16.
SHARE CAPITAL
The Company had on 16th December, 2016 completed Buyback of 12,00,000 (Twelve Lakhs) fully paid up Equity Shares (representing up to about 1.44% of the total number of Equity shares of the Company) from all the Equity Shareholders/ Beneficial owners of the Company who held Equity Shares as on the record date i.e. 2nd November, 2016 ("Record Date") on a proportionate basis through the tender offer using stock exchange mechanism ("Tender offer") at a price of H800/- (Rupees Eight Hundred Only) per Equity Share (including premium of H795/- per share) for an aggregate amount of RS,96 crores. The number of Equity Shares reduced from 8,33,20,383 to 8,21,20,383 post Buyback and accordingly Issued, Subscribed and Paid-up Capital reduced to H41,06,01,915/-.
Apart from the above, there was no changes in the Share Capital during the Financial Year under review.
CORPORATE SOCIAL RESPONSIBILITY
Our Company through, Aarti Foundation & Dhanvallabh Charitable Trust and various other NGOs has been doing work in following Segments:
- Cluster & Rural Development
- Education & Skill Development
- Childcare & Healthcare Facilities
- Women Empowerment & Livelihood Opportunities
- Disaster Relief & Rehabilitation
- Eradication of Hunger & Poverty
- Water Conservation & Environment
- Research & Development work for upliftment of Society
Rural Education, Water Conservation, Tribal Welfare, Agriculture, Animal Husbandry, Health and Hygiene, Disaster Relief and Rehabilitation, are the main areas of focus in the social welfare plans of our CSR Activities. Many of our Pilot projects had been appreciated by various NGO''s and Other Corporate Houses who have also started adopting those models thereby multiplying the magnitude of the reach of these social activities for the benefit of the Society at large.
A brief note on various CSR initiatives undertaken during the year is presented earlier in this Annual report.
CSR annual report is annexed as Annexure-A and forms an integral part of the Report.
MATERIAL DEVELOPMENTS IN HUMAN RESOURCES/ INDUSTRIAL RELATIONS FRONT, INCLUDING NUMBER OF PEOPLE EMPLOYED.
As on March 31, 2017 the Company had 3862 permanent employees at its manufacturing plants and administrative office. The Company recognizes the importance of human value and ensures that proper encouragement both moral and financial is extended to employees to motivate them.
The Company enjoyed excellent relationship with workers and staff during the year under review.
REMUNERATION AND NOMINATION POLICY
The Board of Directors has framed a policy which lays down a framework in relation to remuneration of Directors, Key Managerial Personnel and Senior Management of the Company. The policy also lays down criteria for selection and appointment of Board Members.
The details of this policy are given in the Corporate Governance Report.
PERSONNEL
The statement containing particulars of employees as required under Section 197(12) of the Companies Act, 2013 read with rule 5(2) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 is given in an Annexure and forms part of this report.
In terms of Section 136(1) of the Companies Act, 2013, the Report and the Accounts are being sent to the Members excluding the aforesaid Annexure. Any Member interested in obtaining a copy of the Annexure may write to the Company Secretary at the Registered Office of the Company.
MATERIAL CHANGES AND COMMITMENT IF ANY AFFECTING THE FINANCIAL POSITION OF THE COMPANY OCCURRED BETWEEN THE END OF THE FINANCIAL YEAR TO WHICH THIS FINANCIAL STATEMENTS RELATE AND THE DATE OF THE REPORT
Company has incorporate a Wholly Owned Subsidiary Company in the name of Aarti Polychem Private Limited with an initial authorized share capital of H 1,00,000 (One Lakh) on 25th May, 2017. In spite of that no other material changes and commitment affecting the financial position of the company occurred between the end of the Financial Year to which this financial statements relate and the date of the report.
However, during the year under review there was a material change in the Share Capital pursuant to the Buyback of Equity shares of the Company. The details of which are mentioned under the head Share Capital of this report.
MEETINGS
The details of the number of meetings of the Board held during the Financial Year 2016-17 forms part of the Corporate Governance Report.
RISK MANAGEMENT
Risk Management Committee through its dynamic risk management framework continuously identifies, evaluates and takes appropriate measures to mitigate various elements of risks.
INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY
Your Company has clearly laid down policies, guidelines and procedures that form part of internal control systems, which provide for automatic checks and balances. Your Company has maintained a proper and adequate system of internal controls. This ensures that all Assets are safeguarded and protected against loss from unauthorized use or disposition and that the transactions are authorized, recorded and reported diligently. Your Company''s internal control systems commensurate with the nature and size of its business operations. Internal Financial Controls are evaluated and Internal Auditors'' Reports are regularly reviewed by the Audit Committee of the Board.
Statutory Auditors Report on Internal Financial Controls as required under Clause (i) of Sub-section 3 of Section 143 of the Companies Act, 2013 ("the Act") is annexed with the Independent Auditors'' Report.
MANAGEMENT''S DISCUSSION AND ANALYSIS REPORT
Management''s Discussion and Analysis Report for the year under review, as stipulated under Regulation 34 read with Schedule V to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), is presented in a separate section forming part of the Annual Report.
BUSINESS RESPONSIBILITY REPORTING
Business Responsibility Reporting for the year under review, as stipulated under Regulation 34 read with SEBI Circular No CIR/CFD/CMD/10/2015 dated 4th November, 2015 is forming part of this Annual Report. As a green initiative the BR Report has been hosted on the Company''s website www.aarti-industries.com
DIRECTORS'' RESPONSIBILITY STATEMENT
To the best of their knowledge and belief and according to the information and explanations obtained by them, your Directors make the following statements in terms of Section 134(3)(c) of the Companies Act, 2013 :
a. That in the preparation of the annual financial statements for the year ended 31st March, 2017, the applicable accounting standards have been followed along with proper explanation relating to material departures, if any;
b. That the directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the Financial Year and of the profit and loss of the Company for that period;
c. That the Directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the Assets of the Company and for preventing and detecting fraud and other irregularities;
d. That Directors'' have prepared the annual accounts on a going concern basis;
e. The directors, had laid down internal financial controls to be followed by the Company and that such internal financial controls are adequate and were operating effectively;
f. The directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.
RELATED PARTY TRANSACTIONS
All related party transactions that were entered into during the Financial Year were on arm''s length basis and were in the ordinary course of the business. There are no materially significant related party transactions made by the Company with Promoters, Key Managerial Personnel or other designated persons which may have potential conflict with interest of the Company at large.
All related party Transactions are presented to the Audit Committee. Omnibus approval is obtained for the transactions which are foreseen and repetitive in nature. A statement of all related party transactions is presented before the Audit Committee on quarterly basis, specifying the nature, value and terms and conditions of transactions.
The related party transactions policy is uploaded on the Company''s website at the web-link given below : http://aarti-industries.com/media/investors/corporate_ governance/1496727334_Related_Party_Transaction_ Policy.pdf
The details of Related party transactions are provided in the accompanying financial statements.
Since all related party transactions entered into by the Company were in ordinary course of business and were on an arms length''s basis, Form AOC-2 is not applicable to Company.
STATEMENT ON DECLARATION GIVEN BY INDEPENDENT DIRECTORS UNDER SUB-SECTION (6) OF SECTION 149
All Independent Directors have given declarations that they meet the criteria of independence as laid down under Section 149(6) of the Companies Act, 2013 and Regulation 16 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
CORPORATE GOVERNANCE
Your Company has complied with the mandatory Corporate Governance requirements stipulated under Regulation 34(3) of the Listing Agreement. Report on Corporate Governance is annexed hereto forming part of this report.
CONSOLIDATED FINANCIAL STATEMENT
Your Directors have pleasure in presenting Consolidated Financial Statements which form part of the Annual Report and Accounts.
ANNUAL RETURN
The details forming part of the extract of Annual Return in the Form MGT-9, as required under Section 92 of the Companies Act, 2013 is included in the Report as Annexure-B and forms an integral part of the Report.
DEPOSITS
The Company did not have any deposits at the beginning of the year under review. The Company has neither accepted nor renewed any deposits during the year under review.
The Company does not have any deposits which are not in compliance with the requirements of Chapter V of the Companies Act, 2013.
SECRETARIAL AUDIT
Pursuant to the provisions of Section 204 of the Companies Act, 2013 and rules made there under, the Company has appointed CS Sunil M. Dedhia (COP No. 2031), Proprietor of Sunil M. Dedhia & Co., Company Secretary in Practice to undertake the Secretarial Audit of the Company. The Secretarial Audit Report is included as Annexure-C and forms an integral part of this Report.
The said report does not contain any observation or qualification requiring explanation or comments from the Board under Section 134(3) of the Companies Act, 2013.
PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS
Details of Loans, Guarantees and Investments covered under the provisions of Section 186 of the Companies Act, 2013 are given in the Notes to the financial statements.
BOARD EVALUATION
Pursuant to the provisions of Companies Act, 2013 and the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, a structured questionnaire was prepared after taking into consideration, various aspects of the Board''s functioning, composition of the Board and its Committees, culture, execution and performance of specific duties, obligations and governance.
The performance evaluation of the Independent Directors was completed. The performance evaluation of the Chairman and Non-Independent Directors was carried out by the Independent Directors. The Board of Directors expressed their satisfaction with the evaluation process.
SUBSIDIARY COMPANIES
The Company has 6 (six) direct subsidiaries, namely, Aarti Corporate Services Limited, Alchemie (Europe) Limited, Innovative Envirocare Jhagadia Limited, Ganesh Polychem Limited, Aarti USA Inc., Aarti Polychem Private Limited (incorporated on 25th May, 2017) and 2 (two) indirect subsidiaries namely Shanti Intermediates Private Limited, Nascent Chemical Industries Limited both hold through Aarti Corporate Services Limited.
During the year, the Board of Directors reviewed the affairs of the subsidiaries. In accordance with Section 129(3) of the Companies Act, 2013, we have prepared consolidated financial statements of the Company and all its subsidiaries, which form part of the Annual Report.
Further a statement containing salient features of the financial statement of our Subsidiaries in the prescribed format AOC-1 is included in the Report as Annexure-D and forms an integral part of this Report. The statement also provides the details of performance, financial position of each of the Subsidiaries.
DIRECTORS / KEY MANAGERIAL PERSONNEL
Shri Manoj M. Chheda (DIN: 00022699)and Shri Kirit R. Mehta (DIN: 00051703), Whole time Directors of the Company shall retire by rotation at the ensuing Annual General Meeting and being eligible, offers themselves for re-appointment.
Your Directors also recommend approval for renewal of term of Shri Rashesh Chandrakant Gogri (DIN 00066291), Vice - Chairman and Managing Director of the Company whose present term expired on 8th June, 2017 and Shri Renil Rajendra Gorgi (DIN: 01582147), whole-time Director of the Company whose present term expires on 15th August, 2017.
Your Directors also recommend renewal of term of Shri Rajendra Vallabhaji Gogri (DIN 00061003), Chairman and Managing Director whose present term expires on 30th June, 2018.
Present Term of Shri Ramdas M. Gandhi (DIN : 00029437) and Shri Laxmichand K. Jain (DIN: 00042099) Independent
Directors of the Company expires on 24th September, 2017. Notice(s) have been received from member(s) along with requisite deposits proposing their candidature for appointment as Independent Directors.
During the Year 2016-17, Smt. Hetal Gogri Gala (DIN: 00005499), Whole-time Director was re-appointed for a period of 5 (five) years w.e.f. 1st November, 2016.
SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS
There are no significant material orders passed by the Regulators/Courts which would impact the going concern status of the Company and its future operations.
ENVIRONMENTAL, SAFETY AND HEALTH
Your Company is committed to ensure a sound Safety, Health and Environment (SHE) performance related to its activities, products and services. Your Company had been continuously taking various steps to develop and adopt Safer Process technologies and unit operations. Your Company has been investing heavily in areas such as Process Automation for increased safety and reduction of human error element, Enhanced level of training on Process and Behavior based safety, adoption of safe & environmental friendly production process, Installation of Bioreactors, Chemical ROs, Multiple effect evaporator and Incinerator, etc to reduce the discharge of effluents, commissioning of Waste Heat recovery systems, and so on to ensure the Reduction, Recovery and Reuse of effluents & other utilities. Monitoring and periodic review of the designed SHE Management System are done on a continuous basis.
Some of the ongoing initiatives in this regard as briefed below:
Introducing Aarti Management System: An in-house developed framework of 32 elements detailing procedures and processes catering to all Plant Related Activities - 3 elements namely MOC (to manage change), BBS (major root causes of incidents are due to behavior) and Permit Systems catering to reduce SHE related risks had been launched and being implemented at various levels of operations. Other elements are being developed and reviewed and would be adopted in due course
Review Existing Process Safety Parameters: Structured & regular HAZOP meetings are being carried out as per scheduled HAZOP calendar to further strengthen process safety of existing processes. Also HIRA (Hazard Identification and Risk Assessment) for procedures and practices are being initiated for some of the units and would be gradually implemented across various units.
With these and various other initiatives, your Company firmly places the SHE at the top of its goals and aims to provide a workplace which is safer and healthier for the society at large.
WHISTLE BLOWER POLICY
The Company has a whistle blower policy to report genuine concerns or grievances. The Whistle Blower policy has been posted on the website of the Company and the web link thereto is http://aarti-industries.com/media/investors/ corporate governance/1494923104_Whistle_Blower_ Policy_Ammended.pdf
MATERIAL SUBSIDIARY
The Company does not have any material subsidiary whose net worth exceeds 20% of the consolidated net worth of the Company in the immediately preceding accounting year or has generated 20% of the consolidated income of the Company during the previous Financial Year. A policy on material subsidiaries had been formulated and is available on the website of the Company and the web link thereto is http://aarti-industries.com/media/investors/corporate_ governance/1494923294_Policy_for_determining_ Material_Subsidiary17.6.16.pdf
FAMILIARISATION PROGRAMME FOR INDEPENDENT DIRECTORS.
The Independent Directors of the Company were familiarized and the details of familiarization programmes imparted to them are placed on the website of the Company and the web link thereto is http://aarti-industries.com/media/ investors/corporate governance/1494923569_Details_of_ Familirisation_Programme.pdf
DIVIDEND DISTRIBUTION POLICY
As per Regulation 43A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the top 500 listed companies shall formulate a dividend distribution policy. Accordingly, the policy was adopted to set out the parameter and circumstances that will be taken in to account by the Board in determining the distribution of dividend to its shareholders and/ or retaining profits earned by the company. A policy is available on the website of the Company and the web link thereto is http://www.aarti-industries.com/media/ investors/corporate governance/1494923066_Dividend_ Distribution_Policy.pdf
STATUTORY AUDITORS
Statutory Auditor of the Company M/s. Gokhale & Sathe, Chartered Accountants (Firm Registration. No. 103264W) holds office till the conclusion of the ensuing Annual General Meeting of the Company. They have been holding office as Statutory Auditors of the Company for a period of more than 10 years and hence are not eligible for re -appointment as per section 139(2) of Companies Act, 2013.
In view of the above, Board on the recommendation of Audit Committee appointed M/s. Kirtane & Pandit, Chartered Accountants (Firm Registration. No. 105215W/W100057) as Statutory Auditors of the Company to hold office up to conclusion of 35th Annual General Meeting. At the request of the Company, M/s. Kirtane & Pandit have communicated their eligibility and willingness to accept the office, if appointed. Members are requested to appoint Auditors and to fix their remuneration as mentioned at Item No. 5 of the notice.
AUDITORS'' REPORT
There is no qualification, reservation or adverse remark or disclaimer made by the Auditor in their report.
COST AUDITORS
The Cost Auditor Ms. Ketki D. Visariya (Fellowship No.16028), Cost Accountant, was re-appointed by the Company under provisions of Section 148(5) read with Section 141 of the Companies Act, 2013 and she attended the Audit Committee Meeting, where cost audit reports are discussed.
The due date for filing the Cost Audit Reports in XBRL mode for the Financial Year ended 31st March, 2016 was 30th September, 2016 and the Cost Audit Report were filed by the Cost Auditor on 29th September, 2016. The due date for filing the Cost Audit Reports for the Financial Year ended 31st March, 2017 is 30th September, 2017.
The Company is seeking the ratification from the Shareholders for the Remuneration of Ms. Ketki D. Visariya,
Cost Auditor of the Company for the Financial Year ending 31st March, 2018 vide resolution no. 13 of the Notice of AGM.
NUMBER OF CASES FILED, IF ANY, AND THEIR DISPOSAL UNDER SECTION 22 OF THE SEXUAL HARASSMENT OF WOMEN AT WORK PLACE (PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013
Your Company has Zero tolerance towards any action on the part of any one which may fall under the ambit of ''Sexual Harassment'' at workplace, and is fully committed to uphold and maintain the dignity of every women working with the Company. The Policy framed by the Company in this regard provides for protection against sexual harassment of women at workplace and for prevention and redressal of such complaints.
Particulars |
No. of Complaints |
Number of Complaints pending as on beginning of the Financial Year |
NIL |
Number of Complaints filed during the Financial Year |
NIL |
Number of Complaints pending as on the end of the Financial Year |
NIL |
CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE EARNINGS AND OUTGO
Information required under Section 134(3)(m) of the Companies Act, 2013, read with Rule 8(3) of the Companies (Accounts) Rules, 2014, as amended from time to time, forms a part of this in Annexure-E.
ACKNOWLEDGEMENT
The Board of Directors places on record its sincere appreciation for the dedicated services rendered by the employees of the Company at all levels and the constructive co-operation extended by them. Your Directors would like to express their grateful appreciation for the assistance and support by all Shareholders, Government Authorities, Auditors, financial institutions, Customers, employees, suppliers, other business associates and various other stakeholders.
For and on behalf of the Board
RAJENDRA V. GOGRI
CHAIRMAN AND MANAGING DIRECTOR
Place : Mumbai
Date: 11th August, 2017
Mar 31, 2015
Dear Members,
The Directors are pleased to present this Thirty Second Annual Report
and the Audited Statement of Accounts for the year ended 31st March,
2015.
FINANCIAL RESULTS (RS. in Crores)
Standalone
Particulars 2014-15 2013-14
Net Sales 2,824 2,599
Other Operating Income 47 34
Total Income from Operations (Net) 2,871 2,633
Expenses
a) Cost of Material Consumed 1,646 1,631
b) Purchases of Stock-in-trade 132 117
c) Changes in inventories of Finished Goods, 17 (62)
Work-in-progress and Stock-in-trade
d) Employee Benefits Expenses 90 76
e) Depreciation and Amortisation Expenses 79 87
f) Other Expenses 529 476
Total Expenses 2,493 2,325
Profit/(Loss) from Operations before Other
Income, Finance Costs and Exceptional Items 378 308
Other Income/Exceptional Items 5 10
Profit/(Loss) before Finance Costs 383 318
Finance Costs 137 118
Profit/(Loss) before Tax 246 201
Tax Expenses
a) Provision for Taxation-Current 40 38
(net of MAT entitlement)
b) Provision for Deferred Tax 18 14
Total Tax Expenses 58 52
Share of Profit/(Loss) of Associates - -
Minority Interest - -
Net Profit/(Loss) after consolidation 188 149
Earnings Per Share (RS.) 21.20 16.78
Book Value Per Share (RS.) 102.47 87.90
Consolidated
Particulars 2014-15 2013-14
Net Sales 2,861 2,598
Other Operating Income 47 34
Total Income from Operations (Net) 2,908 2,632
Expenses
a) Cost of Material Consumed 1,644 1,630
b) Purchases of Stock-in-trade 171 117
c) Changes in inventories of Finished Goods, 17 (62)
Work-in-progress and Stock-in-trade
d) Employee Benefits Expenses 94 79
e) Depreciation and Amortisation Expenses 82 88
f) Other Expenses 516 467
Total Expenses 2,524 2,319
Profit/(Loss) from Operations before Other 384 313
Income, Finance Costs and Exceptional Items
Other Income/Exceptional Items 9 11
Profit/(Loss) before Finance Costs 393 324
Finance Costs 138 118
Profit/(Loss) before Tax 255 206
Tax Expenses
a) Provision for Taxation-Current 43 40
(net of MAT entitlement)
b) Provision for Deferred Tax 18 14
Total Tax Expenses 61 54
Share of Profit/(Loss) of Associates 14 11
Minority Interest (2) (1)
Net Profit/(Loss) after consolidation 206 162
Earnings Per Share (RS.) 23.24 18.34
Book Value Per Share (RS.) 114.73 98.29
DIVIDEND
Your Company had declared and paid Interim Dividends of RS. 3.75 ps. (@
75%) per share (of RS. 5/- each). Your directors are pleased to
recommend a Final Dividend of RS. 1.75 ps. (@ 35%) per share (of RS.
5/- each) for the Financial Year 2014-15, aggregating to the Total
Dividend of RS. 5.50 ps. (@ 110%) per share (of RS. 5/- each) for the
Financial Year 2014-15 compared to the Total Dividend of RS. 4.50 ps.
(@ 90%) per share (of RS. 5/- each) for the Financial Year 2013-14. The
total amount of Dividend pay-out for the year would be RS. 48.73 Crores
(Previous Year: RS. 39.87 Crores).
Your Company has transferred RS. 19.00 Crores to General Reserve
(Previous Year: RS. 14.90 Crores) and RS. 30.00 Crores to Debenture
Redemption Reserve (Previous Year: Nil).
FINANCIALS
Your Company is pleased to report continuation of its growth momentum.
Inspite of the inventory losses due to sharp decline in input prices
(trailing the fall in crude prices), your Company had been able to
present the growth in bottom line by over 25%.
Your Company''s Total Income stood at RS. 2,871 Crores, up by 9% as
compared to RS. 2,633 Crores in Financial Year 2013-14. Operating
Profit rose by 15% to RS. 456 Crores for Financial Year 2014-15 as
compared to RS. 395 Crores for Financial Year 2013-14. Operating
Margins increased from 15% for Financial Year 2013-14 to about 16% for
Financial Year 2014-15.
Net Profit Before Tax rose by 22% to RS. 246 Crores in Financial Year
2014-15 as compared to RS. 201 Crores in Financial Year 2013-14.
Likewise, Net Profit after Tax & Deferred Tax also grew by 26% to RS.
188 Crores in Financial Year 2014-15 as compared to RS. 149 Crores in
Financial Year 2013-14.
On a Consolidated basis, your Company''s Total Income stood at RS. 2,908
Crores, up by 10% as compared to RS. 2,633 Crores in Financial Year
2013-14. Operating Profit (before other income) rose by 16% to RS. 466
Crores as compared to RS. 402 Crores in Financial Year 2013-14.
Similarly, Net Profit after consolidation grew by 27% to RS. 206 Crores
in Financial Year 2014-15 as compared to RS. 162 Crores in Financial
Year 2013-14. Likewise, Consolidated EPS surged by about 27% at RS.
23.24 for Financial Year 2014-15, as compared to RS. 18.34 for
Financial Year 2013-14.
With these stable and consistent performances, the Consolidated Profits
for your Company had surpassed RS. 200 Crores mark. After going Public
in 1992, your Company had been able to achieve and cross the historic
RS. 100 Crores consolidated profits in Financial Year 2011-12 and in
next three years'' time your Company has been able to double the same.
With these numbers, the consolidated profits have grown for last 5
years at a CAGR of about 26%, while the revenues have grown at a CAGR
of about 19% during the same period. A large part of this growth is on
account of increased volumes from global markets.
CHEMICAL INDUSTRY - STRUCTURE & DEVELOPMENT
Speciality Chemicals are a group of high value, low volume chemicals
formulated for developing/enhancing properties of specific products.
The customised product requires special technologies, process expertise
and understanding of client needs, and so the industry typically
commands limited competition, yielding higher gross margins and returns
than other chemical sub-segments.
The Global Speciality Chemicals market is growing at a fast pace.
Despite the economic recession, it has recovered and is showing signs
of high growth in the future. According to Tech Navio Analysis, the
Global Speciality Chemicals
market is expected to grow at a CAGR of 5.16% during the period
2013-2018 and reach US $760.9 billion by 2018 (from US$ 619.0 billion
in 2014).
Industry Segmentation
The chemical industry is an integral constituent of the growing Indian
Industry. It includes basic chemicals and its products, petrochemicals,
fertilizers, paints, varnishes, gases, soaps, perfumes and toiletry and
pharmaceuticals. It is one of the most diversified of all industrial
sectors covering thousands of commercial products. This Industry
occupies a pivotal position in meeting basic needs and improving
quality of life. The Industry is the main stay of industrial and
agricultural development of the country and provides building blocks
for several downstream industries, paints, soaps, detergents,
pharmaceuticals, varnish etc.
The Indian Chemical industry has witnessed robust growth in the past
decade and has been ranked 6th largest in the world and 3rd largest in
the Asia according to United Nations Industrial Development
Organisation (UNIDO). The industry has been forecast to reach USD 200
billion mark by 2020.
Indian government is rendering extensive support to give impetus to the
Indian chemical industry and has set up the task force to consider
suggestions for National Chemical Policy to ensure steady growth of the
country''s chemical sector.
Indian Speciality chemicals industry is expected to grow at a robust
pace driven by consumption boom, infrastructure spending and exports to
international markets.
Proxy to play consumption as well as infrastructure theme
The key demand drivers for Speciality chemicals are per capita income
growth, rising urbanisation and infrastructure spending. The per capita
chemical consumption for India in most categories of Speciality
chemicals (paints, dyes, polymers, home and personal care etc.) is only
about 15-20% of the global average, thus, there is a significant
opportunity for growth.
While around 70% of Speciality chemical demand is linked to consumer
spending, the balance is used by construction and infrastructure
industry. As domestic consumer as well as infrastructure spending
slowed in the past couple of years, Indian Speciality chemical
companies were impacted though overall impact was limited due to strong
growth in exports. However, both these dynamics are expected to improve
in medium to long term.
The robust demand for Speciality chemicals (FICCI est: 13%) would be
driven by strong growth in end-user industries itself. While the ones
linked to infrastructure (construction chemicals, paints, water
chemicals, industrial cleaners) are expected to grow at >15%, the other
categories (dyes, personal care, plastic additives, rubber chemicals)
are expected to grow at 10-15%.
Key end user industries for Speciality chemicals in India and their
expected growth rates
Segment 2012 Size Exp. vol.
(in RS. bn) CAGR (%)
Paints and Coatings 4.0 15
Colorants 3.7 10
Speciality polymers 15 15
Home care surfactants 12 5
Plastic additives 10 12
Textile chemicals 0.9 11
Construction chemicals 0.7 25
Water chemicals 0.7 7
Personal care ingredients 0.5 9
Flavors and fragrances 0.5 10
Paper chemicals 0.5 22
Printing inks 0.5 10
Industrial cleaners 0.2 19
Rubber chemicals 0.2 13
Other segments 6.3 15
Total 22.4 13
Source FICCI
Exports to propel further growth
With improving cost competitiveness (particularly w.r.t. China),
favourable IPR framework and strong domestic demand outlook, India is
emerging as a preferred manufacturing destination for Speciality
chemicals. China is losing out its edge over India in chemical
manufacturing due to:
(1) steep cost inflation (labour costs);
(2) stricter compliance of environmental regulations being enforced in
China, while in India the same had been already in place since past few
years; and
(3) Yuan appreciation in recent years.
Chemical exports from India have grown at 22% CAGR over 2010-14,
significantly outpacing the global demand growth (3-4%) and the trend
has continued through in 2015 as well.
Shares in exports of chemicals
Exports from India are likely to get further fillip and India is
expected to increase export market share (from miniscule 2% currently)
with:
* Curtailment of capacities in developed countries: While capacities
are being closed in developed world, a simultaneous scale up of
capacities is being witnessed in emerging economies.
* De-risking of exports by global MNCs: The major MNCs are trying to
de-risk their supply chain by diversifying their
RM procurement away from China (amongst the developing countries).
During the past decade, China aggressively added chemical capacities
and became the largest exporter (amongst the developing countries) to
MNCs. However, as risks associated with Chinese exports increase
(domestic slowdown, currency appreciation etc.), MNCs are seeking to
increasingly prefer India amongst the developing countries for their RM
supplies.
The Indian Chemical Companies are expected to get further fillip under
the "Make in India" drive. Various new projects are proposed to be
commenced with a focus to make India as a manufacturing hub for those
products. This shall increase the direct and indirect demand of various
chemicals. These chemicals are expected to contribute directly or
indirectly as Import Substitute or contribute to the increase in
exports from India.
Your Company is a leading manufacturer of Speciality Chemicals and has
integrated presence across various value chains. Your Company''s
diversified end-user application and customer profile had provided a
significant insulation against the global downturns and various
geographic volatilities. Your Company''s strength to meet the Stringent
and Customised specifications for each of its 800 customers have
helped it gain customer confidence and trust and also to open up new
growth opportunities. Exports, which accounts for half of the total
revenues, is well spread across various customers which your Company
caters across different geographies, as mentioned in the adjacent
chart.
Also significant quanta of domestic supplies are converted/value added
and eventually exported. Thus about 70% of our volumes are directly or
indirectly exported. Your Company''s global market position, strategic
arrangements with key customers, Customised delivery offerings,
increased scale of Operations, ability to meet the stringent
quality requirements of the customers, have enabled your Company to
increase its presence in the global arena over a period of time and
also have helped it to work along with the customers in their growth
plan and thus have been able to add new products around this phase of
growth.
We now present you some highlights of the year passed by, starting with
the brief Segmental financials as below:
(RS. in Crores)
Particulars Speciality Pharmaceuticals
Chemicals
Sales 2,398 303
% of Total Sales 82.5% 10.4%
Export 1,251 164
% of Sales 52.2% 54.1%
EBIT 408 36
% of Sales 17.0% 11.9%
Capital Employed as at 31st March, 2015 1,486 485
ROCE % 27.5% 7.4%
Particulars Home & Personal Total
Care Chemicals
Sales 207 2,908
% of Total Sales 7.1% 100.0%
Export 34 1,449
% of Sales 16.4% 49.8%
EBIT 3 447
% of Sales 1.5% 15.4%
Capital Employed as at 31st March, 2015 87 2193*
ROCE % 3.5% 20.4%
(* includes unallocated Capital Employed of RS. 135 Crores)
As you would note, Speciality Chemicals continues to account for a
major part of Revenues and EBIT. However, it may also be noteworthy,
that Pharmaceuticals Segments, wherein the USFDA approvals had been
accorded to our units in 2011, had breakeven in 2012. The Pharma
Segment revenues had registered a CAGR of over 22% over last four
years, while the EBIT had jumped from RS. 4 Crores to RS. 36 Crores
during the same period. Further details about each of these segments
are presented below:
Speciality Chemicals Segment:
Speciality Chemicals Segment accounts for the majority of revenues and
profits for the Company. RM Price volatility impacts the segment''s
topline the most, but has very limited impact on the bottom line. We
present below a note which explains this in more detail.
Impact of RM Volatility
Since the Company adopts a Cost Plus pricing for its various Speciality
Chemicals, its topline is linked with the Input costs. During Financial
Year 2014-15, we had witnessed sharp corrections in the prices of Crude
Oil during the period of November 2014 to March 2015. As a result, the
prices of various Raw-materials procured by the Company viz, Benzene,
Aniline, Methanol, Phthallic Anhydride, etc had also declined
accordingly. This resulted in the decline in revenues for the segment,
which is evidenced from the below table:
Segments Financials Annual Q1 Q2
(Standalone) Financial Financial Financial
Year 2013-14 Year 2013-14 Year 2013-14
Benzene Price (RS./kg) 90 (for Q4 88 85
Financial Year
2013-14)
Sales Revenue 2,217 614 625
(RS. in Crores)
EBIT (RS. in Crores) 333 98 104
EBIT % 15.0% 16.0% 16.6%
Segments Financials Q3 Q4 Annual
Standalone) Financial Financial Financial
Year 2013-14 Year 2013-14 Year 2013-14
Benzene Price (RS./kg) 70 50 50 (for Q4
Financial
Year 2014-15)
Sales Revenue 568 554 2,361
(RS. in Crores)
EBIT (RS. in Crores) 88* 105 395
EBIT % 15.5% 19.0% 16.7%
* Q3 EBIT lower on account of annual mandatory shutdown of Acid unit,
Forex Mark to market loss and Inventory markdown.
As you would note from above, the Sales revenues had declined in Q3 and
Q4, in spite of having registered a volume growth of about 13%, due to
falling RM prices.
Further, since the Company''s product pricing is on Cost Plus basis,
EBIDTA per KG is constant, hence increase in volumes results into
higher absolute EBIDTA resulting into higher segmental EBIT. This is
reflected in the increase in EBIT, as mentioned in above table.
Further, also note that the EBIT mentioned above were after adjusting
for inventory markdown in Q3 for about RS. 8 Crores. and in Q4 for
about RS. 11 Crores. Hence, in spite of these markdowns, the overall
EBIT for the segment grew by about 19% on Y-o-Y basis.
It may also be noted that the demand for most of the products
manufactured by your Company is in-elastic to the RM price
fluctuations. Further, in case of high value added products, the impact
of the same becomes significantly lower to have any impact.
We now present below the key financials for Speciality Chemicals
Segment:
(RS. in Crores)
KEY FINANCIALS FINANCIAL YEAR FINANCIAL YEAR
2014-15 2013-14
Sales 2,398 2,216
% of Total Sales 82.5% 84.2%
Export 1,251 1,130
% of Segment Sales 52.2% 51.0%
Segment EBIT 408 332
EBIT % 17.0% 15.0%
KEY FINANCIALS FINANCIAL YEAR FINANCIAL YEAR
2012-13 2011-12
Sales 1,757 1,350
% of Total Sales 83.8% 80.7%
Export 946 639
% of Segment Sales 53.8% 47.3%
Segment EBIT 319 217
EBIT % 18.2% 16.1%
As you would note, fall in raw material prices, kept the growth in
topline limited to about 8%, while the increase in volume of initial
and high value added products resulted the increase in Segmental EBIT
by about 23% on Y-o-Y basis and even on CAGR over last four years.
Your Company continues to maintain its leadership position in the
domestic market for its range of Benzene Based Derivatives and enjoys
global market share of about 25% to 40% amongst various products
supplied by them.
For most of the above processes, your Company had reached near to 90%
capacity utilisation. As a result, your Company had been in last 2-3
years initiated various expansion projects to increase its capacities
of various existing processes and also had plans to introduce the new
products to cater to the growing demand of its over 800 domestic and
global customers. Some of these projects are briefed below:
NCB Expansion:
During last year, your Company had started the process of expansion of
its NCB Capacities from 57000 MT to about 75000 MT. During Q3 Financial
Year 2014-15, your Company had commissioned the first phase of its
expansion, thereby enhancing the capacities upto 66000 MT, while the
balance is expected to be commissioned by Q3 Financial Year 2015-16. As
a result, the production of NCB had increased in Q4 Financial Year
2014-15 to 14800 MT as compared to the quarterly average of 13500 MT
for Financial Year 2013-14. Production during Financial Year 2014-15
was about 53400 MT as compared to 54230 MT for Financial Year 2013-14.
The production during first nine months was lower on account of shut
down taken during the year for the on-going brownfield expansion
activities. These incremental capacities would increase our market
share for NCB in domestic and global markets and also provide adequate
feedstock for the related downstream products (viz. Hydrogenated
Products and various other products), having higher EBIDTA. As you
would recollect, your Company had already expanded its Hydrogenation
capacities and now has sufficient capacities to cater to the global
demand for next few years. Increase in the feeder capacities such as
NCB, helps your Company to increase the utilisation of these expanded
hydrogenation capacities as well.
PDA Expansion:
Further, your Company''s scale up of its PDA capacities from 250 tpm to
1000 tpm had reached its final stage of implementation and is expected
to be commissioned in phased manner from Q1 Financial Year 2015-16.
Benzene to PDA Process Flow
These capacities shall increase your Company''s capabilities for
increase its presence in the end-use applications of High End Polymers
& Additives. This will also add your Company as the only Indian source
for few MNCs which presently do not source this product from India.
Introduction of Toluene and Ethylene Based Products:
Your Company''s diversification into Toluene chemistry by way of
introduction of Nitrotoluene and Derivatives is expected to
commercialise by end of current year. Your Company plans to setup a
unit with a capacity of about 30000 tpa. Your Company is confident to
attain faster volume growth in this new value chain, as the
end-customer and the applications are fairly similar or same to the
ones which are presently being serviced by your Company. The
introduction of these products will further strengthen your Company''s
market position and capabilities to supply basket of products catering
to end user application such as Optical Brighteners, Agrochemicals,
Pigments, Pharmaceuticals, etc.
This unit shall also provide the feeder material required for the
proposed Ethylation unit being setup at Dahej SEZ. Your Company would
be setting up the Ethylation unit by adopting the Swiss Technology. It
will be first time in India, that a Company is going to procure
Ethylene by pipeline and operate the greener Ethylation process. Your
Company plans to gradually introduce a range of Ethylene based
chemicals over longer tern catering the end-user applications of
Agrochemicals, Engg. Polymers, Pigments, Additives, etc. The Dahej SEZ
project is presently being carried on by Anushakti Specialities LLP,
which is a 100% subsidiary of your Company. Your Company proposes to
absorb the same into itself during Financial Year 2015-16, so as to
bring the entire chemical operations under one roof. The Company
expects to commission this SEZ unit in Q1 of Financial Year 2016-17.
Greenfield Chlorination Complex
Your Company further proposes expansion of its capacities by way of
setting up new units for other key processes and targets to commission
the same within next 2 year''s time. Your Company plans to setup a
Chlorination Complex at Jhagadia. This complex shall expand your
Company''s capacities in the Chloro Benzene range of chemicals and shall
also provide additional capacities to introduce a new range of
chlorinated compounds. Since Chlorine is manufactured in nearby Chloro
Alkali units, your Company proposes to procure the same by pipeline on
a continuous basis, which adds as a significant logistical benefit to
set up the facility at Jhagadia.
Speciality Chemical Complex
Your Company also proposes to set up another speciality Chemical
complex at Jhagadia to manufacture of range of Speciality Chemicals
from the present value chain and also plans to introduce few new
products which were being developed under secrecy agreement with the
MNC customers.
Co-Generation Power Plant
With large capacities being commissioned over next 12-30 months at
Jhagadia, your Company plans to set up a Captive Co-generation Power
Plant similar to the ones being already operational at its Vapi unit,
but with a higher capacity. This shall help meet the partial power
needs of the unit at Jhagadia at significantly lower power costs. Thus,
this shall bring about cost savings in respect of the future projects
being proposed at Jhagadia.
These projects would cater to the growing demands for
various Agrochemicals and Engg. Polymers and would help the Company
increase its market share in this space.
These capacities would provide the further diversification of the
product mix and would drive the growth beyond Financial Year 2017-18.
Pharmaceuticals:
Indian pharmaceutical industry was valued at USD 12 Bn in 2013. The
market is primarily driven by exports to regulated as well as
semi-regulated markets. Currently, India exports drugs to more than 200
countries and vaccines and bio-pharma products to about 151 countries.
Globally, India ranks 3rd in terms of volume and 14th in terms of
value. Industry estimates show that generic drug user fee amendments in
USA, compulsory licensing and national pharmaceutical pricing policy
have increased the legal expenditures of the top 10 drug makers in
India by ~50% in the past three years.
The regulatory environment in the pharmaceutical sector is more
challenging now than ever before. To meet the new norms, companies will
have to invest in re-establishing their competitive position.
Optimization of product portfolio to target high return products and
building distinguishing capabilities to stay ahead of competition would
be the key to success. The winning companies will be the ones which
analyze their competitive position and meet the rapid changes happening
in the industry by evaluating and speedily implementing the five levers
outlined below.
Over a period of time, Mergers and Acquisitions in Pharma segment have
resulted into consolidation and rationalisation. Gradually the
Innovator companies have started focusing more on Oncology drugs as a
major thrust area. Your Company had been working into this area and is
expected to benefit over long term.
China had been a traditional source of intermediates to various
companies manufacturing APIs world over. However, tighter compliance of
pollution norms, increasing and stricter regulatory processes,
consolidation of various pharma companies, had resulted into restricted
suppliers, which ultimately affects the supply of various
intermediates. This has opened up opportunities in India for
manufacture of various intermediates as Import Substitutes. Your
Company is working for various such intermediates with various
companies and expects to attain a strategic position in the
intermediates space.
Your Company had been looking at older/already off-patented Generics to
be supplied in regulated markets, directly and indirectly, wherein very
few/restricted suppliers operates. With commissioning of expanded
capacities and having a range of 48 commercial APIs, with 33 EUDMFs, 28
US DMF, more than 60% exports coming from regulated markets, your
Company is better placed to increase its share in the regulated
markets.
We present below the key financials for Pharmaceuticals Segment:
(RS. in Crores)
KEY FINANCIALS FINANCIAL YEAR FINANCIAL YEAR
2014-15 2013-14
Sales 303 249
% of Total Sales 10.4% 9.5%
Export 164 117
% of Segment Sales 54.1% 47.0%
Segment EBIT 36 30
EBIT % 11.9% 12.0%
KEY FINANCIALS FINANCIAL YEAR FINANCIAL YEAR
2012-13 2011-12
Sales 187 165
% of Total Sales 8.9% 9.9%
Export 92 66
% of Segment Sales 49.2% 40.0%
Segment EBIT 9 4
EBIT % 4.8% 2.6%
As you would note from above, the segment had been growing at the
fastest pace. Out of incremental sales in Financial Year 2014-15 of
about RS. 54 Crores, growth in exports sales was about RS. 39 Crores,
i.e. more than 70% of incremental growth had been from global markets.
Hence, increased volumes from Global and more particularly Regulated
markets would help in faster paced growth for this segment.
Home & Personal Care Chemicals
Rising per capita income have enabled the increase of consumption of
hygiene and personal care products. Increasing consumption is driving
demand for wide range of Cosmetic Chemicals, Health care products as
well as Hygiene products using Performance Chemicals, Polymers and Oleo
Chemicals. Our PM''s "Swachh Bharat Abhiyaan", is expected to increase
the demand of these chemicals significantly.
We present below the key financials for Home & Personal Care Chemicals
Segment:
(RS. in Crores)
KEY FINANCIALS FINANCIAL YEAR FINANCIAL YEAR
2014-15 2013-14
Sales 207 167
% of Total Sales 7.1% 6.3%
Export 34 34
% of Segment Sales 16.4% 20.4%
Segment EBIT 3 4
EBIT % 1.5% 2.4%
KEY FINANCIALS FINANCIAL YEAR FINANCIAL YEAR
2012-13 2011-12
Sales 152 158
% of Total Sales 7.3% 9.5%
Export 22 21
% of Segment Sales 14.5% 13.2%
Segment EBIT 5 5
EBIT % 3.3% 3.1%
Home & Personal Care Chemicals segment is relatively a low margin
business. Your Company has two manufacturing units, one each at
Pithampur (Madhya Pradesh) & at Silvassa. Your Company plans to carry
out debottlenecking for some of its operations so as to expand the
capacities for export oriented products which have better margins.
These efforts shall help the increase of exports for this segment and
also result into improvement of margins.
SAFETY, HEALTH & ENVIRONMENT (SHE)
Mitigating the Safety, Health and Environment related hazards tops the
priority list of various risks for the Company and is being regularly
monitored with stricter compliances for any deviations. Your Company''s
continuous efforts and thrusts into adopting better, cleaner and cost
efficient technologies in its road to growth had been recognised by the
Chemtech Foundation. The Award Committee of Chemtech Foundation Chaired
by Shri Nadir Godrej, CMD of Godrej Industries Ltd, had accorded your
Company with the Prestigious award of "Outstanding Achievement -
Innovation" - Chemtech CEW Leadership & Excellence Award 2015.
Your Company had been chosen for this prestigious award for its
continuous and commendable efforts in conserving environments as well
as ensuring sustainable growth through path breaking innovation with
thrust on 3Rs of Reduce-Reuse-Recover principle and several other
initiatives. This Award recognizes your Company''s in-house technical
innovations undertaken by the Company across various product
development and continuous process & operations improvements while
adopting eco-friendly technologies and constantly enhancing energy
efficiency, by-products recovery, gainful usage from waste streams and
more.
This award recognizes the efforts of your Company and motivates it to
persist with the efforts for continuous improvement and innovation
keeping always in mind the philosophy of "Growth with Sustainability
for Sustainable Growth". Keeping these principles as an important
element, your Company plans to invest further to capitalize on the
growth opportunities available in the global arena.
Your Company had bought an adjoining plot of land admeasuring about
18,175 sq. mtrs. at Plot no. 806, 807, Phase III, GIDC, Vapi. This
would help in decongesting the existing unit and thus improve the
safety of the operation at Vapi significantly.
Your Company had further invested significant amounts to improve its
setup and mitigate these risks. Some of the initiatives in this regard
as briefed below:
Introduced Aarti Management System: An in-house developed framework of
32 elements detailing procedures and processes catering to all Plant
Related Activities - 3 elements namely MOC (Management of Change), BBS
(major root causes of incidents are due to behavior) and Permit Systems
catering to reduce SHE related risks are launched. Other elements are
being developed and reviewed which will be introduced in this year.
Process Safety studies and audits: To keep the thrust on achieving
intrinsically safe processes, your Company had external safety audits
and study by industry experts such as Chillworth, ABS, Zeplin, etc. In
our journey to excel in field of process safety, your company focused
on increasing in-house competency. Your Company''s operation team has
done about 130 man hours of training on process safety leadership
training conducted by DuPont and over 520 man hours of HAZOP training
conducted by CLI (Centre Labour Institute). Your Company had also
developed in-house capability for calorimetry of hazardous reaction,
which is presently being done by very few Companies in India. Your
Company also shared its journey with industry partners in a talk name
"Chemical Reaction Hazard Management: Challenges & Strategies -- A
perspective at AARTI GROUP OF INDUSTRIES" arranged in TIMA (Tarapur
Industrial Manufacturers Association) Hall, MIDC Tarapur.
Behaviour Based Safety: Belief causes behaviour and behaviour cause
action. As per industry statistics, around 90% incident is due to human
behaviour. Considering this, your Company had initiated Behaviour Based
Safety (BBS) project, to improve behaviours at shop floor. Since
inception, your Company conducted 81 batches covering 2293 employees
(77%) across organization. In order to monitor the behaviour, an online
reporting and tracking system is launched. Totally 17,000 BBS
Observation rounds have been conducted by our employees across plants
Process Automation plan had been implemented for critical unit
operations and is now being evaluated / implemented over a period of
time for other operations as well.
Upgradation of facility into Zero discharge:
Your Company had commissioned various equipments and processes such as
water recovery, RO Plant, etc. and upgraded the two of its facilities
into Zero Liquid discharge facility.
Your company is evaluating further for making other plants as zero
discharge facilities.
Planning to introduce Automated Solid Handling Equipment: Your Company
plans to automate the solid handling of various chemicals. This shall
reduce the hazards of physical exposures related to manual handling of
various chemicals.
With these and various other initiatives, your Company firmly places
the SHE at the top of its goals and aims to provide a workplace which
is safer and healthier for the society at large.
RISK, CONCERNS & ITS MANAGEMENT
Your Company perceives risks or concerns common to industry such as
concerns related to the Macro Indian Economic Outlook, Global Economic
fallout, Regulatory risks, Foreign Exchange volatilities, Higher
Interest rates, Volatile Raw-material prices and other commercial &
business related risks. While Segments like Pharmaceuticals and Home &
Personal Care and Speciality Chemicals with applications into
Agrochemicals are not much affected by the economic cycle and have its
own independent growth drivers, the diversity of end uses of Speciality
Chemicals and the ability of the Company to interchangeably use the
production facilities insulate the Company from any adversity for any
specific end user applications. Further, your Company''s diversified
revenue mix, flexible product mix and increasing export volumes also
help to derisk the business from any domestic economic setbacks as well
as certain specific global uncertainties. Diversified & wide customer
base further reduces risks of dependence of business with few customer
or few products. Your Company is entering into long term supply
arrangement with its key suppliers to ensure continuous and adequate
supply of raw-materials to meet the growing demand for the products.
Chemical businesses are generally working capital intensive and hence
the working capital requirements are also higher. Your Company has been
making continuous efforts to reduce the working capital cycle.
Risk management policy underpins your Company''s efforts to remain a
competitive and sustainable company, enhancing its operational
effectiveness and creating wealth for its employees, shareholders and
stakeholders in pursuance of its strategy. Your Company has constituted
a Risk Management Committee.
The Company has a dynamic Risk Management framework to identify,
evaluate business risks and opportunities. This framework seeks to
create transparency, minimize adverse impact on the business. The
business risk framework defines the risk management approach across the
enterprise at various levels including documentation and reporting. The
framework has different risk models which help in identifying risks,
exposure and potential impact analysis for the Company level.
CORPORATE SOCIAL RESPONSIBILITY
Aarti group: Committed to Social Responsibility.
From the time of the inception of the Company, the Company''s Founder
Visionary and Chairman Emeritus Shri Chandrakant Gogri has upheld the
philosophy of ''giving back to the society'' with utmost fidelity.
Your Company actively contributes to the following segments:
1. Education & Skill Development
2. Healthcare Facilities
3. Women Empowerment and livelihood
4. Water Conservation and Environment
5. Rehabilitation in Disaster Affected areas
6. Eradication of Hunger & Poverty
7. Donating to Govt. bodies viz. Prime Minister & Chief Minister
Relief Funds.
We advocate the concept of universal and all around development and
hence work on "Clusters" in whole, while initiating a spectrum of
development projects within the each identified locations. Our on-going
initiatives are focused on bringing about an overall development in the
rural sector. These initiatives are inspired by the guidelines set by
Hon''ble Former President of India Dr. A.P.J. Abdul Kalam''s PURA
(Providing Urban Amenities to Rural Area) model. Education, sanitation,
health, water management, skill building, environment forms the key
factors of this PURA model. Your Company had been actively involved and
has been under implementation of PURA Model in villages at Kutch,
Gujarat and at Beed (Marathawada, Maharashtra).
A brief about the various activities being undertaken at the Kutch
Cluster for the implementation of PURA model and to being about an
overall development and upliftment of the Cluster is presented below:
Kutch Cluster
Education:
Every year over four hundred students from around 12 villages receive
free Secondary and Higher Secondary Education at Tulsi Vidya Mandir
(TVM). TVM is one of its kind rural school to admit dropouts & rejected
from other schools & poor students and had achieved an average 90%
results in SSC and 95% results in HSC. The Company intends to expand
the TVM horizons by commencing Technical and Army Entrance Training
courses.
Further, a new project named "Vidya Sarthi" had been undertaken,
wherein local youngsters (presently 20) are trained and recruited for
imparting extra coaching to students of Government managed Primary
schools in vicinity of TVM. This model not only provides employment
opportunities to the youngsters but also provides the additional
support to the Government managed schools in achieving the goal of
"Education for all"
Sanitation: After your Company''s engagement, one of the village had
achieved 100% sanitation mark and has an underground drainage system
and waste water recycle plant. Taking cues from our PM''s ''Swachh Bharat
Abhiyaan'' your Company had undertaken to provide toilets to all
families of TVM students of neighbouring 12 villages. Approximately
over 100 toilets would be provided by your Company under this
programme.
Rain water harvesting: A traditional lake was revived to store maximum
rain water. Animals, birds, farmers are benefitted by this "Mirik lake"
Cattle feed depot: Cattle owners from around twenty villages are being
provided cattle feed at subsidized rates from this center.
In addition to above, various Health Camps, Agricultural Training Camps
and other activities are carried out to promote the overall development
of the cluster. The results had been so encouraging that your Company
further plans to set up three PURA model Clusters in due course of
time. The Model implementation was further appreciated by the local
NGOs and other agencies, who had also started replicating the model for
development in other neighbouring Districts.
Your Company had been engaged into similar Cluster development
activities at Beed, Maharashtra which had been adversely affected by
drought situations.
In addition to above, your Company has actively involved into various
activities which are broken into few critical segments. Some of these
activities are briefed below:
1. Education & Skill Development:
Education, in particularly in English Medium in Mumbai region, have
become very expensive and beyond the reach of a lot of Urban Poor
families. Your Company contributes and participates into distributing
Education Aid through Kutch Jain Mahajan. On an average over 2700
students from Jr. KG to XII Std. had been aided under this programme.
Your Company had contributed in Building Infrastructure for Nahur
Welfare Association and Trust, which plans to start CBSE curriculum
school named "Dhan-Vallabh English Medium School" at Mulund, Mumbai.
The School would start with Nursery, Jr. KG & Sr. KG from 2015-16 and
focuses on imparting education to Low income groups of the Urban
Mumbai.
Your Company also actively supports Five Nomad Boys and Girls hostels
accommodating over 300 pupils at Radhanpur in the State of Gujarat.
Your Company also works with Yusuf Meherally Center (YMC) in arranging
and running alternative schools for children of Saltpan workers and
Fishermen on coastal belt of Kutch. At present 21 such schools are
being run whereby over 650 children are being educated.
Your Company had in past adopted the "Ratanpur Boarding School" managed
by "Sushil Trust" and directly supports entire expenditure for
approximately 240 students at this Boarding School, every year.
In addition to this, your Company provides direct help to schools
located nearby its operations/facilities by way of sponsoring text
books/ note books, grant/aid for fees, etc.
To promote the technical educations, your Company gives donation to
Institute of Chemical Technology to enable them to provide interest
free bridge loan to Post Graduation students.
Your Company had also funded the local NGO for setting digital
classroom in 25 rural primary schools run by Govt. near its Bhachau
factory.
2. Health
Considering increased number of patients with kidney-related diseases,
requiring expensive treatment of frequent dialysis, your Company had
donated 10 Dialysis Machines to Ahmedabad based hospitals to offer
treatment for the low income group at very nominal rates.
In addition to above, your Company continuously supports various Health
Camps and Blood Donation camps around and beyond its manufacturing
units. Your Company also sponsors Medical Conference for Doctors
working in rural areas to help them understand the new advancement in
the Medical fields.
3. Woman Empowerment
Your Company had initiated a unique programmed named "Sanskardhan" at
Maninagar, Gujarat where women are provided training in Stitching and
Beautician Courses. Such programs promotes the Spirit of Women
Empowerment and endorses independence and sustainability among them.
Your Company had also started "Nursing School" where women from
different areas and economically backward classes are trained to enable
them procure employment opportunities into Metro Cities and even
abroad. This year, your Company aims at undertaking the training for
approx 250 women under this programme.
In an another initiative, your Company in association with Jan Seva
Charitable Trust giving accommodation along with food supply to
approximately 60 tribal women who had enrolled for higher education.
4. Environment
Your Company had set up "cattle feed depots" in around 27 villages
within the drought affected district of Beed in Maharashtra. The
project also involves the provision of water pumps for bore well along
with 2 check dams on Riddhi and Siddhi rivers. Your Company is keen to
expand the current phase of the project in association with the
Government and the local NGO - Siddhivinayak Parivar.
Your Company had instituted the project of "Parjanya Ecology" to
develop a check dam at Anjar Taluka, Kutch. Reduction of Green spaces
had been a global concern and is also a reason for various climatic and
ecological changes. Your Company, in its efforts to promote and
conserve green spaces, had developed a Garden at Vapi with dedicated
Jogging and walking tracks, seating arrangements for elderly people,
water fountain and such other amenities. Over 80 trees/plants had been
planted at this Vapi Garden.
Your Company had further committed to build several toilets under the
PM''s ''Swachh Bharat Abhiyaan'' across the remote areas of Gujarat over a
span of two years.
5. Rehabilitation in Disaster Affected areas
Aarti industries which holds an expertise of working in collaboration
with the government and local NGOs has carried out rehabilitation in
almost all the disaster affected areas in Kutch, Tamil Nadu, Orissa,
Jammu & Kashmir, Indonesia, Bihar, Uttarakhand and Maharashtra. In
Jammu & Kashmir after the floods in 2014, Aarti rehabilitated
approximately 50 families providing them with housing, kitchen kit,
winter kit, health and checkup at Srinagar. Your Company continues its
efforts to rehabilitate further families in these affected region.
6. Eradication of Hunger & Poverty
With an initiative to provide the basic amenities to the Urban Slum,
under the Urban Slum Rehabilitation programme was adopted by Kutch Jain
Foundation (KJF). Your Company had not only financially supported KJF
but also have been actively involved in the day-to-day functioning of
the foundation. The Foundation is engaged into building Community
Township with livelihood opportunities and provide the needy Urban Slum
families subsidized accommodation at these Township.
In addition to above, your Company participates into a spectrum of CSR
activities evolving around the general upliftment of the economically
backward class of people. Your Company also makes active contribution
to Prime Minister Relief Funds, Chief Minister Relief Funds and such
other Government Bodies to assist them in their relief measures in the
affected areas.
Your Company also plans to contribute for any further activities which
promotes the upliftment of the society and shall always remain
committed to the moral objectives.
CSR annual Report is annexed as Annexure ''A'' and forms an integral part
of the Report.
MATERIAL DEVELOPMENTS IN HUMAN RESOURCES/INDUSTRIAL RELATIONS FRONT,
INCLUDING NUMBER OF PEOPLE EMPLOYED.
As on 31st March, 2015 the Company had 2039 permanent employees at its
manufacturing plants and administrative office. The Company recognizes
the importance of human value and ensures that proper encouragement
both moral and financial is extended to employees to motivate them.
The Company enjoyed excellent relationship with workers and staff
during the last year.
REMUNERATION AND NOMINATION POLICY
The Board of Directors has framed a policy which lays down a framework
in relation to remuneration of Directors, Key Managerial Personnel and
Senior Management of the Company. The policy also lays down criteria
for selection and appointment of Board Members. The details of this
policy are given in the Corporate Governance Report.
PERSONNEL
The statement containing particulars of employees as required under
Section 197(12) of the Companies Act, 2013 read with rule 5(2) of the
Companies (Appointment and Remuneration of Managerial Personnel) Rules,
2014 is given in an annexure and forms part of this report. In terms of
Section 136(1) of the Companies Act, 2013, the Report and the Accounts
are being sent to the Members excluding the aforesaid Annexure. Any
Member interested in obtaining a copy of the Annexure may write to the
Company Secretary at the Registered Office of the Company.
MATERIAL CHANGES AND COMMITMENT IF ANY AFFECTING THE FINANCIAL POSITION
OF THE COMPANY OCCURRED BETWEEN THE END OF THE FINANCIAL YEAR TO WHICH
THIS FINANCIAL STATEMENTS RELATE AND THE DATE OF THE REPORT
No material changes and commitments affecting the financial position of
the Company occurred between the end of the financial year to which
this financial statements relate on the date of this Report.
MEETINGS
The details of the number of meetings of the Board held during the
Financial year 2014-15 forms part of the Corporate Governance Report.
INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY
Your Company has clearly laid down policies, guidelines and procedures
that form part of internal control systems, which provide for automatic
checks and balances. Your Company has maintained a proper and adequate
system of internal controls. This ensures that all Assets are
safeguarded and protected against loss from unauthorized use or
disposition and that the transactions are authorised, recorded and
reported diligently. Your Company''s internal control systems
commensurate with the nature and size of its business operations.
Internal Financial Controls are evaluated and Internal Auditors''
Reports are regularly reviewed by the Audit Committee of the Board.
DIRECTORS'' RESPONSIBILITY STATEMENT
To the best of their knowledge and belief and according to the
information and explanations obtained by them, your Directors make the
following statements in terms of Section 134(3) (c) of the Companies
Act, 2013:
a. that in the preparation of the annual financial statements for the
year ended 31st March, 2015, the applicable accounting standards have
been followed along with proper explanation relating to material
departures, if any;
b. that the directors had selected such accounting policies and
applied them consistently and made judgments and estimates that are
reasonable and prudent so as to give a true and fair view of the state
of affairs of the company at the end of the financial year and of the
profit and loss of the company for that period;
c. that the Directors had taken proper and sufficient care for the
maintenance of adequate accounting records in accordance with the
provisions of the Act for safeguarding the Assets of the Company and
for preventing and detecting fraud and other irregularities;
d. that Directors'' have prepared the annual accounts on a going
concern basis;
e. the directors, had laid down internal financial controls to be
followed by the Company and that such internal financial controls are
adequate and were operating effectively;
f. the directors had devised proper systems to ensure compliance with
the provisions of all applicable laws and that such systems were
adequate and operating effectively.
RELATED PARTY TRANSACTIONS
All related party transactions that were entered into during the
financial year were on arm''s length basis and were in the ordinary
course of the business. There are no materially significant related
party transactions made by the Company with Promoters, Key Managerial
Personnel or other designated persons which may have potential conflict
with interest of the Company at large.
All related party Transactions are presented to the Audit Committee.
Omnibus approval is obtained for the transactions which are foreseen
and repetitive in nature. A statement of all related party transactions
is presented before the Audit Committee on quarterly basis, specifying
the nature, value and terms and conditions of transactions.
The related party transactions policy is uploaded on the Company''s
website at the web-link given below:
http://www.aartigroup.com/pdfs/Related%20Party%20Transaction%20Policy%2
0Pdf.pdf
The details of Related party transactions are provided in the
accompanying financial statements.
Since all related party transactions entered into by the Company were
in ordinary course of business and were on an arms length''s basis, Form
AOC - 2 is not applicable to Company.
STATEMENT ON DECLARATION GIVEN BY INDEPENDENT DIRECTORS UNDER
SUB-SECTION (6) OF SECTION 149
All Independent Directors have given declarations that they meet the
criteria of independence as laid down under Section 149(6) of the
Companies Act, 2013 and Clause 49 of the Listing Agreement.
CORPORATE GOVERNANCE
Your Company has complied with the mandatory Corporate Governance
requirements stipulated under Clause 49 of the Listing Agreement.
Report on Corporate Governance is annexed hereto forming part of this
report.
ANNUAL RETURN
The details forming part of the extract of Annual Return in the Form
MGT-9, as required under Section 92 of the Companies Act, 2013 is
included in the Report as Annexure - ''B'' and forms an integral part of
the Report.
CONSOLIDATED FINANCIAL STATEMENT
Your Directors have pleasure in presenting Consolidated Financial
Statements which form part of the Annual Report and Accounts.
DEPOSITS
The Company has neither accepted nor renewed any deposits during the
year under review. The Company does not have any deposits which are not
in compliance with the requirements of Chapter V of the Companies Act,
2013.
SECRETARIAL AUDIT
The Board had appointed CS Sunil M. Dedhia of Sunil M. Dedhia & Co.,
Practising Company Secretary, to conduct Secretarial Audit for the
financial year 2014-15. The Secretarial Audit Report for the financial
year ended 31st March, 2015 is annexed herewith marked as Annexure ''C''
and forms an integral part to this Report. The Secretarial Audit Report
does not contain any qualification, reservation or adverse remark.
PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS
Details of Loans, Guarantees and Investments covered under the
provisions of Section 186 of the Companies Act, 2013 are given in the
notes to the Financial Statements.
BOARD EVALUATION
Pursuant to the provisions of Clause 49 of the Listing Agreement , a
structured questionnaire was prepared after taking into consideration,
various aspects of the Board''s functioning, composition of the Board
and its Committees, culture, execution and performance of specific
duties, obligations and governance.
The performance evaluation of the Independent Directors was completed.
The performance evaluation of the Chairman and Non-Independent
Directors was carried out by the Independent Directors. The Board of
Directors expressed their satisfaction with the evaluation process.
SUBSIDIARIES AND ASSOCIATES
The Company has 6 (six) subsidiaries, namely, Aarti Corporate Services
Limited, Alchemie (Europe) Limited, Anushakti Specialities LLP,
Innovative Envirocare Jhagadia Limited, Shanti Intermediates Private
Limited and Nascent Chemical Industries Limited and 6 (six) associates
namely, Ganesh Polychem Limited, Anushakti Chemicals and Drugs Limited,
Anushakti Holdings Limited, Aarti Intermediates Private Limited, Aarti
Biotech Limited, Perfect Enviro Control System Limited.
During the year Board of Directors (''the Board'') reviewed the affairs
of the subsidiaries. In accordance with Section 129(3) of the Companies
Act, 2013, we have prepared consolidated financial statements of the
Company and all its subsidiaries, which form part of the Annual Report.
Further a statement containing salient features of the financial
statement of our Subsidiaries/Associates in the prescribed format AOC -
1 is included in the Report as Annexure ''D'' and forms an integral part
of this Report. The statement also provides the details of performance,
financial position of each of the Subsidiaries/ Associates.
DIRECTORS
Shri Renil R. Gogri and Shri Shantilal T. Shah retire by rotation and,
being eligible, offer themselves for re appointment. Your Directors
recommend Shri Renil R. Gogri and Shri Shantilal T. Shah for
re-appointment.
During the Year 2014-15, Independent Directors, namely, Shri Bhavesh R.
Vora, Shri P. A. Sethi and Shri K. V. S. Shyam Sunder were re-appointed
for a period of 5 (five) years with effect from 24th September, 2014
and Shri Ramdas M. Gandhi, Shri Vijay H. Patil and Shri Laxmichand K.
Jain were re-appointed for a period of 3 (three) years with effect from
24th September, 2014.
The Board of Directors appointed Prof. Ganapati D. Yadav and Smt. Priti
P. Savla, Additional Directors of the Company in the category of
Independent Directors with effect from 25th September, 2014 and they
hold office till the date of ensuing Annual General Meeting. Notice(s)
have been received from member(s) along with requisite deposits
proposing their candidature for appointment as such.
Shri Chetan B. Gandhi was appointed as Chief Financial Officer of the
Company w.e.f. 30th May, 2014.
SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS
There are no significant material orders passed by the
Regulators/Courts which would impact the going concern status of the
Company and its future operations.
COMMENTS ON AUDITORS REPORT
There are no qualification, reservation or adverse remark or disclaimer
made:
(i) by the auditor in his report; and
(ii) by the company secretary in practice in his secretarial audit
report.
WHISTLE BLOWER POLICY
The Company has a whistle blower policy to report genuine concerns or
grievances. The Whistle Blower policy has been posted on the website of
the Company (www.aartigroup.com)
MATERIAL SUBSIDIARY
The Company does not have any material subsidiary whose net worth
exceeds 20% of the consolidated net worth of the Company in the
immediately preceding accounting year or has generated 20% of the
consolidated income of the Company during the previous financial year.
Accordingly, a policy on material subsidiaries has not been formulated.
FAMILIARISATION PROGRAMME FOR INDEPENDENT DIRECTORS
The Company has a familiarisation Programme for Independent Directors
with regard to their role, rights, responsibilities in the Company,
Nature of the industry in which the Company operates, the Business
models of the Company etc. and the same is available on the website of
the Company (weblink - http://www.aartigroup.com/pdfs/Family.pdf.).
AUDITORS
In the 31st Annual General Meeting (AGM) of the Company held on 24th
September, 2014, M/s. Gokhale & Sathe, Chartered Accountants (Firm
Regn. No. 103264W) had been appointed as the Statutory Auditors of the
Company for a period up to 3 (three) years to hold office from the
conclusion of the 31st (AGM) until the conclusion of the 34th AGM of
the Company. In terms of the provisions of the Companies Act, 2013, it
is necessary to get the appointment ratified by the shareholders in
every Annual General Meeting until the expiry of the period of original
appointment.
In view of the above, the Board of Directors recommends your
ratification of the appointment of M/s. Gokhale & Sathe, Chartered
Accountants (Firm Regn. No. 103264W) as the Statutory Auditors as
mentioned at Item No. 5 of the Notice.
COST AUDITORS
The Cost Auditor Ms. Ketki D. Visariya (Fellowship No. 16028), Cost
Accountant, re-appointed by the Company under provisions of Section
148(5) read with Section 141 of the Companies Act, 2013 attend the
Audit Committee Meeting, where cost audit reports are discussed.
The due date for filing the Cost Audit Reports in XBRL mode for the
financial year ended 31st March, 2014 was 30th September, 2014 and the
Cost Audit Reports were filed by the Cost Auditor on 26th September,
2014. The due date for filing the Cost Audit Reports for the financial
year ended 31st March, 2015 is 30th September, 2015.
The Company is seeking the ratification from the Shareholders for the
appointment of Ms. Ketki D. Visariya, Cost Auditor of the Company for
the financial year ending 31st March, 2016 vide resolution no. 10 of
the Notice of AGM.
NUMBER OF CASES FILED, IF ANY, AND THEIR DISPOSAL UNDER SECTION 22 OF
THE SEXUAL HARASSMENT OF WOMEN AT WORK PLACE (PREVENTION, PROHIBITION
AND REDRESSAL) ACT, 2013
Your Company has Zero tolerance towards any action on the part of any
one which may fall under the ambit of ''Sexual Harassment'' at workplace,
and is fully committed to uphold and maintain the dignity of every
women working with the Company. The Policy framed by the Company in
this regard provides for protection against sexual harassment of women
at workplace and for prevention and redressal of such complaints.
Particulars NO. OF COMPLAINTS
Number of Complaints pending as on beginning NIL
of the financial year
Number of Complaints filed during the NIL
financial year
Number of Complaints pending as on the end NIL
of the financial year
DETAILS OF CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN
EXCHANGE EARNINGS AND OUTGO:
(A) CONSERVATION OF ENERGY
(i) The steps taken or impact on conservation of energy;
* The Company had been operating various captive and co-generation
Power plants. The Company expects a significant savings in the
consumption of natural resources/fuel by adoption of such process.
* Wherever possible, Variable Frequency Drives are installed to reduce
the power consumption.
* Energy audit is conducted and recommendations are implemented.
* Low Pressure Steam Generation from Process areas to recover heat and
use for Low Pressure Applications.
* Chilling Water Generation from Chlorine tonners for Chilling
Applications.
(ii) Additional Investments & Proposals, if any, being implemented for
Reduction of Consumption of Energy:
* Implementation of Clean Development Mechanism Project, which will
lead to higher recovery of Heat and thus, result in reduction of
emission of green House gases.
* Upgradation of Batch Nitration units into Continuous Nitration units,
shall help in overall optimization of utilities thereby resulting the
reduction in energy consumption.
* The Company proposes to set up additional Captive Co-generation Power
Plant at Jhagadia and Kutch Plants similar to the ones already operated
at Vapi, thereby increasing thermal efficiency and reduced coal
consumption per unit power as power produced without steam
condensation.
* Upgradation of various processes, wherever feasible, considering
optimisation of utilities, thereby resulting the reduction in energy
consumption.
(iii) The capital investment on energy conservation equipments;
Your Company has invested about RS. 24.7 Crores during Financial Year
2014-15 into energy conservation equipments.
(B) TECHNOLOGY ABSORPTION, ADAPTATION AND INNOVATION
(a) Efforts, in brief, made towards technology absorption, adaptation
and innovation:
* Forward Integration for downstream products and expansion also with
in-house technology.
* Continuous endeavour to improve product quality and process yields.
(b) Benefits derived as a result of above efforts:
* Lower project costs for expansion
* Value addition
* Exports of higher value-added products resulting in increased foreign
exchange earning.
(c) Information regarding technology imported during the last 3 years:
NIL
(C) TOTAL FOREIGN EXCHANGE EARNINGS AND OUTGO
The Foreign Exchange Earnings and outgo were RS. 1,449 Crores and RS.
435 Crores respectively (Previous Year: RS. 1,281 Crores and RS. 442
Crores respectively).
ACKNOWLEDGEMENT
The Board of Directors places on record its sincere appreciation for
the dedicated services rendered by the employees of the Company at all
levels and the constructive co-operation extended by them. Your
Directors would like to express their grateful appreciation for the
assistance and support by all Government Authorities, Auditors,
financial institutions, banks, suppliers, other business associates and
last but not the least the Shareholders.
For and on behalf of the Board
Sd/-
Place : Mumbai RAJENDRA V. GOGRI
Dated : 13th May, 2015 CHAIRMAN & MANAGING DIRECTOR
Mar 31, 2014
TO THE MEMBERS OF AARTI INDUSTRIES LIMITED
The Directors are pleased to present this Thirty First Annual Report
and the Audited Statement of Accounts for the year ended 31st March,
2014.
CONSOLIDATED FINANCIAL RESULTS (Rsin Crores)
Particulars 2013-14 2012-13
Net Sales 2,598 2,058
Other Operating Income 34 38
Total Income from Operations (Net) 2,632 2,096
Expenses
a) Cost of Material Consumed 1,630 1,261
b) Purchases of Stock-in-trade 117 93
c) Changes in inventories of Finished Goods,
Work-in-progress and Stock-in-trade (62) (71)
d) Employee Benefits Expenses 79 65
e) Depreciation and Amortisation Expenses 88 83
f) Other Expenses 467 387
Total Expenses 2,319 1,818
Profit/(Loss) from Operations before Other
Income,Finance Costs and Exceptional Items 313 278
Other Income 11 4
Profit/(Loss) before Finance Costs 324 282
Finance Costs 118 95
Profit/(Loss) before Tax 206 187
Tax Expenses
a) Provision for Taxation-Current 40 46
b) Provision for Deferred Tax 14 8
Total Tax Expenses 54 54
Net Profit/(Loss) after Tax 152 133
Share of Profit/(Loss) of Associates 11 2
Minority Interest (1) (1)
Net Profit/(Loss) after consolidation 162 134
Earnings Per Share (Rs) 18.34 15.17
BookValue Per Share (Rs) 98.29 85.36
DIVIDEND
Your Company had declared and paid Interim Dividends ofRs 3.00 ps. (@
60%) per share (ofRs 5/- each). Your Directors are pleased to recommend
a Final Dividend ofRs 1.50 ps. (@ 30%) per share (ofRs 5/- each) for the
FY 2013-14, aggregating to the Total Dividend of Rs 4.50 ps. (@ 90%) per
share (of Rs 5/- each) for the FY 2013-14 compared to the Total Dividend
of Rs 4.00 ps. (@ 80%) per share (ofRs 5/- each) for the FY 2012-13. The
total amount of Dividend pay-out for the year would be Rs 39.87 Crores
(previous year Rs 35.44 Crores).
Your Company has transferred Rs 14.90 Crores to General Reserve (P.Y
Rs 13.15 Crores).
FINANCIALS
Your Company has presented yet another year of consistent and stable
growth. During the year, the Standalone Net Revenues of the Company
grew by over 25% at Rs 2,633 Crores (previous year Rs 2,096 Crores).
Exports revenues also grew to Rs 1,281 Crores, a growth of over 20%
(previous year Rs 1,060 Crores).
Operating profit before Interest, Depreciation and Tax for FY 2013-14
increased by 11% to Rs 395 Crores (previous year Rs 356 Crores). EBIDTA
margins for the Company were at 15.3% for FY 2013-14 from 16.6% in FY
2012-13, on account of higher input costs.
Profit before Tax for FY 2013-14 also increased toRs 201 Crores
(previous yearRs 184 Crores). Profit after Tax and Deferred Tax grew toRs
149 Crores for FY 2013-14 fromRs 131 Crores for FY 2012-13.
Your Company''s Consolidated Income increased by about 26% to Rs 2,632
Crores as compared to Rs 2,096 Crores for last year. Consolidated
EBIDTA also grew by 13% to Rs 412 Crores from Rs 365 Crores last year.
Net Profit after Consolidation surged by 21 % at Rs 162 Crores vis-a-vis
Rs 134 Crores for last year. Consolidated EPS for the FY 2013-14 was at
Rs 18.34 as against Rs 15.17 for the FY 2012-13.
During last few years, with scale up of capacities and introduction of
various high growth and high margin export oriented products, the share
of Exports Revenue to Total Revenue has been increasing. Exports
represent about 50% of the total revenues. Also a bulk of products sold
in domestic markets are converted and ultimately exported. Hence
considering this, about 70% of our output would be exported either
directly or indirectly. The recovery of Global Markets from the
recessionary environment coupled with our strong Global position and
Strategic arrangements with key global customers, has helped us to
increase our volumes both present and incremental on account of higher
production capacities. Our delivery and service commitment helps us to
gain loyalty from our customers, which results into increase in our
exports operations.
ueoqrapmcai spread ot export Revenue CHEMICAL INDUSTRY - STRUCTURE &
DEVELOPMENT
The Global Speciality Chemical Industry size is pegged at around $740bn
(FICCI Speciality Chemical report and 12th Five- Year Plan document)
accounting for roughly 22% of the global chemical industry. This
industry has grown at a CAGRof 3.7% during 2006-11, despite contracting
by around 7% in 2009, due to the global financial crisis. Going
forward, the industry is expected to grow at a CAGR of about 5.4%
annually to reach $970bn by FY 16, based on Industry estimates.
Asia-Pacific and the Middle Eastern countries are expected to
contribute to the bulk of the future growth for the sector.
Indian Speciality Chemical sector has demonstrated strong growth of
around 13%, and is expected to accelerate further, higher than the
average global growth rate. (Source - FICCI). The high rate of growth
for the segment is driven by faster growth in end-user industries such
as paints & coatings, speciality polymers, and home care surfactants,
among others. This is supported by both domestic and export
opportunities. Derisking of business concentration from China by
various global customers coupled with appreciation of Chinese Yuan v/s
Indian Rupee and the rising operating costs in China, shall further
increase the opportunities for Indian Companies to expand the business
in global markets. Your Company expects the encouraging growth
opportunity in sectors like Pigments, Speciality Polymers,
Pharmaceuticals, Agrochemicals, Construction chemicals and Water
Chemicals to support the higher industry growth.
The emergence of a stable Government at Centre has improved the
business sentiment and consumer confidence across Pan India and
improving the future macro outlook. This new and renewed hope of
growth, if supported by positive and proactive steps from the
Government, would restart the revival of Indian Economy and would
result into increase in demand at various sectors. Government
Initiatives in the form of Port based Chemical Parks in SEZ,
Improvement in Infrastructure, Tax concessions, rationalization of Duty
Structure, FDI relaxation, etc. would facilitate further growth of the
Indian Chemical Industry into a major Chemical hub.
Your Company is a leading manufacturer of Speciality Chemicals with
diversified end-uses into Agrochemicals, Pharmaceuticals, High
Performance Polymers, Paints, Pigments, Printing Inks, Rubber
Chemicals, Additives, Surfactants, Dyes, Oil & Gas additives, Flavours
& Fragrances, etc. Your Company''s derisking by diversification has
helped it withstand the volatilities & downturns of a specific end-user
segment and also helps to capitalize on the growth opportunities in
other end-user segments.
With the rationales of Long term sustainability for both growth and
profitability, your Company continued in last year the efforts to adopt
a sustainable framework considering the elements of Safety, Health,
Environment Impact and Energy Efficiency initiatives. Your Company has
made significant investments by installing various Bioreactors,
Chemical Reverse Osmosis, Multiple Effect Evaporator, Incineration,
Electrostatic Filters, Solvent Recovery Systems, Waste Heat Recovery
Systems, etc. Your Company had also been continuously working towards
improvement of process safety as well as increasing the levels of
automation. These would provide long term benefits of Consistency in
Quality, Yield Improvements, Saving in utilities cost, minimization of
human error, etc. Your Company has been constantly improving the
manufacturing process and adoption of greener processes. These efforts
have been appreciated by various MNC customers. Your Company plans to
invest further in these areas to ensure providing greener and safer
manufacturing environment.
Reclassification of Business Segments
The Company is a multi-product and multi-faceted one. The operations
were earlier classified into four segments viz, Performance Chemicals,
Agri Intermediates & Fertilizers, Pharmaceuticals and Home & Personal
Care based on the end-use/ applications.
However, in case of PerformanceChemicals Segment and Agri Intermediates
& Fertilizers Segment, a majority of manufacturing facilities are
common and interlinked. As a result the segmental performance for these
two segments may fluctuate based on the product mix adopted in a
particular reporting period. Thus, for better understanding of the
operations resulting on account of these interchangeable facilities, it
has been decided to merge these two segments into a single reportable
segment under the name of "Speciality Chemicals". Hence the operations
of the Company has been reclassified into three segments viz,
Speciality Chemicals, Pharmaceuticals and Home & Personal Care
Chemicals. This reclassification has also facilitated the
identification of Capital Employed for each of these segments, which
was not possible earlier on account of common manufacturing facilities.
The changed reclassification does not have any financial impact. The
profile of these new business segments are presented below:
The brief Segmental financials are also presented below: (Rsin Crores)
Speciality Pharmaceuticals Home & Personal Total
Chemicals Care Chemicals
Sales 2,216 249 167 2,632
% of Total Sales 84.20% 9.46% 6.34% 100.00%
Export 1,130 117 34 1,281
% of Sales 50.99% 46.99% 20.36% 48.67%
EBIT 332 30 4 366
% of Sales 14.98% 12.05% 2.40% 13.91%
Capital Employed
as at 31st March
2014 1414 377 87 2006*
ROCE% 23.48% 7.96% 4.60% 18.25%
(* Includes unallocated CapitalEmployed of Rs 128 Crores)
As you would note from above, Speciality Chemicals accounts for about
85% of the Revenues and over 90% of EBIT. Further the operations for
Pharmaceutical Segment are growing and have registered a growth in
revenues by about 33%, while the EBIT for the segment had tripled over
last year. Also the EBIT margin for Pharmaceutical Segment has
increased from 5% for FY 2012-13 to 12% for FY 2013-14. This segment is
expected to be poised for faster growth. We shall further review these
segments in details as below:
Speciality Chemicals Segment:
This segment continues to account for majority of the revenues and
profits for the Company. Over last year, the segment had reported a
growth of about 26% in its revenues of which about 12% is attributable
to volume growth and the balance towards the increase in input costs
which has been passed on to the customers. The increase in benzene
prices does not impact EBIT in general, however when looked in
percentage terms, it reduces the EBIT %.
We present below the key financials for Speciality Chemicals Segment:
(Rs in Crores)
Key Financials FY 2013-14 FY 2012-13 FY 2011-12 FY2010-11
Sales 2,216 1,757 1,350 1,228
% of Total Sales 84.20% 83.83% 80.70% 84.49%
Export 1,130 946 639 504
% of Segment Sales 50.99% 53.84% 47.33% 41.04%
Segment EBIT 332 319 217 186
EBIT% 14.98% 18.16% 76.07% 15.15%
Your Company is one of leading global player manufacturing various
Benzene Based Derivatives through a number of chemicals processes at
its Global Scale manufacturing units located at Vapi, Jhagadia, Kutch
in the State of Gujarat and Tarapur in the State of Maharashtra.
A brief structure of Benzene Based Product Profile and Global market
share is presented below:
In addition to the above chemistries, your Company also manufactures a
number of products through Halex Chemistry, Phthalates, Diazotisation,
Denitro Chlorination, Methoxylation, Alkylated Anilines &Toulidines.
The products manufactured under these complex chemistry range from Rs
300/- per kg to over Rs 1500/- per kg. Your Company''s Global scale
capacities and higher market share have helped the Company to
capitalize on the growth opportunities and convert that into higher
volumes. Your Company''s strengths of highly integrated manufacturing
operations through its global size units manufacturing diverse products
having diversified end usage catering to needs of over 800 domestic and
global customers have helped itself to be one of the key player in the
global arena.
This diversity in the end-user profile along with the common
manufacturing units, which can be used for diverse, dynamic and
interchangeable product mix of a variety of Speciality chemicals, not
only ensures better utilization of capacities, but also helps building
customer confidence by providing adequate quantities to meet their
needs. Further, the uniqueness of integrated operations with optimum
isomer/co product balancing and gainful utilization of by-products have
helped your Company to emerge as a "Strategic" supplier to various
MNCsand they consider your Company as the partner in their future
growth. Considering these opportunities, over past two years the
Company has been expanding its various capacities across various
manufacturing sites. The Company has further plans for expansion, of
which the major ones are briefed below. These expansions shall be able
to fuel the growth of the Company for next 4 to 5 years.
Key Expansion Activities:
The proposed debottlenecking/expansion of the NCB capacities
(Nitration) from 57000 MT to 75000 MT is underway and is expected to be
progressively completed in FY 2014-15. Against the present capacity of
about 57000 MT, the production achieved in FY 2013-14 was about 54230
MT (Previous year about 48072 MT).
Your Company further plans to expand its another critical and base
production process viz Chlorination Process by about 15000 tpa i.efrom
present 65000 tpa to 80000 tpa. This expansion shall ensure adequate
supply of first stage products over next 3-4 years for captive
consumption for forward chain of products as well as to meet the
additional demand for these chemicals from global markets. Along with
this, the Company also proposes to set up a Calcium Chloride
Granulation plant. This shall consume the by-product HCL generated in
the process and convert that into commercially marketable product with
high export potential. Your Company already has one such unit in
Bhachau, Kutch and an another one is now being planned at Vapi,
Gujarat. Your Company was the 1st company in India to import such
technology.The Calcium Choride Granules are 100% exported by your
Company to various global customers for Oil-Exploration and De-icing
purposes.
Your Company also plans to expand its capacities for one of its key
Speciality Chemical with diversed end use into Polymers, Dyestuffs &
Additives through Continuous Hydrogenation Process. With this
expansion, your Company would have a dedicated unit to cater to the
growing demand of this Speciality Chemical, from FY 2015-16, having
large export potential. Further, in case of the existing continuous
Hydrogenation unit which caters to the growing, high margin and niche
demand in the segments of Polymers, Agrochemicals, Pigments, etc in
global markets have also been registering a consistent volume growth
due to higher exports. Annual average production of Hydrogenated
compounds in FY 2013-14 was 1650 TPM as compared to 1390 TPM for FY
2012-13, thereby posting a y-o-y volume growth of about 19% and is
expected to grow further in coming periods.
It may be noted that the above volume data are given for reference
purposes & may not be directly comparable, as each hydrogenated product
would have different process time. Thus with different product mix
adopted the process utilisation time would vary & so the output may
also vary.
Your Company has also been upgrading its 6 Batch Nitration capacities
and consolidate the same into Continuous Nitration units over a period
of time. In this regard, Your Company had commissioned one Continuous
Nitration unit, thereby reducing the Batch Nitration units from 6 to 4.
While this shall increase the level of automation of the process, it
shall also facilitate for overall increase in production capabilities.
It shall also result in increasing the consistencies & yields of
various products and simultaneously help to reduce the consumption of
fuel and other utilities, and thus bring about higher volumes with
significant cost savings and more safer and highly automated
operations.
Your Company plans to setup a dedicated block of Continuous
Nitration Unit for manufacture of Nitro Toulenes and derivatives at
Jhagadia. The products manufactured shall be used as intermediates into
end-user industries such as Optical Brighteners, Agro Chemicals,
Pigments, Pharmaceuticals, etc. This unit shall also provide feeder
material required for the proposed Ethylation unit being setup at Dahej
SEZ. The Company has already closed the technological tie-ups and has
taken up this project on fast track basis. The Company plans to
commission this unit in FY 2015-16.
On account of the wide diversity in product applications, the
Speciality Chemicals segment on an overall basis is expected to grow
with Key driving industries for growth of Speciality Chemicals which
are summarized below:
- Polymers & Additives:
Usage of High Performance Polymers has been increasing as a replacement
of metal parts in various mode of transportation worldwide, as an
endeavor to reduce the weight and improve the fuel efficiency. In
addition to this,
these polymers are also used in high growth segments such as Water
Treatment, Power Plant Filter, Electronic media & Telecommunication
devices and various other Electrical Instruments. Aforesaid various
expansions will help to increase the volumes of these Polymer
intermediates to cater the growing international demand.
- Dyes, Paints, Pigments and Printing Inks:
This sector has witnessed a shift in the consumption pattern of
Printing Inks based applications. While the demands for Printing inks
in developed economies are reducing, the same are increasing in
developing economies on account of increasing per-capita income &
consumption (along-with changes in consumption profile), growth in
education and healthcare facilities, etc. The global replacement of
usage of Organic Pigment vis-a-vis metal pigments has been the driving
force behind the significant growth of Pigment applications globally
and shall continue further going forward. The expanded capacity for a
Pigment intermediate commissioned in Q1 FY 2013-14 has already reached
about 85% capacity utilization and your Company further proposes to
scale up the capacities by debottlenecking.
- Agri-Intermediates and Fertilizers:
Your Company is a leading global manufacturer of various Agrochemicals
Intermediates and has presence across all the sub-segments viz
herbicides, insecticides, fungicides, etc. Emphasis on achieving food
grain self-sufficiency, limited farmland availability and growth in
horticulture and floriculture have been the reasons for the growth of
Agrochemicals worldwide. Exports account for over 60% of India''s
Agrochemicals produce and are expected to have a double digit growth
for years to come. Your Company is in talks with few customers for
long-term supply arrangement to meet their increasing requirements.
Your Company''s products are now being sold across all markets such as
NAFTA, Asia, Europe, Latin America, and other territories. This has
also helped to de-risk the business from Indian as well as various
other local climatic changes across the world.
Your Company is also into manufacturing of Single Super Phosphate (a
widely used fertilizer). It is a gainful usage of the by-product Dilute
Sulphuric Acid (generated by other Chemical units) and is marketed
under the guidelines prescribed by Government of India. The production
of SSP saves the Company from the hassles of management and disposal of
the by-product dilute sulphuric acid. However, off-late the challenges
of Cyclicity of Indian Monsoon, High Inventory and Recovery Periods,
Delays in grant of Subsidy, etc have resulted into high working capital
requirement for this business. Considering the same, your Company has
discontinued the expansion of this unit planned earlier. Further, since
overall composition of Fertilizers and Nutrients is less than 4% to the
total revenues, the cyclicity of this business does not materially
affect the overall operations of the Company. The Company is also
undertaking R&D Initiatives to reduce the generation of the by-product
and recycle the same by reconcentration, thereby limiting the exposure
to this volatile business for the time being or till conditions
improve.
Pharmaceuticals:
Pharmaceuticals Industry accounts for almost quarter of the Indian
Chemical Industry. From being a startup and base level operations,
Indian Pharma Companies have evolved to be a leader in the production
of high quality generic drugs. Patent expirations, weak pipeline
quality and increasing focus by Governments to reduce healthcare costs
continue to exert pressure on innovator companies which supports
outsourcing to low-cost nations. Despite challenges, leading Indian
players continue to exhibit strong profitability indicators.Outlook on
the Indian pharmaceutical companies remains favourable as companies
will continue to benefit from recovery in the domestic market, strong
growth potential in generics in developed marketsand potential
outsourcing opportunities.Globally, generics players however
continuetofacecompetitiveenvironment from large innovator companies.
Price erosion, especially through regulatory interventions, remains a
foremost challenge in the European markets. Presence in limited
competition product segments and over-the-counter (OTCs) segment offers
some protection to margins. Most developed markets continue to move
away from branded generics to commoditized un-branded generics and
lower margin tender based business.
Your Company has four manufacturing units of which - two are USFDA
approved facilities & other two are WHO GMP approved facilities. The
plants are cGMP compliant - meeting ICH Q7 standards - thus enabling
buyers to use APIs in all regulated markets. Your Company has 42
commercial APIs with 33 European DMFs, 27 US DMFs and 15 CEP (of which
4 are under approval). There are 12 more APIs under development. Your
Company enjoys distinct advantage of having dedicated USA, Japan and EU
regulatory approvals for Steroids and Anti-Cancer products. Your
Company also enjoys cost efficiencies by being backward integrated for
most of the APIs and thus enhances the margins of its range of
products. In FY 2013-14, your Company scaled up its capacities from 4
lines to 9 lines for manufacturing of APIs at its Tarapur USFDA unit.
We present below the key financials for Pharmaceuticals Segment:
(Rs inCrores)
Key Financials FY2013-14 FY2012-13 FY2011-12 FY2010-11
Sales 249 187 165 131
% of Total Sales 9.46% 8.92% 9.86% 8.98%
Export 117 92 66 46
% of Segment Sales 46.99% 49.20% 40.00% 35.15%
Segment EBIT 30 9 4 (6)
EBIT% 12.05% 4.81% 2.55% NA
The volumes of products under this segment have been consistently
increasing which have helped improvement in margins and segmental
profitability. EBIT for FY 2012-13 increased to Rs 30 Crores v/s Rs 9
Crores for FY 2013-14. EBIT margins have been improving and increased
to about 12% of sales in FY 2013-14 as compared to about 5% of sales
for FY 2012-13. You would note that the incremental sales of aboutRs 62
Crores have resulted into incremental EBITofRs21 Crores. Thus with
incremental EBIT from additional volumes at about 25 to 30%,
incremental volume shall increase the EBIT significantly. Further of
the total exports, exports to regulated markets are over 60%, which
help into improvement of margins. Thus the incremental growth in
revenues would result in a significant improvement in EBIT.
Further, your Company also plans to commission a dedicated unit to
manufacture caffeine, targeting the needs of Cola and Energy Drinks
makers. Thus, with increase in volumes through global markets and with
newer capacities, we expect the segment to grow at faster pace in
coming years.
Home & Personal Care Chemicals
Rising per capita income has enabled the increase of consumption of
hygiene and personal care products. Increasing consumption is driving
demand for wide range of cosmetic chemicals, health care products as
well as hygiene products using performance chemicals, polymers and oleo
chemicals.
We present below the key financials for Home & Personal Care Chemicals
Segment: (Rs in Crores)
Key Financials FY2013-14 FY2012-13 FY2011-12 FY2010-11
Sales 167 152 158 95
% of Total Sales 6.34% 7.25% 9.47% 6.52%
Export 34 22 21 10
% of Segment Sales 20.36% 14.47% 13.21% 10.94%
Segment EBIT 4 5 5 5
EBIT% 2.40% 3.29% 3.11% 5.36%
Home & Personal Care Chemicals segment is relatively a low margin
business. Your Company has two manufacturing units, one each at
Pithampur (Madhya Pradesh) & at Silvassa. Your Company plans to carry
out debottlenecking for some of its operations so as to expand the
capacities for export oriented products which have better margins.
These efforts will help to increase exports for this segment and also
result into improvement of margins.
RISKS AND CONCERNS
Your Company perceives risks or concerns common to industry such as
concerns related to the Macro Indian Economic Outlook, Global Economic
fallout, Regulatory risks, Foreign Exchange volatilities, Higher
Interest rates, Rising Raw-material prices and other commercial &
business related risks. While Segments like Pharmaceuticals and Home &
Personal Care are not much affected by the economic cycle and have its
own independent growth drivers, the diversity of end uses of Speciality
Chemicals and the ability of the Company to interchangeably use the
production facilities insulate the Company from any adversity for any
specific end user applications. Further, your Company''s diversified
revenue mix, flexible product mix and increasing export volumes also
help to derisk the business from any domestic economic setbacks as well
as certain specific
global uncertainties. Diversified & wide customer base further reduces
risks of dependence of business with few customer or few products. Your
Company is also in the process of entering into long term supply
arrangement with its key suppliers to ensure continuous and adequate
supply of raw-materials to meet the growing demand for the products.
Volatility in foreign exchange rates of Indian Rupee vis-a-vis US$ is
now an inherent risk. Your Company''s policy to hedge only those
exposures which are backed by confirmed orders helps it from taking any
unwanted positions and thus is not significantly affected by any such
movements.
Chemical Businesses has lots of inherent process risks. To ensure that
this risks do not arise, your Company had set up its efforts for
adopting greener, cleaner and safer manufacturing operations, your
Company has been increasing and upgrading the level of automation in
the existing processes thereby providing for a safer working
environment.
Chemical businesses are generally working capital intensive and hence
the working capital requirements are also higher. Your Company has
been making continuous efforts to reduce the working capital cycle.
With these efforts and higher cash accruals going forward, debt-equity
ratio is expected to improve in coming years.
INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY
Your Company has clearly laid down policies, guidelines and procedures
that form part of internal control systems, which provide for automatic
checks and balances. Your Company has maintained a proper and adequate
system of internal controls. This ensures that all Assets are
safeguarded and protected against loss from unauthorized use or
disposition and that the transactions are authorised, recorded and
reported diligently. Your Company''s internal control systems
commensurate with the nature and size of its business operations. The
internal Auditors'' Reports are regularly reviewed by the Audit
Committee of the Board.
DIRECTORS'' RESPONSIBILITY STATEMENT
As required u/s. 217(2AA) of the Companies Act, 1956 (the Act):
(i) That in the preparation of the Annual Accounts for the Year ended
31 st March, 2014, the applicable Accounting Standards had been
followed along with proper explanation for material departures, if any;
(ii) That the Directors had selected such accounting policies and
applied them consistently and made judgments and estimates that are
reasonable and prudent so as to give a true and fair view of the state
of affairs of the Company at the end of the financial year of the
profit of the Company for that year;
(iii) That the Directors had taken proper and sufficient care for the
maintenance of adequate accounting records in accordance with the
provisions of the Act for safeguarding the Assets of the Company and
for preventing and detecting fraud and other irregularities;
(iv) That Directors''have prepared the annual accounts on a going
concern basis.
SUBSIDIARY COMPANIES
The Company has 5 subsidiaries, namely, Aarti Corporate Services
Limited, Alchemie Europe Limited, Innovative Envirocare Jhagadia
Limited, Shanti Intermediates Private Limited and Nascent Chemical
Industries Limited. Statement pursuant to Section 212 and summary of
financial information of Subsidiaries are provided in the Annual
Report.
In accordance with the general circular issued by the Ministry of
Corporate Affairs, Government of India, the Balance Sheet, Statement of
Profit and Loss and other documents of the subsidiaries are not being
attached with the Balance Sheet of the Company. The Company will make
available the Annual Accounts of the subsidiaries and the related
detailed information to any member of the Company who may be interested
in obtaining the same. The annual accounts of the subsidiaries will
also be kept open for inspection at the Registered Office of the
Company as well as at the head offices of the Subsidiaries. The
Consolidated Financial Statements presented by the Company include the
financial results of its Subsidiaries.
CONSOLIDATED FINANCIAL STATEMENTS
Your Directors have pleasure in presenting Consolidated Financial
Statements which form part of the Annual Report and Accounts.
DIRECTORS
Shri Kirit R. Mehta and Shri Manoj M. Chheda, Whole-time Directors,
retire by rotation in terms of Section 152 of the Companies Act, 2013
and being eligible, offer themselves for re-appointment.
Pursuant to Section 152 of the Companies Act, 2013, Shri Bhavesh R.
Vora, Shri P. A. Sethi and Shri K. V. S. Shyam Sunder, Independent
Directors will retire at the ensuing Annual General Meeting and being
eligible, seek re-appointment.
The Companies Act, 2013 inter alia provides for appointment of
independent directors. Section 149(10) of the said Act, effective from
1st April, 2014, provide that independent directors shall hold office
for a term of up to five consecutive years on the Board of a company
and shall be eligible for re-appointment on passing a special
resolution by the shareholders of the Company. Section 149(11) of the
said Act provides that no independent director shall be eligible for
more than two consecutive terms of five years. It is also clarified
that existing tenure of an independent director shall not be counted
for the above purpose. Section 149(13) states that the provisions of
retirement by rotation as provided in Section 152(6) and (7) of the
said Act shall not apply to such independent directors.
Our independent directors were appointed as directors liable to retire
by rotation under the provisions of the erstwhile Companies Act, 1956.
The Board has been advised that independent directors so appointed
would continue to serve their existing term as per the resolution
pursuant to which they were appointed. In view of this, independent
directors, namely, Shri Bhavesh R. Vora, Shri P. A. Sethi and Shri K.
V. S. Shyam Sunder, complete their present terms at the ensuing AGM,
and being eligible and seeking re-appointment, be considered for
re-appointment for a period of 5 (five) years with effect from date of
this Annual General Meeting i.e. 24th September, 2014.
Shri Ramdas M. Gandhi, Shri Vijay H. Patil and Shri Laxmichand K. Jain,
are also Independent Directors of the Company, whose period of office
is liable to determination by retirement of Directors by rotation under
theerstwhileapplicable provisions of the Companies Act, 1956. Under
Section 149(10) of the Companies Act, 2013 and Rules made thereunder,
an Independent Director shall now hold office fora term of 5 (five)
consecutive yearson the Board of theCompany and is not subject to
retirement by rotation. In terms of Section 149 and other applicable
provisions of the Companies Act, 2013, and Rules made thereunder, Shri
Ramdas M. Gandhi, Shri Vijay H. Patil and Shri Laxmichand K. Jain,
being eligible and offering themselves for such appointment, be
considered for re-appointment as Independent Directors of the Company
for a period of 3 (three) years with effect from date of this Annual
General Meeting i.e. 24th September, 2014.
Shri Sunil M. Dedhia and Shri Haresh K. Chheda resigned as Independent
Directors of the Company effective from 1st April, 2014. The Board wish
to place on record its appreciation for their guidance to the Company
during their tenure with the Company as such.
CORPORATE GOVERNANCE
Your Company has complied with the mandatory Corporate Governance
requirements stipulated under Clause 49 of the Listing Agreement.
Report on Corporate Governance is annexed hereto forming part of this
report.
DISCLOSURE OF PARTICULARS
Information as per the requirements of Section 217(1 )(e) of the
Companies Act, 1956, read with Rule 2 of Companies (Disclosure of
Particulars in the Report of Board of Directors) Rules, 1988, relating
to Conservation of Energy, Research & Development, Technology
Absorption, Foreign Exchange Earnings and Outgo are annexed hereto
forming part of this Report.
ENVIRONMENTAL, SAFETY AND HEALTH
Your Company is committed to ensure sound Safety, Health and
Environmental (SHE) performance related to its activities, products and
services. The Company is taking continuous steps to develop Safer
Process Technologies and Unit Operations. Your Company has been
investing heavily in areas such as Process Automation for increased
safety and reduction of human error element, Enhanced level of training
on Process and Behaviour based safety, adoption of safe & environmental
friendly production process, Installation of Bioreactors, Chemical ROs,
Multiple effect evaporator and Incinerator, etc to reduce the discharge
of effluents, commissioning of Waste Heat recovery systems, and so on
to ensure the Reduction, Recovery and Reuse of effluents & other
utilities. Monitoring and periodic review of the designed SHE
Management System is done on a continuous basis. The Company already
has two "Zero Discharge" unit and is reviewing the viability for
converting other unit into Zero discharge. The Company is committed to
continuously take further steps to provide a safe and healthy
environment.
CORPORATE SOCIAL RESPONSIBILITY
Your Company has taken several CSR initiatives for over a decade. The
involvement is not only through financial support but also in the form
of Personal and continuous involvement of your Management thereby
ensuring the activities are benefited by their experience and to ensure
the reach of these initiatives to the society at large. Shri
Chandrakant V. Gogri, Chairman Emeritus is driving the CSR
intiatives.The CSR activities of your Company had primarily been
focused on promoting education to the poorest of the poor, Empowering
women, healthcare, affordable housing, support to those affected by
natural calamities.
Aarti Group had set up a school named Tulsi Vidya Mandir at Kutch,
Gujarat in year 2005. Tulsi Vidya Mandir imparts Secondary & Higher
Education to over 400 children coming from about 12 villages. Aarti
Group also founded Mahavir School/College of Nursing at Sabar Kantha,
Gujarat in Year 2008. Mahavir School/College of Nursing is spreading
professional nursing education to around 150 candidates annually in the
interior villages. Thus providing people from interiors with an
alternative option to earn their livelihood. Further Aarti Group also
founded Maninagar Sanskar Dham, at Kutch in Gujarat in year 2011. It is
a kindergarten for children of rag-pickers. These children are nurtured
at the centre for a year and then assisted till obtaining admission to
primary school. Aarti Group has been contributing to Ratanpar Boarding
School located in remote part of kutch. Ratanpar Boarding School is
imparting essential educational and Boarding facility to around 150
students. Your Company along with its employees have contributed to the
cause of rehabilitation of 15 villages affected during flash flood in
Uttarakhand in last monsoon. The Rehabilitation work is in final phase
and would be completed in FY 2014-15.
Apart from the above, the Company continues to support programs such as
organizing on a Blood Donation Camps, Health checkup camps, etc on
regular basis. The Company has been donating to several Hospitals,
Educational Institutions, Trusts, and contributes for green/open
spaces. The Company also contributes for relief measures in times of
natural calamities. In parlance to the objective of providing basic
primary and secondary education in the surrounding areas, your Company
actively contributes for upgradation & infrastructure development of
the schools.
During the year, the sectoral reach had been broadened to include
Military and vocational training, waste water recycling
providing/contributing for education facilities in remote locations and
for Nomads, employment opportunities, etc. with the focus on
eradication of hunger, poverty and malnutrition.
PERSONNEL
As required by the Provision of Section 217(2A) of the Companies Act,
1956, read with Companies (Particulars of Employees) Rules, 1975 as
amended up-to-date, the names and the other particulars of the
Employees are set out in the Annexureto the Directors''Report. However,
as per the Provisions of Section 219(1 )(b)(iv) of the Companies Act,
1956, the Reports and Accounts are being sent to all the Shareholders
of the Company excluding the aforesaid information. Any Shareholder
interested in obtaining such particulars may write to the Company
Secretary at the Registered Office of the Company.
AUDITORS
M/s. Parikh Joshi & Kothare, Auditors of the Company retire at the
ensuing Annual General Meeting. Though eligible, Auditors have informed
that they are not seeking re-appointment as they are in the process of
consolidation of their firm with M/s. Gokhale & Sathe, Chartered
Accountants. At the request of the Company, M/s. Gokhale & Sathe have
Communicated their eligibility and willingness to accept the office, if
appointed. Members are requested to appoint Auditors and to fix their
remuneration.
COST AUDITORS
The Cost Auditor Ms. Ketki D. Visariya (Fellowship No. 16028), Cost
Accountant, re-appointed by the Company under Section 233B of the
Companies Act, 1956 attend the Audit Committee Meeting, where cost
audit reports are discussed.
The due date for filing the Cost Audit Reports in XBRL mode for the
financial year ended 31st March, 2013 was 30th September, 2013 and the
Cost Audit Reports were filed by the Cost Auditor on 27th September,
2013. The due date for filing the Cost Audit Reports for the financial
year ended 31st March, 2014 is 30th September, 2014.
The Company is seeking the ratification from the Shareholders for the
appointment of Ms. Ketki D. Visariya, Cost Auditor of the Company for
the financial year ending 31st March, 2015 vide resolution no. 13 of
the Notice of AGM.
INDUSTRIAL RELATIONS & HUMAN RESOURCES
The Company enjoys coordial relation with its employees at all levels.
Your Company continues to ensure safety and health of its employees.
Your directors record their appreciation of the support and
co-operation of all employees and counts on them to be able to maintain
company''s growth momentum.
ACKNOWLEDGEMENT
The Board of Directors places on record its sincere appreciation for
the dedicated services rendered by the employees of the Company at all
levels and the constructive co-operation extended by them. Your
Directors would like to express their grateful appreciation for the
assistance and support by all Government Authorities, Auditors,
financial institutions, banks, suppliers, other business associates and
last but not the least the Shareholders.
For and on behalf of the Board
Sd/-
Place : Mumbai RAJENDRA V. GOGRI
Dated : 30th May, 2014 CHAIRMAN & MANAGING DIRECTOR
Mar 31, 2013
TO THE MEMBERS OF AARTI INDUSTRIES LIMITED
The Directors are pleased to present this Thirtieth Annual Report and
the Audited Statement of Accounts for the year ended 31st March'' 2013.
RESTRUCTURING UPDATE
During the year'' your Company has merged the manufacturing operations
of its Associate Company'' Anushakti Chemicals and Drugs Limited (ACDL)
into Aarti Industries Limited (AIL) with efect from 1st April'' 2012 in
terms of Scheme of Arrangement duly approved by the High Courts of
Bombay and Gujarat at Ahmedabad. Your Company has allotted 94''71''614
equity shares of" 5/- each to the shareholders of ACDL in terms of the
said Scheme of Arrangement'' whereby the Paid up Share Capital of the
Company has increased by about 12% to " 44''29''58''435 divided into
8''85''91''687 equity shares of" 5/- each fully paid up.
Upon the Scheme of Arrangement having become efective'' the merged
accounts have been drawn up for FY 2012-13 w.e.f. 1st April'' 2012.
Hence to this extent'' the fnancials for FY 12-13 may not be comparable
with previous year. ACDL had manufacturing units at Bhachau in the
State of Gujarat'' Tarapur and Dombivali in the State of Maharashtra
which are now merged into the Company. Apart from synergies derived in
respect of common products'' the said restructuring has increased the
volumes of existing range of products and would also facilitate
addition of newer products with diverse end usages into Fuel Additives''
etc. having high growth possibilities. Restructuring has also helped
spread of overall products and markets specifc risks and improve
operating margin as well.
FINANCIAL RESULTS
(in Lakhs)
Particulars Consolidated
2012-13 2011-12
Net Sales: 205''764 163''226
Other Operating Income 3''861 4''105
Total Income from Operations (Net) 209''625 167''331
Expenses
a) Cost of Material Consumed 126''120 97''926
b) Purchases of Stock-in-trade 9''312 14''049
c) Changes in inventories of
Finished Goods'' Work-in-progress
and Stock-in-trade (7''107) (2''354)
d) Employee Benefts Expenses 6''538 4''705
e) Depreciation and
Amortisation Expenses 8''284 5''485
f) Other Expenses 38''641 28''078
Total Expenses 181''788 147''889
Proft/(Loss) from Operations before
Other Income''
Finance Costs and Exceptional Items 27''837 19''442
Other Income 376 361
Proft/(Loss) before Finance Costs 28''213 19''803
Finance Costs 9''537 7''184
Proft/(Loss) before Tax 18''676 12''619
Tax Expenses
a) Provision for Taxation-Current 4''624 3''356
b) Provision for Deferred Tax 752 260
Total Tax Expenses 5''376 3''616
Net Proft/(Loss) after Tax 13''300 9''003
Share of Proft/(Loss) of Associates 241 1''431
Minority Interest (100) (108)
Net Proft/(Loss) after consolidation 13''441 10''326
Earnings Per Share 15.17 13.45
Book Value Per Share 85.36 74.59
DIVIDEND
Your Company had declared and paid Interim Dividends of Rs. 2.75 (@ 55%)
per share (of Rs. 5/- each). Your Directors are pleased to recommend a
Final Dividend of Rs. 1.25 (@ 25%) per share (of Rs. 5/- each) for FY
2012-13'' thereby total Dividend aggregating to Rs. 4/- (@ 80%) per share
(of Rs. 5/- each) for FY 12-13 compared to the total Dividend of Rs. 3.50
(@ 70%) per share (of Rs. 5/- each) for FY 2011-12. The total amount of
Dividend pay-out for the year would be Rs. 35.44 crs (previous year Rs.
27.21 crs).
Company has transferred Rs. 13.15 Crores to General Reserve (PY Rs. 8.80
Crores).
FINANCIALS
During the year'' your Company has achieved multiple milestones.
Standalone Net revenues of the Company crossed Rs. 2000 Crores mark and
ended at Rs. 2096 Crores (previous year Rs. 1673 Crores). Similarly Exports
had also crossed Rs. 1000 Crores and closed at Rs. 1060 Crores. Hence with
these record breaking performance'' our exports now constitute over 50%
of the total revenues of the Company. The EBIDTA margins for the
Company also improved from 14.6% for FY 11-12 to 17% in FY 12-13.
Operating proft before Interest'' Depreciation and Tax for FY 12-13 was
at Rs. 356 crs (Previous Year Rs. 245 Crores) Proft before tax for FY12-13
was at Rs. 184 Crores (Previous Year Rs. 122 Crores) Proft after Tax and
Deferred Tax grew to Rs. 131 Crores for FY 12-13 from Rs. 87 Crores for FY
11-12.
Consolidated Income increased by 25% to Rs. 2096 Crores as compared to Rs.
1673 Crores for last year. Consolidated EBIDTA also grew by about 45%
to Rs. 365 Crores as against Rs. 253 Crores last year. Net Proft after
Consolidation also recorded a growth of 30% at Rs. 134 Crores as against
Rs. 103 Crores for last year. Consolidated EPS for FY 2012-13 was at Rs.
15.17 as against Rs. 13.45 for FY 2011-12.
During last year'' with introduction of various high growth and high
margin export oriented products'' the share of Exports Revenue to Total
Revenue have crossed the 50% benchmark. The ability to provide
products with required specifcations at desired intervals have added to
the increase in volumes from Global customers over longer term period.
Your Company has entered into various long term supply agreement with
its key customers thereby further strengthening its Global market
positions. Signifcant volume growth is coming from our customers in
Europe and America and in few of the products the demand is more than
the production capabilities of the Company. Exports now'' accounts for
51% of the total revenue and have increased by over 46% to Rs. 1060
Crores for FY 12-13 from Rs. 727 Crores for FY 11-12.
CHEMICAL INDUSTRY Â STRUCTURE & DEVELOPMENT
Chemical Industry is one of the fastest growing industries in the
Indian Economy. At the same time it is also one of the oldest domestic
industry of India which started working soon after IndiaÂs Independence
in 1947. It accounts for 18% of the Indian manufacturing sector output
and is expected to grow by about 12% annually. It constitutes for about
15% of IndiaÂs Exports and has around 8% share in IndiaÂs Imports. From
those early years'' the Chemical Industry in India continued to
contribute to the Economic Growth of Indian Economy. At present'' the
Chemical Industry accounts for almost 13% of Indian GDP.
A network of over 200 national laboratories and 1300 R&D Centres
provide a strong base for further innovations and growth of Indian
Chemical Industry. Government Initiatives in the form of Port based
Chemical Parks in SEZ'' Improvement in Infrastructure'' Tax concessions''
reduction and rationalization of Duty Structure'' FDI relaxation'' etc.
plough the road for further growth of the Indian Chemical Industry into
a major Chemical hub. End user Industries like Agro-Chemicals''
Automotives'' Biotechnology'' Electronics'' Packaging'' Pharmaceuticals''
Pigments'' Polymers'' Surfactants'' etc have been witnessing good demand
and are poised for faster growth.
Thus'' Indian Chemical Industry holds potential to produce quality
chemicals for global consumers because of its diversifed manufacturing
base'' strong IPRs'' availability of qualifed work force'' proximity to
ports'' availability of feedstock'' etc.
With concerns on environmental impact'' the Indian Government has been
working towards ensuring stricter compliance of efuent norms''
categorizing alert zone'' identifying and restricting the operation of
the polluting units. This has made Indian companies to scale up their
units in parity with international standards. In this process'' while a
lot of units have been closed down'' we are also witnessing the
emergence of Indian Global Chemical Companies capable of competing with
the other Asian players'' while also adopting safer and greener
processes.
Your Company is a leading manufacturer of Speciality Chemicals with
diversifed end-uses into Agrochemicals'' Pharmaceuticals'' High
Performance Polymers'' Paints'' Pigments'' Printing Inks'' Rubber
Chemicals'' Additives'' Surfactants'' Dyes'' Oil & Gas additives'' Flavours
& Fragrances'' Home & Personal Care applications'' etc. Your CompanyÂs
derisking by diversifcation has helped it withstand the volatilities &
downturns of a specifc end-user segment and also helps to capitalize on
the growth opportunities in other end-user segments.
Your Company believes that the long term growth and proftability from
the business cannot be sustained without a framework considering the
elements of Safety'' Health'' Environment Impact and Energy Efciency
initiatives. With these principles'' your Company have stepped up its
eforts for the sustainable growth of its businesses. Your Company is
committed to increase the process safety and increasing the level of
automation in its existing areas of operation. This will help in
reducing the manual handling and shopfoor manpower. Your Company has
adopted the 3R Principle'' i.e.'' Reduce  Recover  Reuse. Over last 18
months'' your Company has made substantial Investments into upgrading
the ETP setup and had upgraded two of its Manufacturing Units into Zero
Discharge Unit and also has put in places various processes to
control/limit of generation of efuents and improve on the treatment of
the same. Your Company plans to invest further in these areas to ensure
providing greener and safer manufacturing environment.
Your Company is a multi-product and multi-faceted one. Depending on
these product categories we divided our businesses into four segments.
The profle/composition of these business segments is presented:
We present below the breakup of key segmental fnancials:
(in Crores)
Performance Agri-
Intermediates Pharmac
euticals Home &
Personal Total
Chemicals & Fertilizers Care
Chemicals
Sales 1319 438 187 152 2096
% of
Total Sales 62.93% 20.90% 8.92% 7.25% 100.00%
Export 739 207 92 22 1060
% of Sales 56.03% 47.26% 49.20% 14.47% 50.57%
EBIT 236 83 9 5 333
% of Sales 17.89% 18.95% 4.81% 3.29% 15.89%
While Performance Chemicals and Agri-intermediates segments continues
to account for over 80% of operations'' it may be noted that the growth
in the business this year is mainly driven by the fact that the exports
across all the segments has increased signifcantly. Your CompanyÂs
market position as a major global manufacturer of Chloro Benzenes &
Nitro Chloro Benzenes and their derivatives with committed and
customized delivery solutions have helped us cross Rs. 1000 Crores mark
of global revenues. Your CompanyÂs USP of having highly integrated
operation with process fexibility adds to the growth in customerÂs
confdence which is translated into consistent volume growth even in
times of adversities. Your CompanyÂs diversifed product mix spread
across stream of end user industries catering to smaller as well as
larger MNC conglomerates in each segment / sub-segments have helped the
Company to insulate itself against global economic cycle.
Interchangeable Performance & AgroChemicals manufacturing operations.
The Manufacturing units for these two segments are majorly
interconnected/interlinked at the common manufacturing units located at
Vapi'' Sarigam'' Jhagadia and Bhachau in the State of Gujarat and at
Dombivali & Tarapur in the State of Maharashtra. A signifcant portion
of your CompanyÂs production capabilities are process driven and not
based on a particular product. This gives your Company the fexibility
to change its input mix and manufacture diferent products'' thereby
resulting into optimum utilization of production capabilities as well
as provides fexibility to change the product mix amongst diferent
end-user applications based on market dynamics.
Your Company manufacturers various isomers as well as their downstream
products. Because of the vertical integration'' your Company enjoys
natural insulation against short supply of precursor raw materials.
Thus'' consistent supply of products results into customer confdence and
helps your Company to gain more market share. Your Company has also
been able to convert its by-product from various processes into
commercially viable products'' thereby contributing to the proftability
of the Company.
Hydrogenation Facility at Jhagadia:
Your Company had pioneered by adopting Greener Hydrogenation process
based Swiss Technology in India and have scaled up the capacities to
3000 tpm in Q3FY12-13. This expanded / additional hydrogenation unit
shall help the Company to cater to the growing'' high margin and niche
demand in the segments of Polymers'' Agrochemicals'' Pigments'' etc. in
global markets. This shall also facilitate introduction of export
oriented further value added range of products. Hence with these
expanded capacities coupled with strong market position'' the Company
expects to post signifcant growth in revenues and margins in coming
years. The Company had recorded the production of over 1550 tpm of
hydrogenated products in the quarter ended 31st March 2013. Annual
average production for FY 12-13 was 1390 TPM as compared to 1165 TPM
for FY 11-12. Also'' with the commissioning of the backward integrated
Hydrogen Gas Generation Plant'' your Company is also assured for
continuous supply of the feed raw material for the above mentioned
Hydrogenation Unit. Thus this increase in hydrogenation capacities has
enabled your Company to cater to the growing'' high margin & niche
demand segments of Performance and Agro ingredients in the global
market. Your Company now targets to produce around 2000-2200 tpm of
Hydrogenated products in FY 2013-14.
Key Expansion Activities:
During last fnancial year'' a major German manufacturer had closed down
and discontinued the manufacturing of Nitro Chloro Benzenes due to
lower captive demand. This has opened up a large market (both domestic
as well as for exports) for Nitro Chloro Benzenes. Considering this
your Company has already taken up the expansion of its Nitro Chloro
Benzenes (NCBs) capacities on fast track. Against the present capacity
of about 57000 MT'' the production achieved in FY 12-13 was about 48072
MT (previous year about 42696 MT). Your Company now proposes to expand
the existing capacities of 57000 MT to about 75000 MT with an estimated
capital outlay of about" 25 to 30 Crores and expects to commission the
same by end of current fnancial year.
Your Company is in the process of upgrading its 6 Batch Nitration
capacities and consolidate the same into 4 Continuous Nitration units.
While this will increase the level of automation of the process'' it
will also facilitate overall increase in production capabilities. It
will also result in increasing the consistencies & yields of various
products and simultaneously help to reduce the consumption of fuel and
other utilities. This would thus also entail higher volumes with
signifcant cost savings with more safer and highly automated
operations.
New Investment at Dahej SEZ:
Your Company had set up a new venture in 2012 under the name of
Anushakti Specialities LLP in which your Company holds 90% stake and
the balance 10% stake was held by ACDL which stake has since merged
with the Company upon the restructuring as aforesaid.
This LLP has purchased a plot of about 50''000 sq. mtrs at Dahej SEZ and
is in the process of setting up an Ethylenation unit for manufacturing
ethylene based products with end-user application as Agro Chemicals and
Speciality Chemicals'' majorly in Global Markets. Your Company is in the
process of fnalizing the newer technologies which shall be commissioned
at this unit. The unit is expected to be commissioned in FY 2014-15.
With availability of key raw materials in Dahej'' we propose to purchase
the same by pipeline. Considering the niche product segment'' growing
global demand'' and the benefts available at SEZ'' this unit is expected
to signifcantly add to turnover and proftability of the Company.
Upon the Scheme of Arrangement with ACDL being efective'' your Company
now holds 100% stake in Anushakti Specialties LLP. Your Company
proposes to absorb this entity into itself subject to regulatory
approvals as may be specifed.
Performance Chemicals
With the merger of manufacturing division of Anushakti Chemicals &
Drugs Ltd. (ACDL) becoming efective'' products of ACDL having
applications as Polymer Additives and Oil & Gas Additives had been
added to the segment of Performance Chemicals. With the additions of
ACDLÂs products'' the Performance Chemicals now provides for a
consistent and sustained growth to CompanyÂs operations.
We present below the key fnancials for Performance Chemicals:
Key Financeal FY 2012-13 FY 2011-12 FY 2010-11
Sales 1319 968 1030
% of Total Sales 62.93% 57.85% 70.89%
Export 739 496 412
% of Segment Sales 56.03% 51.27% 39.99%
Segment EBIT 236 142 145
EBIT % 17.89% 4.65% 4.07%
(* Figures for 12-13 may not be comparable as the same are inclusive of
the fgures of ACDL after adjusting the same for interse transactions
between AIL and ACDL)
As you would note'' this segment accounts for about 63% of the total
revenues (previous year 58%) of the Company. Exports of Performance
Chemicals accounts for 70% of the total exports of the Company and
constitute over 56% of the segment revenue.
The diversity in end user segments from High Performance Polymers''
Paints'' Pigments'' Printing Inks'' Rubber Chemicals'' Additives''
Surfactants'' Dyes'' Oil & Gas Additives'' Flavours & Fragrances'' etc. is
the inherent strength and de-risks the segment from individual end-user
downturns. The wider customer base from varied industry also reduces
the credit risk and thus provides sustainability and stability to the
CompanyÂs operations.
Performance Chemicals segment broadly comprises of Speciality Chemicals
with applications into
a. Polymers & Additives''
b. Dyes'' Pigments'' Paints'' Printing Inks''
c. Oil & Gas Additives'' Rubber Chemicals'' Flavours & Fragrances'' Water
Treatment'' Construction Chemicals'' Resins'' etc.
On account of the wide diversity in product applications'' the segment
on an overall basis is expected to grow with Key driving industries for
growth of Performance Chemicals are summarised below.
- Polymers & Additives:
Usage of High Performance Polymers has been increasing as a replacement
of metal parts in various mode of transportation worldwide'' as an
endeavor to reduce the weight and improve the fuel efciency. In
addition to this'' these polymers are also used in high growth segments
such as electronic media & telecommunication devices and various other
Electrical Instruments. With the availability of additional
Hydrogenation Capacities'' your Company expects to increase the volumes
of these Polymer intermediates to cater the growing international
demand.
With a view to capitalize on the by-product Hydro Chloric Acid by
converting it into a gainful product'' a Calcium Chloride Granulation
unit was set up by ACDL at Bhachau which unit has since been merged
with the Company. Your Company has for the frst time in India'' imported
this technology for granulation of Calcium Chloride. This unit improves
the quality of end product and will be able to manufacture high grade
granules'' which are used into Oil Exploration and de-icing activities.
This products will be mainly exported and is expected to fetch
signifcant higher margins.
- Dyes'' Paints'' Pigments and Printing Inks:
This sector has witnessed a shift in the consumption pattern of
Printing Inks based applications. While the demand for Printing inks in
developed economies are reducing'' the same is increasing in developing
economies on account increasing per-capita income & consumption
(along-with changes in consumption profle)'' growth in education and
healthcare facilities'' etc.
The global replacement of usage of Organic Pigment vis-Ã -vis Metal
Pigments has been the driving force behind the signifcant growth of
Pigment applications globally and shall continue further going forward.
With a signifcant Japanese player having ofcially closed production of
a key Pigment & Printing Ink intermediate in the frst quarter'' an
opportunity has opened up for increasing our presence in the Pigment
application. Your Company has immediately taken steps to increase the
capacities for this application. The Company has already supplied these
products to the prospective customers and is in the process of
qualifying with these new customers for these products. This enhanced
new capacity is presently under commissioning. We expect further volume
growth in these products from FY 13-14 onwards so as to meet the supply
gap arising as aforesaid.
While the demand from global markets for Pigments and Paint application
has been increasing'' the demand from the dyes sector is still afected
by downturn. Your Company is monitoring this situation and shall take
adequate steps for product realignment once the demand picks up.
Your CompanyÂs strong position in this segment will help further to
capitalize on the global growth opportunities.
Agri-Intermediates and Fertilizers
IndiaÂs Agrochemicals Industry valued at about US$ 2 bn'' is the fourth
leading producer of Agrochemicals after USA'' Japan and China and has
been growing annually at about 7.5%. Emphasis on achieving foodgrain
self-sufciency'' limited farmland availability and growth in
horticulture and foriculture have been the reasons for the growth of
Agrochemicals worldwide.
Exports account for over 60% of IndiaÂs Agrochemicals produce and are
expected to have a double digit growth in years to come. Many foreign
companies are tying up with local manufacturers to expand into this
sector for domestic & global requirements.
The launch of nutrient based subsidy programme for more efective scheme
of distribution of the subsidy directly to the end users would beneft
the direct end-users in long term and it will also ensure has
distribution of the subsidy to the eligible people at large. In
addition to these administrative reforms'' the Government has also
rolled out a series of tax incentives to further promote the growth of
this high growing Fertilizer and Agro based-businesses in India.
Your Company is a leading global manufacturer of various Agrochemicals
Intermediates and has presence across all the sub-segments viz.
herbicides'' insecticides'' and other agrochemicals.
We present below the key fnancials for Agri Chemicals & Fertilizers
Segment:
( in Crores)
Key Financeal FY 2012-13 FY 2011-12 FY 2010-11
Sales 438 382 198
% of Total Sales 20.90% 22.85% 13.60%
Export 207 143 92
% of Segment Sales 47.26% 37.52% 46.46%
Segment EBIT 83 75 41
EBIT % 18.95% 19.73% 20.71%
P.S: A major part of domestic sales is used to manufacture products for
export markets.
Your Company has been focusing on the growth opportunities for these
products in global markets and has been closely working with the Global
Leaders in this space to cater to their customized requirements of
agrochemicals. After years of eforts to develop this market'' the
Company has been witnessing consistent growth in the exports of these
products. Your CompanyÂs products are now being sold across all markets
such as NAFTA'' Asia'' Europe'' Latin America'' and other territories.
This has also helped to de-risk the business from various local
climatic changes as also across the world. This is witnessed by y-o-y
growth in exports of these products as shown in the table above.
Your Company is also manufacturing Single Super Phosphate (SSP) (a
widely used fertilizer). It is a gainful usage of the by-product Dilute
Sulphuric Acid (generated by other Chemical units) and is marketed
under the guidelines prescribed by Government of India. The production
of SSP also saves the Company from the hassles of management and
disposal of the said by-product. India is amongst the largest
manufacturer and consumer of SSP across the world. An area wise
consumption data of SSP is presented below:
State Consumption %
Rajasthan 1242 28.11%
Madhya Pradesh 852 19.28%
Maharashtra 631 14.29%
West Bengal 479 10.85%
Gujarat 298 6.75%
Uttar Pradesh 258 5.83%
Andhra Pradesh 228 5.16%
Chattishgarh 168 3.80%
Tamilnadu 168 3.80%
Karnataka 56 1.26%
Assam 32 0.73%
Haryana 6 0.14%
Total 4417 100.00%
Source: Fertilizer Association of India
States of Maharashtra'' Gujarat'' Madhya Pradesh and Rajasthan accounts
for over 68% of IndiaÂs total consumption of SSP. Your Company thus
enjoys the locational benefts of having manufacturing unit in Gujarat''
thereby also benefting from the reduced freight costs as compared to
other States. During FY 2012-13'' there had been a drought situation in
major parts of India. As a result the sale for SSP (Fertilizer) had
been afected. Inspite of having lower volumes in frst half'' our sales
of SSP for FY 2012-13 was around 65446 MT as compared 63266 MT in FY
2011-12. Considering our existing capacity of 100''000 MT'' we account
only about 2% of IndiaÂs Production Capacities and about 1.4% of
IndiaÂs total consumption. In view of this'' we expect to have sales
volumes of about 80000 - 90000 MT of SSP for FY 2013-14.
With the expansion in other manufacturing capabilities'' need for
additional SSP capacities (for captive consumption of by- product) is
expected. Envisaging the same'' your Company is exploring the
feasibility for setup an additional SSP unit with capacity to
manufacture 200''000 Tons at Jhagadia'' Gujarat to cater to the demand in
the States of Gujarat'' Rajasthan and Madhya Pradesh.
Pharmaceuticals
Pharmaceuticals Industry accounts for almost quarter of the Indian
Chemical Industry. From being a startup and base level operations''
Indian Pharma Companies have evolved to be a leader in the production
of high quality generic drugs.
Patent expirations'' weak pipeline quality and increasing focus by
Governments to reduce healthcare costs continue to exert pressure on
innovator companies which supports outsourcing to low-cost nation like
India. Despite challenges'' leading Indian players continue to exhibit
strong proftability indicators.
Outlook on the Indian pharmaceutical companies remains favourable as
companies will continue to beneft from recovery in the domestic market''
strong growth potential in generics developed markets and potential
outsourcing opportunities.
Globally'' generics players however continue to face competitive
environment from large innovator companies. Price erosion'' especially
through regulatory interventions'' remains a foremost challenge in the
European markets. Presence in limited competition products segments and
over-the-counter (OTCs) segment ofers some protection to margins. Most
developed markets continue to move away from branded generics to
commoditized un-branded generics and lower margin tender based
business.
Your Company has four manufacturing units of which - two are USFDA
approved facilities & other two are WHO GMP approved facilities. These
plants are cGMP compliant - meeting ICH Q7 standards - thus enabling
buyers to use APIs in all regulated markets. Unlike other companies''
your Company has capacities for inhouse production of intermediates and
hence it is not dependent on China for the same. This helps your
Company to reduce the costs for its APIs and thus enhances the margins
of its range of products.
We present below the key fnancials for Pharmaceuticals Segment:
(in Crores)
Key Financeal FY 2012-13 FY 2011-12 FY 2010-11
Sales 187 165 131
% of Total Sales 8.92% 9.86% 8.98%
Export 92 66 46
% of Segment Sales 49.20% 40.00% 35.15%
Segment EBIT 9 4 (6)
EBIT % 4.81% 2.55% NIL
The volumes of these products have been consistently increasing which
has helped improvement in margins and segmental proftability. The same
is evident from increase in revenues as tabulated above. Similarly'' the
EBIT for FY13 increased to " 9.5 Crores as against" 4 Crores for FY
2011-12. You would note that the EBIT margins have been improving and
it increased to over 5% of sales in FY13 as compared to 2.55% of sales
for FY12. Thus the incremental growth in revenues in this segment will
result into signifcant improvement in EBIT. We expect the segment to
grow as faster pace in coming years.
Home & Personal Care Chemicals
Rising per capita income have enabled the increase of consumption of
hygiene and personal care products. Increasing consumption is driving
demand for wide range of cosmetic chemicals'' health care products as
well as hygiene products using performance chemicals'' polymers and oleo
chemicals.
We present below the key fnancials for Home & Personal Care Chemicals
Segment:
( in Crores)
Key Financeal FY 2012-13 FY 2011-12 FY 2010-11
Sales 152 158 95
% of Total Sales 7.25% 9.47% 6.52%
Export 22 21 10
% of Segment Sales 14.47% 13.21% 10.94%
Segment EBIT 5 5 5
EBIT % 3.29% 3.11% 5.36%
Home & Personal Care Chemicals segment is relatively a low margin
business. Your Company has two manufacturing units'' one each at
Pithampur (Madhya Pradesh) & at Silvassa. Your CompanyÂs plans to
optimize its production capabilities to suitably alter/revise the
product mix has helped marginal improvement in margins inspite of
reduction in sales volumes. The commissioning of the Spray Dryer
project in Q4FY2012-13 and the product reshufing exercise is expected
to improve the margins in coming quarters. Your Company is also
focusing on increase in exports of its products under this segments.
This will help in better realization and improvement of margins.
SEGMENT-WISE PERFORMANCE
(in Lakhs)
Sr.
No. Particulars Standalone Consolidated
(A) Primary Segments :
Business Segments
1 Segment Revenue
a) Performance Chemicals 131''948 131''961
b) Agri-Intermediates & Fertiliser 43''818 43''818
c) Pharmaceuticals 18''684 18''684
d) Home & Personal Care Chemicals 15''162 15''162
TOTAL 209''612 209''625
2 Segment Results Proft / (Loss)
(Before Tax and Interest
from each Segment)
a) Performance Chemicals 23''587 23''587
b) Agri-Intermediates & Fertilizer 8''308 8''308
c) Pharmaceuticals 945 945
d) Home & Personal Care Chemicals 503 503
TOTAL (A) 33''343 33''343
Less: Interest 9''500 9''537
Other Unallocable Expenditure (Net) 5''459 5''130
TOTAL (B) 14''959 14''667
TOTAL PROFIT BEFORE TAX (A-B) 18''384 18''676
(B) Secondary Segments :
Geographical Segments
a) India 103''651 103''664
b) Out of India 105''961 105''961
TOTAL 209''612 209''625
SEGMENT CAPITAL EMPLOYED
Fixed Assets used in the CompanyÂs business or Liabilities contracted
have not been identifed to any of the reportable segments'' as the Fixed
Assets and services are used interchangeably between segments. The
Company believes that it is currently not practicable to provide
segment disclosures relating to capital employed.
RISKS AND CONCERNS
Your Company perceives risks or concerns common to industry such as
concerns related to the Macro Indian Economic Outlook'' Global Economic
fallout'' Regulatory risks'' Foreign Exchange volatilities'' Higher
Interest rates'' Rising Raw-material costs and other commercial &
business related risks. Segments like Agrochemicals'' Pharmaceuticals
and Home & Personal Care are not much afected by the economic cycle and
have its own independent growth rates. Further your CompanyÂs
diversifed revenue mix'' fexible product mix and increasing volumes from
value added products helps to insulate the business from any economic
setbacks.
Volatility in foreign exchange rates of Indian Rupee vis-a-vis US$ is
now an inherent risk. Your CompanyÂs policy to hedge only those
exposures which are backed by confrmed orders protects it from taking
any unwanted positions and thus is not signifcantly afected by any such
movements.
Chemical Businesses have lot of inherent process risks. To ensure that
this risks do not arise'' your Company had stepped up its eforts for
adopting greener'' cleaner and safer manufacturing operations. Your
Company have also been increasing and upgrading the level of automation
in the existing processes thereby providing for a safer working
environment.
Chemical businesses are generally working capital intensive and hence
the working capital requirements are also higher. Your Company has
been making continuous eforts to reduce the overall working capital
cycle. With these eforts and higher cash accruals going forward''
debt-equity ratio is expected to be better in coming years.
INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY
Your Company has clearly laid down policies'' guidelines and procedures
that form part of internal control systems'' which provide for automatic
checks and balances. Your Company has maintained a proper and adequate
system of internal controls. This is to ensure that all assets are
safeguarded and protected against loss from unauthorized use or
disposition and that the transactions are authorised'' recorded and
reported diligently. Your CompanyÂs internal control systems
commensurate with the nature and size of its business operations. The
internal Auditors Reports are regularly reviewed by the Audit
Committee of the Board.
DIRECTORSÂ RESPONSIBILITY STATEMENT
As required u/s. 217(2AA) of the Companies Act'' 1956 (the Act):
(i) That in the preparation of the Annual Accounts for the Year ended
31st March'' 2013'' the applicable Accounting Standards had been followed
along with proper explanation for material departures'' if any;
(ii) That the Directors had selected such accounting policies and
applied them consistently and made judgments and estimates that are
reasonable and prudent so as to give a true and fair view of the state
of afairs of the Company at the end of the fnancial year of the proft
of the Company for that year;
(iii) That the Directors had taken proper and sufcient care for the
maintenance of adequate accounting records in accordance with the
provisions of the Act for safeguarding the Assets of the Company and
for preventing and detecting fraud and other irregularities;
(iv) That Directors have prepared the annual accounts on a going
concern basis.
SUBSIDIARY COMPANIES
The Company has 3 subsidiaries'' namely'' Aarti Corporate Services
Limited'' Shanti Intermediates Private Limited'' Nascent Chemical
Industries Limited. The Statement pursuant to Section 212 and summary
of fnancial information of Subsidiary Companies is provided in the
Annual Report.
In accordance with the general circular issued by the Ministry of
Corporate Afairs'' Government of India'' the Balance Sheet'' Statement of
Proft and Loss and other documents of the subsidiary companies are not
being attached with the Balance Sheet of the Company. The Company will
make available the Annual Accounts of the subsidiary Company and the
related detailed information to any member of the Company who may be
interested in obtaining the same. The annual accounts of the subsidiary
will also be kept open for inspection at the Registered Ofce of the
Company as well as at the head ofce of the Subsidiary Company. The
Consolidated Financial Statements presented by the Company include the
fnancial results of its Subsidiary Company.
CONSOLIDATED FINANCIAL STATEMENTS
Your Directors have pleasure in presenting Consolidated Financial
Statements which form part of the Annual Report and Accounts.
DIRECTORS
In accordance of the provisions of the Companies Act'' 1956'' and the
Articles of Association of the Company'' Smt. Hetal Gogri Gala'' Shri
Shantilal T. Shah'' Shri Ramdas M. Gandhi'' Shri Haresh K. Chheda and
Shri Parimal H. Desai retire by rotation and being eligible'' ofer
themselves for re-appointment. A brief profle of the Directors proposed
to be appointed/re- appointed is given in the notice of the ensuring
Annual General Meeting.
CORPORATE GOVERNANCE
Your Company has complied with the mandatory Corporate Governance
requirements stipulated under Clause 49 of the Listing Agreement.
Report on Corporate Governance is annexed hereto forming part of this
report.
DISCLOSURE OF PARTICULARS
Information as per the requirements of Section 217(1)(e) of the
Companies Act'' 1956'' read with Rule 2 of Companies (Disclosure of
Particulars in the Report of Board of Directors) Rules'' 1988'' relating
to Conservation of Energy'' Research & Development'' Technology
Absorption'' Foreign Exchange Earnings and Outgo are annexed hereto
forming part of this Report.
ENVIRONMENTAL'' SAFETY AND HEALTH
Your Company is committed to ensure sound Safety'' Health and
Environmental (SHE) performance related to its activities'' products and
services. The Company is taking continuous steps to develop Safer
Process Technologies and Unit Operations. Your Company has been
investing heavily in areas such as Process Automation for increased
safety and reduction of human error element'' enhanced level of training
on Process and Behaviour based safety requirements'' adoption of
expensive but safe & environment friendly production processes''
Installation of Bioreactors'' Chemical ROs'' Multiple efect evaporator
and Incinerator'' etc. to reduce the discharge of efuents'' commissioning
of Waste Heat recovery systems'' and so on to ensure the Reduction''
Recovery and Reuse of efuents & other utilities. Monitoring and
periodic review of the designed SHE Management System is done on a
continuous basis. Your Company already has two "Zero Discharge units
and is reviewing to convert couple of more units as Zero Discharge
units in future. The Company is committed to continuously take further
steps to provide a safe and healthy environment.
CORPORATE SOCIAL RESPONSIBILITY
As contribution towards community development to fulfll the companyÂs
obligations towards the society'' Aarti Industries Limited alongwith its
Promoters and Associate Companies (collectively referred as Aarti
Group) have taken several initiatives to this cause in its journey so
far. In addition to the Financial Support'' your Management is
personally and continuously involved to ensure the reach of these
initiatives to the society at large. Few of these initiatives founded
and continuously supported by Aarti Group are briefed hereunder:
Aarti Group had set-up a school named Tulsi Vidya Mandir at Kutch''
Gujarat in the year 2005'' and have been aiding regularly to meet its
objectives. Presently'' Tulsi Vidya Mandir imparts Secondary & Higher
Secondary education to over 350 children coming from about 12 villages.
Aarti Group also founded Mahavir School/College of Nursing at Sabar
Kantha'' Gujarat in the year 2008'' with an objective to spread
professional nursing education to the interior villages. Every year
around 200 candidates from interior villages are enrolled and trained
in Nursing Profession. With the objective to uplift the lower segment
of our society'' Maninagar Sanskar Dham'' at Kutch in Gujarat'' was
founded by Aarti Group in the year 2011. On an average over 40 slum
kids are nurtured by this institution.
Aarti Group had also set-up Mahavir Health Centre at Alam Nagar'' Bihar
in the year 2010'' to provide better healthcare facilities in this part
of Bihar. This Centre is equipped with latest equipments including its
own OPD'' X-Ray'' and Pathology facilities. On an average around 50
patients are treated at this Centre. With the objective to provide
relief from the recent drought situation prevailing in Maharashtra''
Aarti Group undertook various drought relief activities in the village
of Beed'' Maharashtra. Under this programme'' Aarti Group deployed
several water tankers to provide this basic amenity. It also arranged
for distribution of fodder and temporary shelter to cattles afected by
this severe drought.
In addition to above'' your Company organizes many activities on regular
basis including Blood Donation Camps'' Health checkup camps'' etc. The
Company has been donating to several Hospitals'' Educational
Institutions'' Trusts'' and contribution for area beautifcations. The
company also contributes for relief measures in times of natural
calamities. In parlance to the objective of providing basic primary and
secondary education in the surrounding areas'' your company actively
contributes for the upgradation & infrastructure development of the
schools. The Company envisages the upliftment of society by way of
enlightening and educating the masses. In this regard the company plans
to promote cheap as well as subsidized housing facilities for its
employees and also deserving members of the society. The company thus
promotes the Shelter'' Health and Education led modal for the general
upliftment of the society. With the view to contribute for upliftment
of society'' our Chairman Emeritus'' Shri Chandrakant V. Gogri has
committed a major portion of his time for these Philanthropic
activities. Your Company has extended its full support to this cause
and shall always remain committed for the same.
PERSONNEL
As required by the Provision of Section 217(2A) of the Companies Act''
1956'' read with Companies (Particulars of Employees) Rules'' 1975 as
amended up-to-date'' the names and the other particulars of the
Employees are set out in the Annexure to the Directors Report.
However'' as per the Provisions of Section 219(1)(b)(iv) of the
Companies Act'' 1956'' the Reports and Accounts are being sent to all the
Shareholders of the Company excluding the aforesaid information. Any
Shareholder interested in obtaining such particulars may write to the
Company Secretary at the Registered Ofce of the Company.
AUDITORS
M/s. Parikh Joshi & Kothare'' Auditors of the Company retire at the
ensuing Annual General Meeting and are eligible for reappointment.
Members are requested to appoint Auditors and to fx their remuneration.
COST AUDITORS
The Cost Auditor Ms. Ketki Visariya (Fellowship No. 16028)'' Cost
Accountant'' re-appointed by the Company under Section 233B of the
Companies Act'' 1956 attend the Audit Committee Meeting'' were cost audit
reports are discussed.
The due date for fling the Cost Audit Reports for the fnancial year
ended 31st March'' 2012 under the new XBRL format was 28th February''
2013 and the Cost Audit Reports for Organic-inorganic Chemicals'' Bulk
Drugs and Fertilizers were fled by the Cost Auditors on 28th February''
2013. The due date for fling the Cost Audit Reports for the fnancial
year ended 31st March'' 2013 is 30th September'' 2013.
INDUSTRIAL RELATIONS & HUMAN RESOURCES
The Company enjoys cordial relation with its employees at all levels.
Your Company continues to ensure safety and health of its employees.
Your Directors record their sincere appreciation of the support and
co-operation of all employees and counts on them to maintain CompanyÂs
growth momentum.
ACKNOWLEDGEMENT
The Board of Directors places on record its sincere appreciation for
the dedicated services rendered by the employees of the Company at all
levels and the constructive co-operation extended by them. Your
Directors would also like to express their grateful appreciation for
the assistance and support by all Government Authorities'' Auditors''
fnancial institutions'' banks'' suppliers'' other business associates and
last but not the least the Shareholders.
For and on behalf of the Board
Sd/-
Place : Mumbai RAJENDRA V. GOGRI
Dated : 16th May'' 2013 CHAIRMAN & MANAGING DIRECTOR
Mar 31, 2012
TO THE MEMBERS OF AARTI INDUSTRIES LIMITED
The Directors are pleased to present this Twenty Ninth Annual Report
and the Audited Statement of Accounts for the year ended 31st March,
2012.
FINANCIAL RESULTS (Rs in Lakhs)
Particulars Standalone Consolidated
2011-12 2010-11 2011-12 2010-11
Net Sales: 163,226 140,368 163,226 142,572
Other Operating Income 4,105 2,728 4,105 2,728
Total Income from
Operations (Net) 167,331 143,096 167,331 145,300
Expenses
a) Cost of Material
Consumed 84,445 68,554 84,445 68,554
b) Purchases of Stock-
in-trade 14,049 18,213 14,049 19,468
c) Changes in inventories
of Finished Goods, Work-
in-progress and Stock-in-
trade (2,354) (1,633) (2,354) (1,528)
d) Employee Benefits
Expenses 4,552 3,887 4,705 3,929
e) Depreciation and
Amortisation Expense 5,397 4,792 5,485 4,981
f) Other Expenses 42,175 34,726 41,559 35,088
Total Expenses 148,264 128,539 147,889 130,492
Profit/(Loss) from
Operations before Other
Income,
Finance Costs and
Exceptional Items 19,067 14,557 19,442 14,808
Other Income 284 400 361 417
Profit/(Loss) before
Finance Costs 19,351 14,957 19,803 15,225
Finance Costs 7,151 5,596 7,184 5,621
Profit/(Loss) before Tax 12,200 9,361 12,619 9,604
Tax Expenses
a) Provision for
Taxation-Current 3,230 2,500 3,356 2,585
b) Provision for Deferred Tax 251 183 260 328
Total Tax Expenses 3,481 2,683 3,616 2,913
Net Profit/(Loss) after Tax 8,719 6,678 9,003 6,691
Share of Profit/(Loss)
of Associates - - 1,431 1,544
Minority Interest - - (108) (86)
Net Profit/(Loss) after
consolidation - - 10,326 8,149
Earnings Per Share 11.36 8.70 13.45 10.62
Book Value Per Share 64.79 58.20 74.59 66.34
DIVIDEND
Your Company had declared and paid Interim Dividend of Rs 2.00 (@ 40%)
per share (of Rs 5/- each). Your Directors are pleased to recommend
Final Dividend of Rs 1.50 (@ 30%) per share (of Rs 5/- each) for the year
2011-12. The total amount of Dividend pay-out for the year would be Rs
27.21 Crores (previous year Rs 19.18 Crores).
FINANCIALS
During the year under review, the Standalone Operating Income has
increased by 17% from Rs 1430.96 crs for FY 2010-11 to Rs 1673.31 crs in
FY 2011-12. Also the Operating Profit before Interest, Depreciation and
Tax increased to Rs 244.64 crs as compared to Rs 193.49 crs for the last
year recording a growth of over 26%. Operating Margin for the year
increased to 14.6% from last year's 13.5%. Likewise the Profit before
tax also increased by 30% to Rs 122.00 crs for FY 2011-12 from Rs 93.61
crs in FY 2010-11. Further, Profit after tax and deferred tax also grew
more than 30% to Rs 87.19 crs for FY 2011-12 from Rs 66.78 crs for FY
2010-11.
Similarly, the Company's consolidated Income also increased by 15% to Rs
1673.31 crs as compared to Rs 1453.00 crs for last year. Net Profit
after Consolidation for the Company was at Rs 103.26 crs vis-a-vis Rs
81.49 crs for last year. Consolidated EPS for the year 2011-12 was at Rs
13.45 as against Rs 10.62 for the year 2010-11.
With global scale manufacturing units with the latest technologies high
level of automation and with adequate technical capabilities, your
Company is consider as leading global manufacturer. The Company exports
its products across the world to over 60 countries catering to the
needs of over 300 global customers. Exports now, accounts for 42% of
the total revenue and have increased by over 23% to Rs 726.73 crs for FY
2011-12 from Rs 582.43 crs for FY 2010-11.
CHEMICAL INDUSTRY - STRUCTURE & DEVELOPMENT
The Chemical Industry is critical for the economic development of any
country, providing products and enabling technical solutions for
virtually all sectors of the economy.
The global chemical industry is witnessing a gradual eastward shift.
The industry is increasingly moving eastwards in line with the shift of
its key consumer industries (e.g. automotive, electronics, etc.) to
leverage greater manufacturing competitiveness of emerging Asian
economies (especially India & China) and also to serve the increasing
local demand. Substantial new capacities in the world are expected to
come up in Asia and Europe. Operating profits in the sector have
increased and many companies were able to push stronger cash flows down
to the bottom line. However, the overall growth of the chemical sector
was hampered by economic slowdown across US and Europe.
With Asia's growing contribution to the global chemical industry, India
emerges as one of the focused destination for chemical companies
worldwide. With the current size of approximately $108 billion, the
Indian chemical industry accounts for ~ 3% of the global chemical
industry. Two distinct scenarios for the future emerge, based on how
effectively the industry leverages its strengths and manages
challenges. In the base case scenario, with current initiatives of
Industry & Government, the Indian chemical industry can grow at 11%
p.a. to reach size of $224 billion by 2017. High end-use demand based
on increasing per capita consumption, improved export competitiveness
and resultant growth impact for each sub-sector of the chemical
industry can also lead to an overall growth rate of over 15% p.a. and a
size of $290 billion by 2017 (~ 6% of global industry). This has a
potential for further upside in the future considering India's
increasing competitiveness in manufacturing.
The draft manufacturing policy recently approved by the Union Cabinet
targets increasing the share of manufacturing in GDP to at least 25% by
2025 (from current 16%). These zones will enjoy fast track clearances
from the Environment Ministry and State Pollution Boards, Special
Policy Regimes, Tax Concessions and more favourable labour laws.
Investments in manufacturing in the chemical sector are absolutely
essential to ensure growth of the Indian chemical industry.
With rising concerns about climate change and depleting natural
resources, focus on sustainability is another key trend impacting the
global chemical industry. Chemical companies are increasingly working
towards reducing energy intensity of their operations, minimizing
effluent discharge, increasing the share of recyclable products in
their portfolio and diversifying their raw material base to include
bio-feedstock.
During last 6-8 months, the Indian Rupee had depreciated by over 22%
vis-a-vis US Dollars. This has added to the competitive advantage of
Indian Exporters while competing in global markets. Further the
devaluation of Indian Rupee has also made imports dearer, thus the
share of Indian manufactured goods in domestic consumption is expected
to increase.
Your Company is a leading manufacturer of Speciality Chemicals with
diversified end-uses into Agrochemicals, Pharmaceuticals, High
Performance Polymers, Paints, Pigments, Printing Inks, Rubber
Chemicals, Additives, Surfactants, Dyes, Flavours & Fragrances, Home &
Personal Care applications, etc. Your Company makes continuous efforts
to explore and innovate new products & processes in all segments. This
diversified end-user base helps the Company to derisk itself from
downturn in any individual business segment and also to capitalize on
the growth opportunities in each of the end-user segments. Your Company
had made substantial Investments during last financial year into
upgrading the ETP setup of the Company including setting up additional
process to minimise the quantity and impurity profile of the effluents.
With this efforts, the Company had upgraded two of its Manufacturing
Units into Zero Discharge Unit and also has put in place various
processes to control/limit generation of effluents and improve on the
treatment of the same.
For better focus on core businesses, the Company has classified its
business segments based on the nature of product and their respective
end-uses. Based on this, the new segments are Performance Chemicals,
Agri-Intermediates & Fertilizers, Pharmaceuticals and Home & Personal
Care chemicals. The profile/composition of these business segments is
as under:
Breakup of Segmental revenue for 2011-12 :
Performance Agri-
inter
mediates Pharma
ceuticals Home &
Personal Total
Chemicals &
Fertili
zers Care
Chemicals
Sales (Rs in
crs) 967.98 382.30 164.62 158.41 1673.31
% of Total Sales 57.85% 22.85% 9.84% 9.47% 100.00%
Export (Rs in crs) 496.31 143.42 66.08 20.92 726.73
% of Sales 51.27% 37.52% 40.14% 13.21% 43.43%
Performance Chemicals and Agri-Intermediates & Fertilizers accounts for
over 80% of the Company's total revenue and over 87% of the total
exports of the Company.
Manufacturing Setup for Performance Chemicals & Agri-intermediates &
Fertilizers:
The manufacturing operations for these two segments are substantially
interconnected/interlinked at its common manufacturing units located at
Vapi, Sarigam, Jhagadia in the State of Gujarat and at Tarapur in the
State of Maharashtra. A significant portion of your Company's
production capabilities are process driven and not based on a
particular product. This gives your Company flexibility to change its
input mix and manufacture different products, thereby enabling optimum
utilization of production capabilities as well as provides flexibility
to change the product mix amongst different end-user applications based
on market dynamics.
Your Company manufactures Isomers as well as their downstream products.
Because of the vertical integration, your Company enjoys natural
insulation against short supply of precursor raw-materials. Thus,
consistent supply of products results in to customer confidence and
helps your Company to gain better market share. Your Company has also
been able to convert its by-products from various processes into
commercially viable products, thereby contributing to the profitability
of the Company.
By-Products Gainful Usage
Steam From Sulphuric Acid Plant Power generation (6MW Power Plant) &
Distillation ONCB/PNCB)
Dilute Hydrochloric Acid Chloro Sulfonic Acid & Calcium
Chloride
Dilute Sulphuric Acid Single Super Phosphate (SSP)
fertilizer & Di Calcium Phosphate
(Nutrients)
Your Company has global scale of manufacturing units with a varied mix
of diversified and value added chain of products supplied to a customer
base of over 600 domestic and 300 global customers. The customized
delivery solutions have positioned your Company as "Preferred supplier"
to various MNCs for past several years. All this have helped your
Company to emerge as a market leader in India and also globally ranks
at 1st - 5th position for more than 75% of its top 50 products.
Hydrogenation Facility at Jhagadia:
Your Company has been the pioneer of the Greener Hydrogenation process
based on Swiss Technology in India. Your Company upgraded its greener
hydrogenation process from semi-batch to continuous (in 2010) -
enhancing the production capabilities by more than 100% (from 700 tpm
to 1500 tpm). An additional unit is under development, which will
increase the aggregate capacity to about 3,000 tpm by end of fiscal
2012-13. Also, a backward integrated Hydrogen Gas Generation Plant is
being set up to cater to the increase in captive demand for hydrogen
gas. The increase in hydrogenation capacities has enabled your Company
to cater to the growing, high margin & niche demand in the segments of
Performance Chemicals and Agri-intermediates in the global market.
Further expansion in capacities coupled with strong market position
will enable your Company to significantly boost up the revenues from
these segments.
By setting up/upgradation of the effluent treatment infrastructure at
Jhagadia, since April 2012, the unit is now capable of zero discharge
of liquid effluent by recycling of waste water generated therein. This
will not-only help reduce the burden on environment but also help the
Company in future for further expansion programmes.
Performance Chemicals
Performance Chemicals are defined as a "group of relatively high value,
low volume chemicals known for their end user applications or
performance enhancing properties." In contrast to base or commodity
chemicals, Performance Chemicals are recognized for what they do and
not 'what they are'. Performance Chemicals provide the required
solution to meet the customer application needs. It is a highly
knowledge driven segment. The critical success factors for the
Performance Chemicals segment include understanding of customer needs
and product/ application development.
Global Performance Chemicals industry is estimated to be ~ $740 billion
accounting for ~ 22% of the global chemical industry.
This segment accounts for about 58% of the total revenues of the
Company. Exports of Performance Chemicals accounts for about 70% of the
total exports of the Company. It can be seen from the table below, the
share of exports in the segment revenue has increased to 51% in FY
2011-12 from 40% in FY 2010-11.
(Rs in crs.)
Particulars FY 2009-10 FY 2010-11
Local Export Total Local Export Total
Performance 541.81 341.02 882.83 596.14 411.90 1008.04
Chemicals
Particulars FY 2011-12*
Local Export Total
Performance Chemicals 471.67 496.31 967.98
(* due to slowdown in dyes sector, the capacities of Performance
Chemicals were utilized for manufacture of Agrochemical Intermediates
during FY 2011-12.)
Performance Chemicals segment broadly comprises of Speciality Chemicals
with applications into:
a) Polymers & Additives,
b) Dyes, Pigments, Paints, Printing Inks,
c) Rubber Chemicals, Flavours & Fragrances, Water Treatment,
Construction Chemicals, Resins, etc.
On account of the wide diversity in product applications, this segment
on an overall basis is expected to grow with Key driving industries for
growth of Performance Chemicals summarised below.
Polymers & Additives
Over the years lots of innovations have been carried out in the areas
of providing more fuel efficient modes of transports (such as
Automobiles, Airplanes, etc). Starting from continuous process of
improvement/refinement in combustion technologies to replacement of
metal components with High Performance Engineering Polymers, changes
are being made continuously to reduce the weight and improve on the
fuel efficiency. In addition to this, these polymers are also used in
high growth segments such as Electronic Media & Telecommunication
devices and various other Electrical Instruments. Your Company has been
expanding the capacities for its Polymer intermediates having
applications into such High Performance Engineering
Polymers. With the kind of growth being witnessed in these sunrise
sectors across the world, we expect volumes for these Polymers
Intermediates to increase significantly.
Dyes, Paints, Pigments and Printing Inks
This sector has witnessed a shift in the consumption pattern of
Printing Inks based applications. While the demand for Printing inks in
developed economies are reducing, the same is increasing in developing
economies on account increasing per-capita income & consumption
(along-with changes in consumption profile), growth in education and
healthcare facilities, etc.
The global replacement of usage of Organic Pigment vis-a-vis Metal
Pigments has been the driving force behind the significant growth of
Pigment applications globally and shall continue further going forward.
While the dyes sector has been hit hard due volatility in cotton and
other feed stock prices, there are signals of the demand gradually
picking up and hence we expect that the demand for dyes should increase
going forward.
Your Company being a leading player in this segment and equipped with
its strong market positioning and widespread global reach is better
placed to capitalize on these growth opportunities in global arena.
Agri-intermediates and Fertilizers
The Indian's crop protection chemicals market is growing with a rate of
around 7.5% driven by steady export growth of crop protection chemicals
from India at the cost of Chinese products. The country is the fourth
leading producer of Agrochemicals after USA, Japan and China.
Increasing population, high emphasis on achieving food grain self
sufficiency, limited farmland availability coupled with pressure to
increase yield per hectare and growth in horticulture and floriculture
are expected to increase the usage of agrochemicals across the world.
India's exports of agrochemicals are steadily rising. Many foreign
companies are tying up with local manufacturers to expand into this
sector for domestic & global requirements.
The Indian Government has framed a new fertilizer policy under which
the Government will not fix the producer's price for the new units, to
encourage growth in the fertilizer sector. However, the Government has
announced a nutrient based subsidy programme and more effective scheme
for distribution of the subsidy, directly to the end users (farmers) is
also under consideration.
(Rs in crs.)
Particulars FY 2009-10 FY 2010-11
Local Export Total Local Export Total
Agrochemicals &
Active Ingredients 59.92 96.76 156.68 74.31 92.16 166.47
Fertilizers &
Nutrients 32.10 NIL 32.10 31.16 NIL 31.16
Total 92.02 96.76 188.78 105.47 92.16 197.63
Particulars FY 2011-12
Local Export Total
Agrochemicals & 198.02* 143.43 341.45
Active Ingredients
Fertilizers & Nutrients 40.86 NIL 40.86
Total 238.88 143.43 382.31
*major part of this is used to manufacture products for export markets.
Your Company is the leading global manufacturer of various
Agrochemicals intermediates and has presence across all the
sub-segments. With further expansion in its production capabilities and
with strong relationship with major global MNCs in this segment, your
Company expects to post significant growth in this segment going
forward. Thus growth in the exports due to the global demand of
Agrochemicals would be the key driving factor. Further the increase in
export operations across all markets such as NAFTA, Asia, Europe, Latin
America, and other territories, also helps to de-risk the business from
Indian as well as various other local climatic changes across the
world.
India is the 3rd largest consumer of Single Super Phosphate (SSP)-one
of the most widely used fertilizers. The annual consumption of SSP in
India is about 30 lakh MT. Your Company is expanding its capacity and
plans to increase the volumes to about 1,00,000 MT from FY 2013-14
onwards (from 63,264 MT in FY 2011-12). The Company also has plans to
increase the volumes for nutrients (Di Calcium Phosphate, a broadly
used cattle-feed) going forward.
Pharmaceuticals
The Indian domestic pharma market reached US$12.31 billion in 2010 and
is poised to accelerate at 9.9% between 2012 and 2015. After a brief
period of sluggishness, the growth momentum in the domestic
formulations market is back on track. Structural demand drivers
include -
a) rise in household income levels,
b) increase in prevalence of lifestyle related diseases,
c) improved healthcare infrastructure/delivery systems and
d) rise in penetration in smaller towns and rural areas continue to
support long-term growth.
Patent expirations, weak pipeline quality and increasing focus by the
Government to reduce healthcare costs continue to exert pressure on
innovator companies which supports outsourcing to low-cost nations.
Despite challenges, leading Indian players continue to exhibit strong
profitability indicators.
Outlook on the Indian pharmaceutical companies remains favourable as
companies will continue to benefit from recovery in the domestic
market, strong growth potential in generics developed markets and
potential outsourcing opportunities.
Globally, generics players however continue to face competitive
environment from large innovator companies. Price erosion, especially
through regulatory interventions, remains a foremost challenge in the
European markets. Presence in limited competition product segments and
over-the-counter (OTCs) segment offers some protection to margins. Most
developed markets continue to move away from branded generics to
commoditized un-branded generics and lower margin tender based
business.
Your Company has four manufacturing units of which two are USFDA
approved facilities & other two are WHO GMP approved facilities. The
plants are cGMP compliant, meeting ICH Q7 standards, thus enabling
buyers to use API in all regulated markets. Recently one of the USFDA
unit manufacturing intermediates have been converted into a Zero
Discharge Unit by adoption of cleaner processes with latest effluent
treatment arrangement.
Exports contribute more than 40% of your Company's total revenue from
pharmaceuticals segment & about 50% of the total exports are in
lucrative regulated markets of USA & EU.
Your Company has 10 new Active Pharmaceuticals Ingredients (APIs) under
development. Several other APIs are awaiting partners' approval. The
Company enjoys distinct advantage of having dedicated USA, Japan and EU
approvals for steroids and anti-cancer products.
Your Company has a dedicated team of about 50 scientists working in
separate R&D block for Contract Research And Contract Manufacturing
Services (CRAMS). Your Company offers end to end solutions from process
development to toll manufacturing & is currently servicing 4 of the top
drug discovery companies.
Company's pharmaceutical segment achieved break even in FY 2011-12 and
is poised for faster growth going forward. Home & Personal Care
Chemicals
With growing affluence, Indian consumers are able to spend more on
hygiene and personal care products. Increasing consumption is driving
demand for wide range of cosmetic chemicals, health care products as
well as hygiene products using Performance Chemicals, Polymers and Oleo
Chemicals. India is also becoming major arm for Oleo Chemicals derived
from organic sources and is participating in the global market. This
segment is expected to grow at a rapid pace surpassing the growth of
other segments in this sector.
Home & Personal Care Chemicals segment is relatively a low margin
business. The Company has two manufacturing units, one each at
Pithampur (Madhya Pradesh) & at Silvassa. Your Company plans to
optimize its production capabilities to suitably alter/revise the
product mix and explore new markets to improve the margins.
SEGMENT-WISE PERFORMANCE
For better understanding of businesses, the Company has classified its
business segments based on the nature of product and their respective
end-uses. Based on this, the new segments are Performance Chemicals,
Agri-Intermediates & Fertilizers, Pharmaceuticals and Home & Personal
Care Chemicals. The profile/composition of these business segments is
as under:
CONSOLIDATED SEGMENT REPORTING (Rs in Lakhs)
Sr.
No. Particulars Financial
Year Financial
Year
2011-2012 2010-2011
(A) Primary Segments : Business Segments
1 Segment Revenue
a) Performance Chemicals 96,798 103,009
b) Agri-intermediates & Fertilizer 38,230 19,763
c) Pharmaceuticals 16,462 13,056
d) Home & Personal Care Chemicals 15,841 9,472
TOTAL 167,331 145,300
2 Segment Results Profit/(Loss)
(Before Tax and Interest from each Segment)
a) Performance Chemicals 14,180 14,492
b) Agri-intermediates & Fertilizer 7,541 4,108
c) Pharmaceuticals 419 (631)
d) Home & Personal Care Chemicals 492 508
TOTAL (A) 22,632 18,477
Less: Interest 7,184 5,621
Other Unallocable Expenditure (Net) 2,829 3,252
(B) 10,013 8,873
TOTAL PROFIT BEFORE TAX (A-B) 12,619 9,604
(B) Secondary Segments : Geographical Segments
a) India 98,933 90,376
b) Out of India 68,398 54,924
TOTAL 167,331 145,300
Segment Capital Employed
Fixed Assets used in the Company's business or Liabilities contracted
have not been identified to any of the reportable segments, as the
Fixed Assets and services are used interchangeably between segments.
The Company believes that it is currently not practicable to provide
segment disclosures relating to capital employed.
RISKS AND CONCERNS
Your Company is monitoring the global economic and political events and
the likely impact of the same to the performance of the Company and has
been taking necessary steps to mitigate and/or insulate itself from the
same. Your Company perceives risks or concerns common to industry such
as concerns related to the Macro Indian Economic Outlook, Global
Economic fallout, Regulatory risks, Foreign Exchange volatilities,
Higher Interest rates, Rising Raw-material costs and other commercial &
business related risks. Your Company's diversified revenue mix,
flexible product mix and increasing volumes from Agrochemicals and
Pharmaceuticals sector, the effect on any economic setback is expected
to be minimal.
Recently, we have witnessed large volatilities in the foreign exchange
rates of Indian Rupee vis-a-vis US Dollars. Your Company follows a
policy to hedge only those exposures which are backed by confirmed
orders and does not enter into any long term foreign exchange
instruments based on probable future exposures.
Chemical businesses are generally working capital intensive and hence
the working capital requirements are also higher. Your Company has
been making continuous efforts to reduce the working capital cycle.
With the increase in volumes and higher cash accruals going forward,
debt-equity ratio is expected to better in coming years.
INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY
Your Company has clearly laid down policies, guidelines and procedures
that form part of internal control systems, which provide for automatic
checks and balances. Your Company has maintained a proper and adequate
system of internal controls. This is to ensure that all Assets are
safeguarded and protected against loss from unauthorized use or
disposition and that the transactions are authorised, recorded and
reported diligently. Your Company's internal control systems are
commensurate with the nature and size of its business operations. The
internal Auditors' Reports are regularly reviewed by the Audit
Committee of the Board.
DIRECTORS' RESPONSIBILITY STATEMENT
As required u/s. 217(2AA) of the Companies Act, 1956 (the Act):
(i) That in the preparation of the Annual Accounts for the Year ended
31st March, 2012, the applicable Accounting Standards have been
followed along with proper explanation for material departures, if any;
(ii) That the Directors have selected such accounting policies and
applied them consistently and made judgments and estimates that are
reasonable and prudent so as to give a true and fair view of the state
of affairs of the Company at the end of the financial year of the
profit of the Company for that year;
(iii) That the Directors have taken proper and sufficient care for the
maintenance of adequate accounting records in accordance with the
provisions of the Act for safeguarding the Assets of the Company and
for preventing and detecting fraud and other irregularities;
(iv) That Directors' have prepared the annual accounts on a going
concern basis.
SUBSIDIARY COMPANIES
In accordance with the general circular issued by the Ministry of
Corporate Affairs, Government of India, the Balance Sheet, Profit and
Loss Account and other documents of the Subsidiary Companies are not
being attached with the Balance Sheet of the Company. The Company will
make available the Annual Accounts of the Subsidiary Companies and the
related detailed information to any member of the Company who may be
interested in obtaining the same. The annual accounts of the Subsidiary
will also be kept open for inspection at the Registered Office of the
Company as well as at the head office of the Subsidiary Companies. The
Consolidated Financial Statements presented by the Company include the
financial results of its Subsidiary Companies.
CONSOLIDATED FINANCIAL STATEMENTS
Your Directors have pleasure in presenting Consolidated Financial
Statements which form part of the Annual Report and Accounts.
DIRECTORS
In accordance with the provisions of the Companies Act, 1956, and the
Articles of Association of the Company, Shri Sunil M. Dedhia, Shri
Manoj M. Chheda, Shri Kirit R. Mehta, Shri, Laxmichand K. Jain and Shri
Vijay H. Patil retire by rotation and being eligible, offer themselves
for re-appointment. A brief profile of the Directors proposed to be
appointed/re-appointed is given in the notice of the ensuing Annual
General Meeting.
CORPORATE GOVERNANCE
Your Company has complied with the mandatory Corporate Governance
requirements stipulated under Clause 49 of the Listing Agreement.
Report on Corporate Governance is annexed hereto forming part of this
report.
DISCLOSURE OF PARTICULARS
Information as per the requirements of Section 217(1)(e) of the
Companies Act, 1956, read with Rule 2 of Companies (Disclosure of
Particulars in the Report of Board of Directors) Rules, 1988, relating
to Conservation of Energy, Research & Development, Technology
Absorption, Foreign Exchange Earnings and Outgo are annexed hereto
forming part of this Report.
ENVIRONMENTAL, SAFETY AND HEALTH
Your Company is committed to ensure sound Safety, Health and
Environmental (SHE) performance related to its activities, products and
services. The Company is taking continuous steps and also developing
environment friendly processes for effective resource management with
specific focus to energy, water and basic raw materials. Monitoring and
periodic review of the designed SHE Management System is done on a
continuous basis. The Company has recently converted/upgraded two of
its manufacturing unit into "Zero Discharge" unit. The Company is
committed to further strengthen pollution prevention and waste
abatement practices and strives to provide a safe and healthy
environment.
CORPORATE SOCIAL RESPONSIBILITY
As contribution towards community development to fulfill the Company's
obligations towards the society, Company organizes many activities on
regular basis including Blood Donation Camps, Health checkup camps,
etc. The Company has been donating to several Hospitals, educational
institutions, trusts and contribution for area beautifications. The
Company also contributes for relief measures in times of natural
calamities. In parlance to the objective of providing basic primary and
secondary education in the surrounding areas, your company actively
contributes for the upgradation & infrastructure development of the
schools. The Company envisages the upliftment of society by way of
enlightening and educating the masses. In this regard the Company plans
to promote cheap as well as subsidized housing facilities for its
employees and also deserving members of the society. The Company thus
promotes the Shelter, Health and Education led modal for the general
upliftment of the society.
PERSONNEL
As required by the Provision of Section 217(2A) of the Companies Act,
1956, read with Companies (Particulars of Employees) Rules, 1975 as
amended up-to-date, the names and the other particulars of the
Employees are set out in the Annexure to the Directors' Report.
However, as per the Provisions of Section 219(1)(b)(iv) of the
Companies Act, 1956, the Reports and Accounts are being sent to all the
Shareholders of the Company excluding the aforesaid information. Any
Shareholder interested in obtaining such particulars may write to the
Company Secretary at the Registered Office of the Company.
AUDITORS
M/s. Parikh Joshi & Kothare, Auditors of the Company retire at the
ensuing Annual General Meeting and are eligible for reappointment.
Members are requested to appoint Auditors and to fix their
remuneration.
COST AUDITORS
The Cost Auditor Ms. Ketki Visariya, Cost Accountant, re-appointed by
the Company under Section 233B of the Companies Act, 1956 attend the
Audit Committee Meeting, where cost audit reports are discussed.
The due date for filing the Cost Audit Reports for the financial year
ended 31st March, 2011 was 30th September, 2011 and the Cost Audit
Reports were filed by the Cost Auditors on 30th September, 2011. The
due date for filing the Cost Audit Reports for the financial year ended
31st March, 2012 is 30th September, 2012.
INDUSTRIAL RELATIONS & HUMAN RESOURCES
The Company enjoys co-ordial relation with its employees at all levels.
Your Company has continues to ensure safety and health of its
employees. Your Directors record their appreciation of the support and
co-operation of all employees and counts on them to be able to maintain
Company's growth momentum.
ACKNOWLEDGEMENT
The Board of Directors places on record its sincere appreciation for
the dedicated services rendered by the employees of the Company at all
levels and the constructive co-operation extended by the staff. Your
Directors would like to express their grateful appreciation for the
assistance and support by all Government Authorities, Auditors,
Financial Institutions, Banks, suppliers, other business associates and
last but not the least the Shareholders.
For and on behalf of the Board
Sd/-
Place : Mumbai CHANDRAKANT V. GOGRI
Dated : 25th May, 2012 CHAIRMAN
Mar 31, 2011
Dear Members,
The Directors are pleased to present this Twenty Eighth Annual Report
and the Audited Statement of Accounts for the year ended 31st March,
2011.
FINANCIAL RESULTS (Rs. in Lakhs)
Particulars Standalone Consolidated
2010-11 2009Ã10 2010-11 2009-10
Gross Sales 151,327 132,526 153,530 133,710
Less:- Excise Duty 7,645 4,837 7,645 4,837
a) Net Sales 143,682 127,689 145,885 128,873
b) Add:- Other Operating
Income 2,508 1,249 2,508 1,249
Total 146,190 128,938 148,393 130,122
Expenditure
a) (Increase) / Decrease in
Stock in Trade and work in
progress (1,633) (3,285) (1,528) (2,905)
b) Consumption of raw
materials 70,150 65,297 70,150 65,297
c) Purchase of Traded Goods 18,213 11,397 19,468 11,468
d) Employee Cost 3,887 3,403 3,929 3,454
e) Depreciation 4,792 4,475 4,981 4,707
f) Other Expenditure 36,224 31,914 36,585 32,411
Total 131,633 113,201 133,585 114,432
Profit from Operations
before Other Income,
Interest & Exceptional Items 14,557 15,737 14,808 15,690
Other Income 400 181 417 185
Profit before Interest &
Exceptional Items 14,957 15,918 15,225 15,875
Interest 5,596 5,171 5,621 5,199
Profit after Interest but
before Exceptional Items 9,361 10,747 9,604 10,676
Exceptional Items - - - -
Profit from Ordinary
Activities before Tax 9,361 10,747 9,604 10,676
Tax Expenses:-
a) Provision for taxation
-Current 2,500 3,146 2,585 3,178
b) Provision for Deferred Tax 183 590 328 650
Total 2,683 3,736 2,913 3,828
Net Profit From Ordinary
Activities After Tax 6,678 7,011 6,691 6,848
Extra-ordinary Items - - - -
Net Profit 6,678 7,011 6,691 6,848
Minority Interest - - (86) (11)
Share of Profit from Associate Net - - 1,544 1,398
Net Profit after consolidation - - 8,149 8,235
DIVIDEND
Your Company had declared and paid Interim Dividend of Rs. 1.25 ps. (@
25%) per share (of Rs. 5/- each). Your Directors are pleased to
recommend Final Dividend of Rs. 1.25 ps. (@ 25%) per share (of Rs. 5/-
each) for the year 2010-11. The total amount of Dividend pay-out for
the year would be Rs. 19.18 Crores same as previous year.
FINANCIALS
During the year under review, the Company had achieved the turnover of
Rs. 1538.35 crs as against Rs. 1337.75 crs in the previous year.
Operating profit before Interest, Depreciation, Tax & Non-operating
expenses was at Rs. 198.30 crs as compared to Rs. 205.69 crs for the
last year. Profit before tax had been Rs. 93.61 crs for FY 10-11 as
compared to Rs. 107.47 crs in FY 09-10.
Company posted Profit After Tax and Deferred Tax of Rs. 66.78 crs
vis-ÃÂ -vis Rs. 70.11 crs for the last year. Company's performance was
affected in mid of the year on account of the major expansion
programmes carried out by the Company and hence the profitability is
marginally impacted in FY 10-11 as compared to the previous year.
Company's consolidated Gross Income was Rs. 1560.38 crs as compared to
Rs. 1349.59 crs for the year 2009-10. Further, the share of profit from
associates increased from Rs. 13.98 crs to Rs. 15.44 crs in FY 2010-11.
The Net Profit after consolidation of the Company was Rs. 81.49 crs
vis-ÃÂ -vis Rs. 82.35 crs for the last year. Consolidated EPS for FY
2010-11 was at Rs. 10.62 as against Rs. 10.73 for FY 2009-10.
DIRECTORS' RESPONSIBILITY STATEMENT
As required u/s. 217(2AA) of the Companies Act, 1956 (the Act):
(i) That in the preparation of the Annual Accounts for the Year ended
31st March, 2011, the applicable Accounting Standards had been followed
along with proper explanation for material departures, if any;
(ii) That the Directors had selected such accounting policies and
applied them consistently and made judgments and estimates that are
reasonable and prudent so as to give a true and fair view of the state
of affairs of the Company at the end of the financial year of the
profit of the Company for that year;
(iii) That the Directors had taken proper and sufficient care for the
maintenance of adequate accounting records in accordance with the
provisions of the Act for safeguarding the Assets of the Company and
for preventing and detecting fraud and other irregularities;
(iv) That Directors' have prepared the annual accounts on a going
concern basis.
SUBSIDIARY COMPANIES
In accordance with the general circular issued by the Ministry of
Corporate Affairs, Government of India, the Balance Sheet, Profit and
Loss Account and other documents of the Subsidiary Companies are not
being attached with the Balance Sheet of the Company. The Company will
make available the Annual Accounts of the subsidiary companies and the
related detailed information to any member of the Company who may be
interested in obtaining the same. The annual accounts of the respective
subsidiary companies will also be kept open for inspection at the
Registered Office of the Company as well as at the head office of the
respective Subsidiary Companies. The Consolidated Financial Statements
presented by the Company include the financial results of its
Subsidiary Companies.
CONSOLIDATED FINANCIAL STATEMENTS
Consolidated Financial Statements are enclosed which form part of the
Annual Report and Accounts.
DIRECTORS
In accordance with the provisions of the Companies Act, 1956, and the
Articles of Association of the Company, Shri Rashesh C. Gogri, Shri
Parimal H. Desai, Shri K. V. S. Shyam Sunder, Shri P. A. Sethi and Shri
Bhavesh R. Vora retire by rotation and, being eligible, offer
themselves for re-appointment. A brief profile of the Directors
proposed to be appointed/re-appointed is given in the notice of the
ensuing Annual General Meeting.
CORPORATE GOVERNANCE
Your Company has complied with the mandatory Corporate Governance
requirements stipulated under Clause 49 of the Listing Agreement.
Report on Corporate Governance is annexed hereto forming part of this
report.
DISCLOSURE OF PARTICULARS
Information as per the requirements of Section 217(1)(e) of the
Companies Act, 1956, read with Rule 2 of Companies (Disclosure of
Particulars in the Report of Board of Directors) Rules, 1988, relating
to Conservation of Energy, Research & Development, Technology
Absorption, Foreign Exchange Earnings and Outgo are annexed hereto
forming part of this Report.
ENVIRONMENTAL, SAFETY AND HEALTH
Your Company is committed to ensure sound Safety, Health and
Environmental (SHE) performance related to its activities, products and
services. The Company is taking continuous steps and also developing
environment friendly processes for effective resource management with
specific focus to energy, water and basic raw materials. Monitoring and
periodic review of the designed SHE Management System is done on a
continuous basis. The Company is committed to strengthen pollution
prevention and waste abatement practices and strives to provide a safe
and healthy environment.
CORPORATE SOCIAL RESPONSIBILITY
As contribution towards community development to fulfill the company's
obligations towards the society, Company organizes many activities on
regular basis including Blood Donation Camps, Health checkup camps,
etc. The Company has been donating to several Hospitals, educational
institutions, trusts, and contribution for area beautifications. The
Company also contributes for relief measures in times of natural
calamities. With the objective of providing basic primary and secondary
education in the surrounding areas, your Company actively contributes
for the up gradation & infrastructure development of the schools. The
Company envisages the upliftment of society by way of enlightening and
educating the masses. The Company plans to promote cheap as well as
subsidized housing facilities for its employees and also deserving
members of the society. The Company thus promotes the Shelter, Health
and Education led modal for the general upliftment of the society.
PERSONNEL
As required by the Provision of Section 217(2A) of the Companies Act,
1956, read with Companies (Particulars of Employees) Rules, 1975 as
amended up-to-date, the names and the other particulars of the
Employees are set out in the Annexure to the Directors' Report.
However, as per the Provisions of Section 219(1)(b)(iv) of the
Companies Act, 1956, the Reports and Accounts are being sent to all the
Shareholders of the Company excluding the aforesaid information. Any
Shareholder interested in obtaining such particulars may write to the
Company Secretary at the Registered Office of the Company.
AUDITORS
M/s. Parikh Joshi & Kothare, Auditors of the Company, retire at the
ensuing Annual General Meeting and are eligible for reappointment.
Members are requested to appoint Auditors and to fix their
remuneration.
COST AUDITORS
The Cost Audit Report relating to Chemicals manufactured by the Company
for the financial year 2009-10 was submitted to the Central Government
on 20th September, 2010 within prescribed time. Ms. Ketki Visariya,
Cost Accountant, was re-appointed as the cost auditor for the financial
year 2011-12 and the report for the year 2010-11 will be submitted to
the Central Government in due course.
INDUSTRIAL RELATIONS & HUMAN RESOURCES
The Company enjoys co-ordial relation with its employees at all levels.
Your Company has continued to ensure safety and health of its
employees. Your Directors record their appreciation of the support and
co-operation of all employees and counts on them to be able to maintain
Company's growth momentum.
ACKNOWLEDGEMENT
The Board of Directors places on record its sincere appreciation for
the dedicated services rendered by the employees of the Company at all
levels and the constructive co-operation extended by the staff. Your
Directors would like to express their grateful appreciation for the
assistance and support by all Government Authorities, Auditors,
financial institutions, banks, suppliers, other business associates and
last but not the least the Shareholders.
For and on behalf of the Board
Sd/-
Place: Mumbai CHANDRAKANT V. GOGRI
Dated: 30th May, 2011 Chairman
Mar 31, 2010
The Directors are pleased to present this Twenty Seventh Annual Report
and the Audited Statement of Accounts for the year ended 31st March,
2010.
FINANCIAL RESULTS
(Rs. in Lakhs)
2009-10 2008 - 09
Gross Sales and other Sales Income: 133775 153575
Less: Excise Duty 4837 8877
Net Sales 128938 144698
Less: (Increase)/ Decrease in Stock (3285) 423
Consumption of Raw Materials 65297 75950
Staff Cost 3403 3017
Other Expenditure 43135 41084
Total Expenditure: 108550 120474
Operating Profit Before Interest,
Depreciation & Tax 20388 24224
Add: Other Income 182 229
Less: Non Operating Expenses 177 244
Profit Before Interest, Depreciation & Tax: 20393 24209
Less: Interest 5171 8936
Depreciation 4475 3871
Profit Before Tax: 10747 11402
Less: Provision for Taxation - Current 3146 2401
Provision for Taxation - Deferred 590 554
Profit After Tax: 7011 8447
Add: Profit Brought Forward - Previous Year 23825 20911
Add: Prior Years Adjustments (9) (114)
Profit available for Appropriation: 30827 29244
Appropriations
Transfer to Debenture Redemption Reserve 2000 2000
Transfer to General Reserve 710 850
Interim Dividend 1381 1311
Proposed Dividend 537 884
Tax on Dividend 326 373
Balance carried to Balance Sheet 25873 23826
Earning Per Share (Basic & Diluted) (Rs.) 9.14 11.46
DIVIDEND
Your Company had declared and paid Interim Dividend of Rs. 1.80 ps. (@
36%) per share (of Rs. 5/- each). Your Directors are pleased to
recommend Final Dividend of Rs. 0.70 ps. (@ 14%) per share (of Rs.
5/-each) for the year 2009-10.The total amount of Dividend pay-out for
the year would be Rs. 19.18 Crores as compared to Rs. 21.95 Crores for
the previous year.
OPERATIONS
During the year under review, the Company had made Total Sales Income
of Rs. 1337.75 Crores as against Rs. 1535.75 Crores, due to reduction
in the average input costs in FY 09-10. While maintaining the growth
momentum in quantity terms, the Company has made the Operating Profit
Before Interest, Depreciation and Tax and Non-operating expenses of
over Rs. 200 Crores for the second consecutive year i.e. Rs. 205.69
Crores as compared to Rs. 244.52 Crores for the previous year. Likewise
the Profit Before Tax had again been over Rs. 100 Crores i.e. Rs.
107.47 Crores as compared to Rs. 114.01 Crores for the previous year.
The Company posted Profit After Tax & Deferred Tax of Rs. 70.11 Crores
as against Rs. 84.47 Crores for the previous year.
Similarly, the Companys consolidated Gross Income was at Rs. 1349.59
Crores as compared to Rs. 1550.02 Crores for the year 2008-09. The
Consolidated Profit After Tax & Deferred Tax was at Rs. 68.49 Crores as
against Rs. 87.07 Crores for the previous year. Consolidated EPS for
the year 2009-10 was at Rs. 10.73 ps. as against Rs. 12.84 ps. for the
year 2008-09. Further the share of profit from associates increased
from Rs. 13.09 Crores to Rs. 13.97 Crores in FY 2009-10.
EXPORTS
Due to the reduction in the input costs, the Exports for the Company
had been Rs. 522.17 Crores as against Rs,588.44 Crores in the previous
year.The Company expects to increase the exports by introduction of
newer products and volume growth in the existing products range.
CHEMICAL INDUSTRY - STRUCTURE AND DEVELOPMENT
The Chemical Industry in last one year has gone through the stages of
recovery & revival. While FMCG, and Pharma based products had a very
marginal or no impact of recession, the textiles & dyes, pigments and
polymers industries were the most affected by the slowdown. With the
recovery in the global markets, the demand for the products with
applications into Textiles, Automotives, Pigments, Paints, etc. is
expected to grow significantly.
OPPORTUNITIES, THREAT AND OUTLOOK
Over the last one year, the global economy has changed significantly.
Number of global majors have faced financials problems. This in fact,
has helped Asian companies to capture the demand gaps and increase
their volumes in these segments. Further, with the companies now
stabilizing and increasing their inventory norms from bare minimum to
optimum levels, prospects of better monsoon resulting in growth in
agrochemicals products and increase in the volumes in end user segments
of Polymers, Pigments, Textiles, etc., shall provide good growth
opportunities to the Company.
While the impact of global recession was comparatively lower in the
Indian markets, our currency remained vulnerable to the changes in the
global markets. Your Company has been closely monitoring these
movements and has taken appropriate actions, from time to time, to
hedge its currency risks.
During the year under review, Your Company has successfully
commissioned and commercialized the indigenously developed facilities
for manufacturing Nitro Toluenes and its various Derivatives developed
at its In-house R&D centre.This has added a new stream of Basic &
Speciality Products expanding Companys products range. The Toluene
based chemicals will have applications into end-user industries such as
Dyes, Pigments, Speciality Chemicals, Agrochemicals, etc., Further,
more products are under development and will be commercialized in due
course. While some of the products would serve as import substitutes,
some have a good potential in International markets. Your Company would
be pioneer to manufacture some of these products in India.
Your Company is also in the process of commissioning its upgraded
Hydrogenation Technology facilities, which would be put to commercial
use from 2nd quarter of 2010-2011. The upgraded technology would
significantly increase the production capability of existing range of
products and would also facilitate introduction of several new
Specialty Chemicals.
With the merger of erstwhile Surfactant Specialities Ltd. into Aarti
Industries Ltd. last year, your Company has added a stream of
Surfactants, Personal Care and Oral care products sourced by the major
FMCG companies in India. Your Company plans to increase its capacities
and range of products to cater to the growing demand of the FMCG
sector. With these rationales, your Company is in the process of
setting up a new unit at Pithampur, Madhya Pradesh for manufacturing
these products.The unit has certain strategic and logistical benefits
which would help strengthen its share in the domestic markets.
Your Company has posted a growth of around 17% in its Pharmaceuticals
Segment. During the year under review, the Company has also got
approval from US Food & Drug Administration for its units at Tarapur
and Vapi for new range of API products.The Company expect to increase
its volumes to the Regulated markets such as North American & Europe
markets and hence expects to break even in current financial year.
SEGMENT-WISE PERFORMANCE
(Rs. in Lakhs)
Sr. No. Particulars Financial Year Financial Year
2009-2010 2008-2009
(A) Primary Segments : Business
Segments Segment Revenue
a) Basic Chemicals 25,440 36,089
b) Specialty Chemicals 99,537 111,219
c) Agro Chemicals 5,391 5,857
d) Pharmaceuticals 11,792 10,025
Total 142,160 163,190
Less: Inter-segment Revenue 8,384 9,615
Net Sales / Incomes From
Operations 133,776 153,575
Segment Results
(Profit) (+) Loss (-) Before Tax
And Interest from each Segment
a) Basic Chemicals 5,682 7,468
b) Specialty Chemicals 14,045 15,647
c) Agro Chemicals 650 1,493
d) Pharmaceuticals (636) (1,027)
Total (A) 19,741 23,581
Less: Interest 5,171 8,936
Other Un-allocable Expenditure
Net of Income
3,823 3,244
Total (B) 8994 12,180
Total Profit Before Tax (A - B) 10,747 11,401
(B) Secondary Segment: Geographical Segments
a) India 84,784 95,359
b) Out of India 48,991 58,216
Total 133,775 153,575
Segment Capital Employed
Fixed Assets used in the Companys business or Liabilities contracted
have not been identified to any of the reportable segments, as the
Fixed Assets and services are used interchangeably between segments.
The Company believes that it is currently not practicable to provide
segment disclosures relating to capital employed.
RISKS AND CONCERNS
Fears of continuation of recession / double meltdown would impact the
pace of growth world over. Your Company perceives risks or concerns
common to industry such as regulatory risks, exchange risk, high
raw-material cost and other commercial & business related risks.
INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY
Your Company has clearly laid down policies, guidelines and procedures
that form part of internal control systems, which provide for automatic
checks and balances. Your Company has maintained a proper and adequate
system of internal controls. This is to ensure that all Assets are
safeguarded and protected against loss from unauthorized use or
disposition and that the transactions are authorised, recorded and
reported diligently. Your Companys internal control systems are
commensurate with the nature and size of its business operations. The
internal Auditors Reports are regularly reviewed by the Audit
Committee of the Board.
DIRECTORS RESPONSIBILITY STATEMENT
As required u/s. 217(2AA) of the Companies Act, 1956 (the Act):
(i) That in the preparation of the Annual Accounts for the Year ended
31 st March, 2010, the applicable Accounting Standards had been
followed along with proper explanation for material departures, if any;
(ii) That the Directors had selected such accounting policies and
applied them consistently and made judgments and estimates that are
reasonable and prudent so as to give a true and fair view of the state
of affairs of the Company at the end of the financial year of the
profit of the Company for that year;
(iii) That the Directors had taken proper and sufficient care for the
maintenance of adequate accounting records in accordance with the
provisions of the Act for safeguarding the Assets of the Company and
for preventing and detecting fraud and other irregularities;
(iv) That Directors have prepared the annual accounts on a going
concern basis.
SUBSIDIARY COMPANIES
On an application made by the Company under Section 212(8) of the
Companies Act, 1956, the Central Government vide letter dated 27th
April, 2010 exempted the Company from attaching a copy of the Balance
Sheet and the Profit and Loss Account of its Subsidiary Companies and
other documents required to be attached under Section 212(1) of the Act
to the Annual Report of the Company. Accordingly, the said documents
are not being attached with the Balance Sheet of the Company. A gist of
the financial performance of the Subsidiary Companies is contained in
the report.The Annual Accounts of the Subsidiary Companies are open for
inspection by any Member/Investor and the Company will make available
these documents/details upon request by any Member of the Company or to
any Investor of its Subsidiary Companies who may be interested in
obtaining the same. Further, the Annual Accounts of the Subsidiary
Companies will also be kept for inspection by any Investor at its
Registered Office of the Company and at the Head Offices of the
Subsidiary Company concerned.
FINANCIAL STATEMENTS
Your Directors have pleasure in presenting Consolidated Financial
Statements which form part of the Annual Report and Accounts.
DIRECTORS
In accordance with the provisions of the Companies Act, 1956, and the
Articles of Association of the Company, Shri Vijay H. Patil, Smt.
Hetal G. Gala, Shri Shantilal T. Shah, Shri Ramdas M. Gandhi and Shri
Haresh K. Chheda retire by rotation and being eligible, offer
themselves for re-appointment. A brief profile of the Directors
proposed to be appointed/re-appointed is given in the notice of the
ensuing Annual General Meeting.
CORPORATE GOVERNANCE
Your Company has complied with the mandatory Corporate Governance
requirements stipulated under Clause 49 of the Listing Agreement.
Report on Corporate Governance is annexed hereto forming part of this
report.
DISCLOSURE OF PARTICULARS
Information as per the requirements of Section 217(1)(e) of the
Companies Act, 1956, read with Rule 2 of Companies (Disclosure of
Particulars in the Report of Board of Directors) Rules, 1988, relating
to Conservation of Energy, Research & Development,Technology
Absorption, Foreign Exchange Earnings and Outgo are annexed hereto
forming part of this Report.
ENVIRONMENTAL, SAFETY AND HEALTH
Your Company is committed to ensure sound Safety, Health and
Environmental (SHE) performance related to its activities, products and
services. The Company is taking continuous steps and also developing
environment friendly processes for effective resource management with
specific focus to energy, water and basic raw materials. Monitoring and
periodic review of the designed SHE Management System is done on a
continuous basis.The Company is committed to strengthen pollution
prevention and waste abatement practices and strives to provide a safe
and healthy environment.
CORPORATE SOCIAL RESPONSIBILITY
As contribution towards community development to fulfill the Companys
obligations towards the society. Company organizes many activities on
regular basis including Blood Donation Camps, Health checkup camps,
etc. The Company has been donating to several Hospitals, educational
institutions, trusts, and contribution for area beautifications. The
Company also contributes for relief measures in times of natural
calamities. In parlance to the objective of providing basic primary and
secondary education in the surrounding areas, your company actively
contributes for the upgradation & infrastructure development of the
schools.
PERSONNEL
As required by the Provision of Section 217(2A) of the Companies Act,
1956, read with Companies (Particulars of Employees) Rules, 1975 as
amended up-to-date, the names and the other particulars of the
Employees are set out in the Annexure to the DirectorsReport. However,
as per the Provisions of Section 219(1)(b)(iv) of the Companies Act,
1956, the Reports and Accounts are being sent to all the Shareholders
of the Company excluding the aforesaid information. Any Shareholder
interested in obtaining such particulars may write to the Company
Secretary at the Registered Office of the Company.
AUDITORS
M/s. Parikh Joshi & Kothare, Auditors of the Company retire at the
ensuing AnnualGeneral Meeting and are eligible for reappointment.
Members are requested to appoint Auditors and to fix their
remuneration.
COST AUDITORS
The Report of Ms. Ketki Visariya, Cost Accountant, in respect of Audit
of the Cost Accounts of the Company will be submitted to the Central
Government in due course. She has been re-appointed as the Cost Auditor
of the Company subject to approval of the Government of India to
conduct Cost Audit of prescribed Chemicals manufactured by the Company
for the year 2010-11.
INDUSTRIAL RELATIONS & HUMAN RESOURCES
The Company enjoys co-ordial relations with its employees at all
levels. Your Company has continued to ensure safety and health of its
employees. Your Directors record their appreciation of the support and
co-operation of all employees and counts on them to maintain Companys
growth momentum.
ACKNOWLEDGEMENT
The Board of Directors places on record its sincere appreciation for
the dedicated services rendered by the employees of the Company at all
levels and the constructive co-operation extended by the staff. Your
Directors would like to express their grateful appreciation for the
assistance and support by all Government Authorities, Auditors,
financial institutions, banks, suppliers, other business associates and
last but not the least the Shareholders.
CAUTIONARY STATEMENT
Statement in the Annual Report describing the Companys objectives,
projections, expectations and estimates regarding future performance
may be "Forward Looking Statements"and are based on currently available
information.The Management believes these to be true to the best of its
knowledge at the time of preparation of this Report. However, these
statements are subject to certain future events and uncertainties,
which could cause actual results to differ materially from those which
may be indicated in such
statements.
For and on behalf of the Board
Sd/-
Place: Mumbai CHANDRAKANT V. GOGRI
Dated: 26th May, 2010 Chairman
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article